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v 	   Abstract 
The biogenesis of membrane proteins is an essential process in biology. It requires the 
protection of hydrophobic transmembrane domains from aggregation in the cytosol as 
well as targeting to the proper membrane. Tail-anchored (TA) proteins have a single 
transmembrane helix near their carboxyl termini and require a post-translational 
mechanism for targeting and insertion. In yeast, the Guided Entry of Tail-anchored 
proteins (GET) pathway delivers TA proteins to the endoplasmic reticulum (ER). A 
sorting complex comprising Get4, Get5, and Sgt2 load ER destined TA proteins onto the 
targeting factor Get3. X-ray crystallography, solution NMR, and small angle X-ray 
scattering were used to characterize this assembly. Get4 and Get5 form an extended 
adapter complex. Get4 maintains Get3 in a state competent to receive TA proteins. The 
N-terminus of Get5 tightly binds Get4, while the C-terminus of Get5 is a 
homodimerization domain, resulting in a heterotetrameric assembly. A ubiquitin-like 
domain within Get5 binds the heat-shock protein (HSP) co-chaperone Sgt2, providing a 
physical link between ER destined TA protein targeting and protein folding pathways. 
Sgt2 is also an extended homodimeric complex, and can directly bind four major classes 
of HSPs. The Get4/Get5/Sgt2 sorting complex is multivalent, flexible and the binding of 
individual components is transient. These results build a model for post-translational 
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1 	   Introduction 
The right place at the right time 
The living cell is complex enough that its internal workings effectively mirror human 
civilization. The cell needs to acquire scarce, raw materials from a harsh environment, 
transform them into useful building blocks, direct these products to specific destinations, 
protect itself from external and internal threats and deal with the waste that is generated 
during all of these events. This is only the surface, and the analogy can be carried much 
further. The issues we squabble over are the same issues the cell has been dealing with 
for billions of years. Admittedly, putting an appropriate perspective on the scope of 
biology requires some melodrama.  
However, treating the cell in this regard overlooks the remarkable fact that these struggles 
exist at all levels of organization in biology, from within individual cells to populations 
of cells, from tissues to organs to organisms, to communities, ecosystems, political states 
and nations. The reason the cell presents a unique area of study, though, is while higher 
levels can be explained by breaking them into their smaller biological constituents, the 
cell is a collection of chemicals guided by the most basic thermodynamic principles. It is 
the foundation, a battleground in understanding how the fundamental physical properties 
of the universe dictate life. Arguably the goal of biochemistry and molecular biophysics 
is to understand how actions occurring at the level of individual atoms and chemical 
bonds translate into biological responses. Aside from satisfying curiosity, this knowledge 
often has practical value in medicine and technology.  
	  	  
2 	  If the cell only obeys physical laws, what distinguishes the chemical reactions occurring 
within it from chemistry occurring outside of it? The most direct answer is control, and 
this can be further elaborated on. One aspect of control is temporal. The cell ultimately 
decides what chemical reactions can occur at any given time through its genetic 
programming. RNA and proteins are the encoded tools that perform these programs. The 
reactions that do occur, whether driven by environmental cues such as resource 
availability or physical stress, in turn dictate what genetic program to follow through 
transcriptional regulation. Coupled with intricate systems of protein modification and 
degradation, the cell can rapidly switch between the reactions it can perform.  
A second form of control is spatial. Certain sets of reactions require or produce 
compounds that are otherwise incompatible with the materials of other sets. In the violent 
example of phagocytosis, the indiscriminate proteases required to digest a consumed cell 
must be separated from the rest of the cellular environment of the predator. The cell 
satisfies these requirements through compartmentalization. It can be as deceptively 
simple as providing a membrane separating the inside the cell and the space immediately 
outside of it, as in bacteria. Or as in the case of eukaryotes, it consists of a suite of 
membrane-enclosed substructures called organelles, each performing drastically different 
chemistry. Membranes themselves additionally provide level of spatial control by 
restricting some chemistry to a two-dimensional surface. 
Two requirements arise from this simplistic model of biochemistry. Biomolecules must 
be synthesized with high fidelity at the proper time, and they must be directed to the 
proper location. For a major class of biomolecules, the proteins, the first process is 
	  	  
3 	  translation and folding, and the second process is known as targeting. For many 
eukaryotic proteins, the processes are streamlined by the secretory system. Proteins are 
synthesized in the cytosol by ribosomes, and then a single, generic marker directs them to 
the endoplasmic reticulum (ER). Once in the ER, additional specific markers further 
direct proteins to the various organelles through vesicular trafficking. The initial targeting 
event to the ER is performed concurrently with synthesis for the majority of proteins by 
the signal recognition particle pathway (reviewed in (Shan and Walter, 2005)).  
A co-translational pathway targets the majority of secretory proteins 
Proteins are synthesized by the ribosome reading a messenger RNA transcript. It is a 
linear process, with the nascent protein emerging into the environment one amino acid at 
a time in the encoded order. Relatively early in synthesis of secretory proteins, a stretch 
of residues called a signal peptide will become exposed (Blobel and Dobberstein, 1975). 
This sequence is recognized by the signal recognition particle (SRP), which binds to both 
the nascent protein and the surface of the translating ribosome (Walter and Blobel, 1981). 
The ribosome/SRP/nascent protein complex is captured by the ER-membrane associated 
SRP receptor (Gilmore et al., 1982). The ribosome and nascent protein are then 
transferred to a protein-conducting pore called the translocon (Simon and Blobel, 1991). 
As synthesis continues, the new protein passes through the translocon, unfolded, into the 
ER lumen. This process is called co-translational translocation. The system also can 
incorporate transmembrane proteins through a lateral gating mechanism, allowing the 
translocon to open into the plane of the membrane (Van den Berg et al., 2004). In this 
case, the first transmembrane helix can dually serve as a signal sequence and is 
	  	  
4 	  designated a signal anchor sequence. Once incorporated in the membrane, these proteins 
are trafficked through the same vesicular system as the soluble, luminal proteins. 
Transmembrane proteins serve innumerous roles in the cell, ranging from structural and 
mechanical functions to enzymes to environmental sensors. Unlike soluble proteins, a 
transmembrane protein is exposed to three distinct environments: two aqueous 
environments on either side of the membrane, and the lipidic membrane itself. This is 
reflected in the diversity of structure observed. A transmembrane protein may consist of a 
single membrane-spanning helix, or it may thread back and forth across the membrane 
with multiple membrane-spanning helices. The positions of soluble termini of the protein 
chain may be in the same or opposite membrane face. There is apparently limitless 
variation on the lengths of soluble terminal domains and the loops connecting 
transmembrane helices. 
The co-translational translocation pathway is remarkable because it can target and insert 
nearly all varieties of transmembrane proteins. There is one topologically restricted 
exception, however. If a single membrane-spanning helix is located near the carboxyl 
terminus of the nascent protein, the signal anchor sequence cannot bind the SRP because 
it sequestered within the ribosomal exit tunnel (Kutay et al., 1993). These proteins are 
called tail-anchored (TA) proteins and require post-translational targeting. 
The biogenesis of TA proteins utilizes a distinct pathway 
Post-translational targeting itself is not a rare process in biology. In the bacterial version 
of the secretory system, most secreted soluble proteins cross the cell membrane post-
translationally (reviewed in (Driessen and Nouwen, 2008)). A cytosolic motor protein 
	  	  
5 	  called SecA binds to the signal sequence, and using energy generated from ATP 
hydrolysis, pushes unfolded protein through the translocon. Although the SecA system is 
absent in eukaryotes, mitochondrial and chloroplast proteins are targeted through other 
post-translational systems. 
A post-translational targeting system specific to the ER that could accommodate TA 
proteins, however, proved more elusive to identify. Early investigation on synaptobrevin, 
a model TA protein involved in vesicle fusion (a SNARE protein), targeting to the ER 
required ATP hydrolysis, as well as unidentified ER membrane proteins distinct than the 
SRP/translocon machinery (Kutay et al., 1995). Some experimental evidence suggested 
that the SRP (Abell et al., 2004) or the chaperones Hsp40 and Hsp70 (Abell et al., 2007) 
can deliver TA proteins to the ER, although it is unclear how membrane insertion is 
performed by these routes, and how widely utilized they are as the data conflict with the 
earlier report (Kutay et al., 1995).  
A breakthrough in our understanding of TA proteins occurred in 2007. Using sucrose 
density gradient fractionation and chemical crosslinking of in vitro translation systems, a 
40 kDa ATPase was discovered to be the major protein associated with TA proteins in 
the soluble fraction of rabbit reticulocyte lysate (Favaloro et al., 2008; Stefanovic and 
Hegde, 2007). Designated TRC40, for Transmembrane domain Recognition Complex, 
this protein satisfies the postulated requirements for a targeting factor, including 
reversible binding to the ER membrane, and it can insert TA proteins when allowed to 
hydrolyze ATP. Prior to this discovery, the yeast homolog of TRC40, named Get3, was 
genetically linked to two membrane proteins, Get1 and Get2, and together appeared 
	  	  
6 	  significant for the recovery of ER resident proteins from the Golgi (Schuldiner et al., 
2005). After the characterization of TRC40, Get3 proved to perform an identical role in 
yeast, with Get1 and Get2 forming the proteinaceous ER components required for 
insertion (Schuldiner et al., 2008). Knockouts of Get1 or Get2 lead to cytosolic 
aggregates of TA protein and Get3; a Get3 knockout leads to diffuse cytosolic 
localization of TA proteins. In any of these knockouts, ER TA proteins begin to appear in 
the mitochondria.  
Get1, Get2 and Get3 were reassigned as TA protein targeting machinery, and the GET 
pathway was renamed for Guided Entry of Tail-anchored proteins (a full model of the 
pathway is presented in appendix Figure A.1). Shortly after, a genetic investigation of the 
unfolded protein response in the ER uncovered two more GET proteins (Jonikas et al., 
2009). Little was known about Get4, other than that it is a conserved eukaryotic protein 
(Fernandes et al., 2008). More information was available for Get5 (also annotated as 
Mdy2). Mdy2 deletion leads to mating deficiency in yeast, with reduction in shmoo 
formation (Hu et al., 2006). Get5 was also known to interact with Sgt2, a heat shock 
protein (HSP) co-chaperone (Liou et al., 2007). There was some data suggesting Get5 
also associates with the ribosome; however this interaction was destabilized by relatively 
low salt concentration (Fleischer et al., 2006). In our own investigations, we found no 
convincing evidence that Get4 or Get5 are ribosome-associated proteins. Regardless, 
Get4 and Get5 were postulated as acting upstream of Get3. Confirmation of a role for 
Sgt2 in TA protein targeting came through further genetic analysis, where it was shown 
that deletion of the gene resulted in a similar phenotype to other GET pathway members 
(Costanzo et al., 2010). A quantitative analysis of existing double-knockout phenotype 
	  	  
7 	  data proposed a linear “activity pathway” of Sgt2 followed by Get5, Get4 and finally 
Get3 (Battle et al., 2010). 
By this point in time several structures of Get4 were available, including one from our 
laboratory (Bozkurt et al., 2010; Chang et al., 2010; Chartron et al., 2010). We 
characterized the Get4/Get5 complex in solution and showed that Get4 could bind Get3. 
These data led us to propose that Get4 somehow regulated Get3 prior to TA protein 
recognition, and Sgt2 and its associated chaperones either aided or branched to an 
alternate pathway. Concurrent to our structural work, Vladimir Denic’s group provided 
direct experimental evidence for functions for Sgt2, Get4 and Get5 in TA protein 
targeting (Wang et al., 2010). Both Get4 and Get5 are required for efficient loading of 
TA proteins to Get3. Moreover, the C-terminal domain of Sgt2 is shown to directly bind 
the transmembrane domain of TA proteins. Amazingly, Sgt2 only seems to bind ER 
destined TA proteins as opposed to mitochondrial TA proteins, which can be bound to 
HSPs. ER proteins typically have shorter, more hydrophobic transmembrane domains and 
a mechanism for this discrimination remains an exciting question to be answered. From 
all this data, it appears that Get4 and Get5 form an adaptor complex that links Sgt2 and 
Get3, a broad HSP co-chaperone to a dedicated ER targeting factor. 
Meanwhile, the story became more complicated in the mammalian system. A complex 
acting upstream of TRC40 was discovered, and it does contain homologs of Get4 and 
Get5, named TRC35 and Ubl4A respectively (Leznicki et al., 2010; Mariappan et al., 
2010). However, it additionally contains a large, ~1100 amino acid protein named Bag-6 
(alternatively named Bat-3 or Scythe). This complex has an additional role in selecting 
	  	  
8 	  protein substrates for ubiquitin-mediated degradation. These substrates may either be 
misfolded or mislocalized proteins as well as ER associated degradation (ERAD) 
retrotranslocated substrates (Hessa et al., 2011; Minami et al., 2010; Wang et al., 2011). 
SGTA, the human homolog of Sgt2, appears to have a direct role in handling substrates 
for both pathways and it will be exciting to determine the full interplay between targeting 
and quality control (Xu et al., 2012). Differences between fungal and mammalian 
homologs will be discussed throughout. 
The GET pathway has proven fertile for structural biologists. Its attractiveness stemmed 
from the novel and important functions it performed, and that many components had no 
apparent homology to known proteins structures. It was also practical that many pathway 
members were soluble proteins. Christian Suloway spearheaded the efforts within our 
laboratory, determining the X-ray crystal structure of Get3 from S. cerevisiae and the 
filamentus fungus Aspergillus fumigatus (Suloway et al., 2009). I became involved by 
aiding the refinement and analysis of these structures. Within five months, four other 
reports of the Get3 structure were published (Bozkurt et al., 2009; Hu et al., 2009; Mateja 
et al., 2009; Yamagata et al., 2010). The structure and function of Get3 are the topics of 
Christian’s thesis. A summary of Get3, models for its function and phylogenetic insights 
are provided in the appendix. The work presented as chapters here focuses on the 
complex composed by Get4, Get5, Sgt2 and various cellular chaperones. 
Chapter 1 describes the initial structural analysis of the Get4 and Get5 proteins. A crystal 
structure of the majority of Get4 and the N-terminal domain of Get5 is presented. We 
identified the C-terminal domain of Get5 as a homodimerization domain and provided the 
	  	  
9 	  first characterization of the binding interface between Get4 and Get3. The Get5 
homodimerization domain becomes the topic of chapter 2, where we determined a crystal 
structure and a solution NMR structure of the domain as well as a NMR structure of a 
homolog. Chapter 3 shifts focus to Sgt2, where a crystal structure of the HSP-binding 
TPR domain is presented from a fungal homolog. The structure gives insight into the 
relatively promiscuous binding of the domain. We further characterize Sgt2 using small-
angle X-ray scattering. Chapter 4 ties the earlier chapters together and investigates the 
interaction between Sgt2 and the Get4/Get5 complex. Solution NMR and crystal 
structures are presented for the homodimerization domain of Sgt2 and the human 
homolog SGTA, as well as for the ubiquitin-like domain of Get5. NMR is further used to 
determine the structure of the complex between Sgt2 and Get5. Chapter 4 closes this 





STRUCTURAL CHARACTERIZATION OF THE GET4/GET5 COMPLEX AND ITS 
INTERACTION WITH GET3 
Abstract 
The recently elucidated Get proteins are responsible for the targeted delivery of the 
majority of tail-anchored (TA) proteins to the endoplasmic reticulum. Get4 and Get5 
have been identified in the early steps of the pathway mediating TA substrate delivery to 
the cytoplasmic targeting factor Get3. Here we report a crystal structure of Get4 and an 
N-terminal fragment of Get5 from Saccharomyces cerevisae. We show Get4 and Get5 
(Get4/5) form an intimate complex that exists as a dimer (two copies of Get4/5) mediated 
by the C-terminus of Get5. We further demonstrate that Get3 specifically binds to a 
conserved surface on Get4 in a nucleotide dependent manner. This work provides further 
evidence for a model in which Get4/5 operates upstream of Get3 and mediates the 
specific delivery of a TA substrate. 
Adapted from 
Chartron, J.W., Suloway, C.J., Zaslaver, M., and Clemons, W.M., Jr. (2010). Structural 
characterization of the Get4/Get5 complex and its interaction with Get3. Proc. Natl. 




Targeted delivery of membrane proteins is a critical process. For a special class of 
membrane proteins, tail-anchored (TA) proteins, the targeting pathways have only 
recently begun to be understood. These proteins are a large and diverse class of integral 
membrane proteins found in all organisms. Examples include SNAREs, apoptosis factors, 
and protein translocation components. TA proteins are characterized by having a single 
transmembrane helix (TM) at their extreme C-terminus. Due to this topological 
constraint, these proteins are not able to follow the signal recognition particle (SRP) 
dependent cotranslational pathway that typifies most integral membrane proteins. Instead, 
these proteins must find their correct membrane for insertion post-translationally 
(Borgese et al., 2007; Kutay et al., 1995; Kutay et al., 1993; Rabu et al., 2009). 
The newly characterized GET pathway (Guided Entry of Tail-anchored proteins) is the 
major targeting pathway for TA proteins in yeast. The first protein identified to 
specifically recognize a TA protein substrate is the ATPase Get3, which protects TA 
proteins in the cytoplasm and targets them to the endoplasmic reticulum (Favaloro et al., 
2008; Jonikas et al., 2009; Schuldiner et al., 2005; Schuldiner et al., 2008; Stefanovic and 
Hegde, 2007). Deletions of this protein lead to mistargeting of TA proteins and growth 
sensitivity in a variety of conditions (Hillenmeyer et al., 2008; Jonikas et al., 2009). 
Recently, a number of structural studies of Get3 have led to the model where Get3 
undergoes a dramatic conformational change upon nucleotide binding shifting from an 
open to a closed form and generating a TM binding pocket (Bozkurt et al., 2009; Hu et 
al., 2009; Mateja et al., 2009; Suloway et al., 2009; Yamagata et al., 2010)
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many structures, the precise mechanism of how Get3 binds and releases substrate is not 
fully understood. At the ER, the Get3 TA protein complex binds two integral membrane 
proteins, Get1 and Get2, that are thought to act as receptors for the release of the protein 
substrate (Schuldiner et al., 2008). Upstream of Get3 are two proteins, Get4 and Get5 that 
are the subjects of this study. 
Get4 [yeast locus Yor164c, human locus C7orf20 and cee in fish (Fernandes et al., 2008)] 
is a highly conserved protein that is estimated to have arisen early in evolution (Figure 
1.1A) (Fernandes et al., 2008). Its high homology, 26% identity from yeast to humans, 
belies the fact that until recently very little was known about its biological role. It 
contains no known motifs and has only been annotated based on a series of genome-wide 
screens. Get4 localizes to the cytoplasm (Huh et al., 2003) and, although not essential, 
knockouts in yeast lead to sensitivity in a number of growth conditions (Giaever et al., 
2002) whereas disruption of the homologue in Caenorhabditis elegans retards growth 
(Kamath et al., 2003; Simmer et al., 2003). Multiple protein interaction studies in yeast 
have implicated Get4 in binding to Get5 and Get3 and associating with Sgt2 and Hsp90-
like proteins (Costanzo et al., 2010; Fleischer et al., 2006; Ito et al., 2001; Krogan et al., 
2006; McClellan et al., 2007). 
Get5/Mdy2 [yeast locus Yol111c, known as GdX/Ubl4a in mammals (Hu et al., 2006)] is 
a multidomain protein (Figure 1.1B). The N-terminal domain (Get5-N) is found only in 
fungi where it is conserved. Following that is a ubiquitin-like domain (Get5-Ubl) 
(Toniolo et al., 1988) and a C-terminal domain (Get5-C). Get5 was originally annotated 









most yeast proteins that contain a Ubl, Get5 does not interact with polyubiquinated 
proteins nor does it bind the 26S proteasome (Saeki et al., 2002). A biochemical and 
genetic study linked Get5 to both Sgt2, a tetratricopeptide repeat (TPR) containing 
protein (D'Andrea and Regan, 2003), and to Ydj1, a J-domain containing Hsp40 
homologue that interacts with the cytosolic Hsp70 homologues Ssa1p/Ssa2p (Liou et al., 
2007).1 
Genomic screens suggest that Get4 and Get5 form a stable complex (referred to here as 
Get4/5). Using epistatic arrays and biochemistry, Jonikas et al. showed that these two 
proteins were also involved in the GET pathway (Jonikas et al., 2009). These proteins 
operated upstream of Get3 and, based on a study where Get5 was found bound the 
ribosome (Fleischer et al., 2006), it was suggested that these proteins acted as the 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Figure 1.1. Sequence alignments of Get4 and Get5. (A) Sequences of Get4 were 
aligned using ClustalX (Larkin et al., 2007). Residue coloring is based on the program 
output (amino acid type). Species in order are Scer (Saccharomyces cerevisiae), Afum 
(Aspergillus fumigatus), Spom (Schizosaccharomyces pombe), Atha (Arabidopsis 
thaliana), Cele (Caenorhabditis elegans), Xlae (Xenopus laevis), Hsap (Homo sapiens), 
and Dmel (Drosophila melanogaster). Numbering above the sequences is based on S. 
cerevisiae, with residues observed in the crystal structure in black and residues absent in 
red. Mutants generated for this study are indicated above the numbering, with double 
mutants connected with bars, and are highlighted based on wild type (cyan), weak 
(yellow) or weakest (red) interactions with Get3. Secondary structure is shown on top 
with helices indicated by boxes and β-strands by arrows color ramped to match Figure 
1B. (B) Alignment of Get5. Species in order are Scer (Saccharomyces cerevisiae), Agos 
(Ashbya gossypii), Calb (Candida albicans), Dhan (Debaryomyces hansenii), Ppas 
(Pichia pastoris), Afum (Aspergillus fumigatus), Drer (Danio rerio), Dmel (Drosophila 
melanogaster), and Hsap (Homo sapiens). Secondary structure in the N-domain is from 
the crystal structure, whereas secondary structure of the Ubl-domain is based on the 
NMR structure of human Ubl4A (PDB ID code 2DZI). Residues 179–205 are predicted 
to be helical and are colored cyan. The arrow above residue 148 indicates the start of the 
C-domain peptide observed during purications. I44 and K48 labeled vertically above the 
Ubl-domain designation refer to residues in ubiquitin specically addressed in the text. 
The L120A/K120A mutant is indicated in yellow representing a moderate growth defect. 	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ribosome receptor for Get3. Kar2p, a resident ER protein, is secreted in mutants defective 
in TA targeting. A screen for these mutants confirmed Get4 and Get5 as part of the GET 
pathway (Copic et al., 2009). 
During the preparation of this manuscript the first structure of yeast Get4 and a fragment 
of Get5, generated from unintended proteolysis, was published (Chang et al., 2010). The 
authors used two-hybrid screens to explore general interactions of Get4/5 implicating 
Sgt2 and Ydj1 binding to Get5 and Get3 binding to the N-terminal half of Get4. A second 
structure of Get4 alone from Chaetomium thermophilumhas also been published (Bozkurt 
et al., 2010). 
Here we report an independent structure of Get4 with an N-terminal fragment of Get5 
(Get4/5-N) in a unique crystal form. Using the structure as a guide, we show that the full-
length Get4/5 complex exists as a dimer (two copies of Get4/5) and identify important 
functional residues and the binding interface with Get3. Our results further define the 
structural elements of Get4/5 and provide strong evidence for the current model that has 
Get4 and Get5 acting as upstream factors of Get3 in the Get targeting pathway. 
Results 
Purification and structure determination of Get4/5-N 
Full-length Get4/5 was expressed in Escherichia coli and purified using affinity 
chromatography. We were able to express Get4 alone; however, all of the protein went 
into inclusion bodies in all tested expression conditions. Further purification of Get4/5 
by anion exchange chromatography resulted in two separate peaks. These peaks were 
stable and were injected onto a size exclusion column where they both ran separately 
	  	  
17 
and larger than expected based on molecular weight (see below). Both failed to 
crystallize. 
To address the possibility that disorder might have prevented crystallization, we 
performed in situ proteolysis by including protease in the crystallization trials. Crystals 
grew quickly using chymotrypsin and contained nearly full-length Get4 and the N-
terminal third of Get5 (Get4/5-N). To improve crystallization, we performed limited 
proteolysis (Figure 1.2A) and then purified Get4/5-N by ion exchange chromatography 
(Figure 1.2B,C). Initial crystals were hexameric rods with reproducible twists halfway 
down their length that did not diffract. We found that several additives containing amines 
generated trigonal crystals. The final crystals grew using L-proline as an additive and 
diffracted to 2.8 Å (Figure 1.2D). 
The structure was solved using seleno-methionine, single wavelength anomalous 
dispersion (SAD) phasing and 3-fold noncrystallographic symmetry. The final structure 
contained three almost identical Get4/5-N in the asymmetric unit, main-chain r.m.s.d. of 
approximately 0.6 Å (Figure 1.3C). The most complete Get4/5-N model contains nearly 
all of Get4, residues 9-299, and the N-terminus of Get5, residues 3–56 (Figure 1.3A). The 
structure refined to an Rfactor of 18.2% and an Rfree of 22.4%. Crystallographic statistics 




Figure 1.2. Proteolysis, purication, and crystallization. (A) Chymotrypsin is added to 
Ni-NTA anity puried Get4/5 on ice with aliquots removed at the indicated time points in 
hours and separated by SDS-PAGE. “Full” represents dimeric Get4/5 prior to the 
addition of enzyme. The identities of the Get4-Xtal, Get5-Ubl-C and Get5-N bands were 
confirmed by tryptic digest followed by LC/MS. The 1 h time point, indicated with an 
asterisk, represents the degree of digestion used for further purication (B) Anion 
exchange chromatogram of Get4/5 after digest by chymotrypsin using a 30–130 mM 
NaCl gradient. Conductivity is plotted as the red trace and A280 as the blue trace. The 
numbers above peaks represent lanes in C. (D) Representative crystals of Get4/5-N. 
Crystals are grown in 17% PEG 6000, 0.14 M ammonium sulfate, 0.1 M Bis-tris pH 5.5 
with the following additives: None, 10 mM spermidine, 10 mM sarcosine, 10 mM 
Trimethylamine-HCL, or 10 mM L-proline. 
	  	  
19 
Description of the Structure of the Get4/5-N Complex  
Get4, which has no predicted sequence motifs, is essentially two rectangular blocks 
formed by right-handed α-helical coils that can be divided into N-terminal and C-
terminal domains (N-domain and C-domain) (Figure 1.3B). The N-domain consists of 
the first 7 helices that are similar in length and are reminiscent of the TPR motif 
(D'Andrea and Regan, 2003). Unlike this motif, they do not contain an obvious internal 
consensus nor exhibit any curvature, a common feature of helical repeats. The C-domain 
continues with right-handed helical coils; however, the helix and loop lengths are more 
diverse. The loop between helices α11 and α12 is formed by two β-strands (β-tongue). 
The helix α13 makes a sharp turn into helix α14 that then bends to form helix α15 
generating a U shape.  
Get5-N forms an extended peptide that wraps tightly around the C-domain of Get4 
(Figure 1.4). It begins with a helix that docks in a groove formed by helices α12, α13, 
and the β-tongue of Get4 (Figure 1.3A). Outside of the conserved hydrophobic 
interactions of the helix, the rest of Get5-N forms relatively few specific interactions to 
Get4 (Figure 1.4). The helix is followed by an extended, highly ordered loop that follows 
a groove contacting the loops formed by α12/α13, α10/α11, and α8/α9 in Get4 via 
backbone contacts. Comparing the structure to sequence conservation, the lengths of 
these Get4 loops are highly conserved implying that this platform is important in higher 
eukaryotes as well. The rest of Get5-N follows a groove formed by α8, α10, and α15 and 
then finally contacting the loop between α7/α8 of Get4. α8 is bookended by Get5-N and 






Figure 1.3. The structure of Get4/5-N. (A) Top view of Get4/5-N with Get4 color-
ramped from N- (blue) to C-terminus (red) and Get5-N shown in magenta. Secondary 
structure elements are labeled as in Figure 1.1. (B) Side view relative to (A) with N- and 
C-domains indicated. (C) The asymmetric unit with each chain colored individually and 
labeled as in the deposited coordinates. (D) A cartoon of the structure based on (B). The 








Figure 1.4. Binding of Get5-N. Get4 is shown as an accessible surface colored from 
positive (blue) to negative (red) Coulombic charge in an orientation similar to Figure 
1.1A. Get5-N is shown as sticks in magenta with residues that are conserved making 
specific contacts in yellow.form helix α15 generating a U shape. The C-terminus forms 
an extended peptide that docks against a neighboring molecule. 
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Comparison to Other Get4 and Get5-N Structures 
When the three molecules in our asymmetric unit are aligned based on their N-domain 
there is a clear twist in Get4 at α7/α8 that results in a relative bend in the C-domain. The 
greatest difference is between the A molecule and the C molecule with a relative rotation 
of about 5° and a maximal shift of about 4 Å (Figure 1.5A). In the Get4/5-N structure by 
Chang et al., there is very little difference between the four molecules in their 
asymmetric unit [Protein Data Bank (PDB) ID code 2 wpv] (Figure 1.5B) (Chang et al., 
2010). When aligned individually relative to our structure, there are no major differences 
in the overall fold of the N-domain (Figure 1.5B) or the C-domain (Figure 1.5C); 
however, there is a larger twist between the two domains that results in a 10° rotation 
and a 6 Å shift (Figure 1.5B). Part of this rotation is taken up by a shift in α10 (Figure 
1.5C).  Other differences are extensions of most of the termini in the structure reported 
here. The structure of Get4 reported by Bozkurt et al. shows the conservation of the 
overall fold of Get4 and appears to be in a conformation similar to our A molecule; 
however, there are some significant distortions, presumably the result of the missing 
Get5-N (PDB ID code 3lpz) (Figure 1.5D) (Bozkurt et al., 2010). 
Surface Features of Get4 
As noted, based on sequence the overall fold of Get4 appears to be conserved across 
eukaryotes excluding the β-tongue (Figure 1.1A). The internal fold accounts for the 
majority of the highly conserved residues. Only two surfaces at the ends of the molecule 
have a high level of conservation (Figure 1.6A). The C-domain conserved surface 





The largest conserved surface is the N-domain face (Figure 1.6A). The overall surface of 
Get4/5-N is acidic with a single basic patch directly correlating to the conserved face of 
the Get4 N-domain (Figure 1.6B).2 
Dimerization 
As stated above, Get4/5 eluted as two peaks by ion exchange chromatography. Each 
peak ran anomalously large on a size exclusion column in the expected size range of 4–8 
copies relative to typical globular proteins (Figure 1.7A, blue trace). We confirmed that 
the lower molecular weight peak corresponded to a single copy of Get4/5 and the higher 
molecular weight peak to two copies of Get4/5 by multiangle light scattering (MALS) 
(Figure 1.8A). We refer to these two forms as the “monomer” and dimer in the rest of 
the text. We noted that the dimer peak was stable while the monomer peak partially 
converted to the dimer peak over time. These results suggest that the proteins have 
exaggerated hydrodynamic properties relative to what would be predicted based on 
molecular weight. 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Figure 1.5. Comparison to other crystal structures. All views are from the bottom of 
Get4/5-N relative to figure 1.1A. (A) Aligning the three molecules in the asymmetric unit 
relative to the first six helices in molecule A. The molecules are colored the same as in 
figure 1.1C. The rotation relative to the domains is indicated. (B) Similar to (A) with the 
A/B molecule colored N-domain (blue), C-domain (red), and Get5-N (magenta). The four 
molecules in the asymmetric unit of Chang et al. (1 wpv) are aligned to the N-domain as 
in (A) colored by Get4 (green) and Get5-N (cyan). (C) Similar to (B) but molecules 1 
wpv-A/B are aligned to the C-domain. The shifted α10 is indicated. (D) The Bozkurt et 
al. (3lpz) Get4 (green) aligned to the A molecule N-domain. Included are a C-terminal 




Figure 1.6. Surface conservation and charge. (A) Get4 shown as an accessible surface 
and Get5-N as a ribbon colored from most (orange) to least (purple) conserved. The 
fungal specific β-tongue is shown as a cyan ribbon. (B) As in A with the total accessible 






Analyzing the sequence features of Get5, there are two probable flexible loops 
connecting the Ubl to the N- and C-domains that could account for the larger radius. 
Addition of chymotrypsin to either monomer or dimer immediately cleaved the loop 
between Get5-N and the Get5-Ubl-C fragment; however, the loop connecting to the C-
domain was resistant to cleavage (Figure 1.2A). When this proteolyzed mix was run on 
the size exclusion column the peak shifted dramatically to a much smaller size with a 
small shoulder that eluted earlier (Figure 1.7A, cyan trace). The two dominant proteolysis 
fragments, Get4/5-N and Get5-Ubl-C, could be purified by ion exchange chromatography 
(Figure 1.2B,C). When these fragments were run on the size exclusion column Get4/5-N 
(Figure 1.7A, red trace) corresponded to the bulk of the proteolysis peak and Get5-Ubl-C 
was the leading shoulder (purple trace). These peaks were clearly resolved; therefore, 
Get4/5-N does not form a stable complex with Get5-Ubl-C. The estimated extinction 
coefficient is much lower for Get5-Ubl-C and the smaller leading shoulder in the protease 
fragment reflects this (cyan trace). Get5-Ubl-C (15.9 kDa), a dimer by MALS, ran 
anomalously large on the sizing column even ahead of the larger Get4/5-N (40 kDa) 
(Figure 1.7A) This implies a model that involves dimerization of Get4/5 by the Get5-Ubl-
C fragment (Figure 1.7B).3  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Figure 1.7. Dimerization by Get5-C. (A) Size exclusion chromatograms from various 
constructs of Get4/5 after affinity purification. “Chym” represents Get4/5 after a 15-
minute chymotrypsin digest. The absorbances are normalized to the highest recorded 
value. The dimer and monomer peaks for full-length Get4/5 are indicated. (B) Cartoon of 
the Get4/5 dimerization by Get5-C. Constructs used in A and C are indicated by colored 
boxes. (C) Domain swapping by dimerization. His-tagged proteins, indicated by “h”, with 
and without Get5-C are mixed with untagged protein containing Get5-C for 0 and 12 h. 	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The mass of the Get4/5 monomer peak by MALS was approximately 8 kDa larger than 
that predicted for Get4/5 and contained a small peptide in the range of 7 kDa (Figure 1.8). 
We tested the peptide by mass spectrometry and N-terminal sequencing and determined 
that it corresponded to an internal start site at the single methionine in our Get5 construct; 
i.e., it was an expressed Get5-C domain. The extra C-domain in the monomer prevented 
dimer formation with full-length Get4/5 leading to the conclusion that this domain was 
involved in dimerization. To further explore this we expressed and purified the additional 
constructs of Get5-Ubl-C, Get4/5-ΔC and Get5-Ubl (Figure 1.7B). The constructs 
without C-domains both ran as monomers as predicted (green and orange traces, 
respectively). Get5-Ubl-C behaved similarly to the cleaved Get5-Ubl-C fragment and we 
again detected a fraction of the protein bound to a Get5-C peptide similar to the full-
length monomer (Figure 1.8B). Get5-C, including its disordered loop, is found in all 
eukaryotes and in yeast the sequence of its C-terminal helical region is consistent with a 
possible coiled-coil, as predicted by COILS (Lupas et al., 1991).We hypothesized that 
two different constructs of Get4/5 may exchange their C-domains to form mixed Get4/5 
dimers. To test this, various constructs of Get4/5 (Figure 1.9A) were mixed with full-
length Get4/5 and the products were analyzed after a 12 h incubation (Figure 1.7C). An 
affinity tagged Get4/5-ΔC was unable to capture a full-length Get4/5 after 12 h (lane 2 
compared to lane 1); however, Get5-Ubl-C was able to capture Get4/5 (lane 4) and 
Get4/5 could capture Get5-Ubl-C (lane 8). Get5-Ubl alone was unable to capture Get4/5 
(lane 6). These results verify that the C-domain was responsible for Get4/5 dimerization 




Figure 1.8. Multiangle light scattering. (A) Overlay of size exclusion chromatograms 
using a Shodex KW 803 column. Traces represent UV absorbance (left axis). For each 
peak, molecular weight as determined using multiangle light scattering and refractive 
index is plotted (right axis). (B) Coomassie-stained SDS-PAGE of samples used in (A).
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A coiled-coil prediction for the Get5 C-terminal region was found in higher eukaryotes 
but was not seen in all fungi. An example is Aspergillus fumigatus Get4/5, and we 
wanted to see if Get4/5 formed a dimer in this species. By MALS, the purified full-
length AfGet4/5 corresponded to a stable dimer (Figure 1.8A). We never detected a 
monomer fraction for this species nor did we ever see the equivalent of the Get5-C 
fragment (Figure 1.8B). To confirm dimerization by the C-domain, we 
generated AfGet4/5 constructs with the C-domain removed (Af4/5-ΔC) and the Get5 Ubl-
C-domain alone (Af5-Ubl-C). All three Af constructs behaved the same as 
their Sc equivalents on a size exclusion column (Figure 1.10A,B). Additionally, 
the Af constructs were able to exchange based on the presence of the C-domain (Figure 
1.10C lanes 1-10). Not surprisingly, the Sc5-Ubl-C was not able to swap with the Af5-
Ubl-C confirming that dimerization is conserved independent of sequence (Figure 1.10C, 
lanes 13 and 14). 
In Vitro Interaction of Get4/5 and Get3 
 Previous studies have demonstrated that Get4/5 can form a complex with Get3; 
however, these studies did not address the specifics of the interaction nor did they 
address the role of nucleotide in binding (Jonikas et al., 2009; Yu et al., 2008). We 
further explored this interaction using purified components. Initially, an affinity-his-
tagged Get4/5 was used to test the binding of Get3 (Figure 1.11A) Using Ni-affinity 
beads, very little Get3 could be captured by Get4/5 when mixed in the absence of 
nucleotide (lane 2). The addition of ADP (lane 3) or ATP (lane 4) dramatically increased 




Figure 1.9. Mutant purification. (A) Coomassie-stained SDS-PAGE of various puried 
Get4/5 constructs. Get4/5 Chym is the result of a 15 minute room temperature 
chymotrypsin digest. Get4/5-N Frag and Get5-UblC Frag are purified from the 
chymotrypsin digest using anion exchange chromatography as in Figure 1.2B. Get4-h/ 5-
C, Get5-UblC, and Get5-Ubl are generated at the genetic level. (B) Cartoon diagram of 
Get4/5 dimer with constructs boxed and colored as in A. (C) Size exclusion 
chromatograms of mutants of Get4/5 using a Superdex 200 10/300 column. The 






Figure 1.10. Dimerization of AfGet4/5 by Get5-C. (A) Size exclusion chromatograms 
of constructs of Get4/5 from Sc, as in Figure 1.9A, and Af (dashed lines). The 
absorbances are normalized to the highest recorded value. (B) Cartoon of constructs used 
in (A) indicated by colored boxes. (C) Domain swapping by dimerization. His-tagged 
proteins, indicated by “h,” with and without Get5-C are mixed with untagged protein 
containing Get5-C for 0 and 12 h. Respective Af and Sc constructs are indicated. 
Asterisks (*) represent expected bands for successful capture. 
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open form (Hu et al., 2009; Mateja et al., 2009; Suloway et al., 2009); however, 
structures of Get3 adopt both open and closed forms in the presence of nucleotide 
(Bozkurt et al., 2009; Mateja et al., 2009; Suloway et al., 2009). The fact that binding is 
enhanced by nucleotide would imply that nucleotide has shifted the equilibrium from the 
open to the closed form, and it is the closed form that is recognized by Get4/5. Get3 was 
able to capture Get4/5 (lane 6) but this was not enhanced by nucleotide (lanes 7 and 8). 
Our Get3 has an N-terminal affinity tag, and binding this to beads may also shift the 
equilibrium to the closed form. Get3 captured only Get4/5-N from our proteolyzed pool 
and not Get5-Ubl-C (lane 9); therefore, Get3 binds specifically to Get4/5-N. 
Based on these results, we searched for mutants that would affect Get4/5 binding to Get3. 
The most conserved surface of Get4 is on the N-terminus where there is a patch of highly 
conserved positive residues (Figure 1.6). To evaluate potential effects of these charged 
residues in the Get3 interaction, we mutated pairs of positive charges to aspartates to 
fully disrupt possible interfaces (K12D/K15D, R19D/K23D, H33D/R37D, and 
R42D/R45D). In addition, to rule out the general effects of charge swapping, we 
generated another pair of mutants of unconserved residues (K65D/K67D) as a control. 
Finally, we mutated the highly conserved Tyr 29, Tyr 30, and Glu 31 to alanines 
(YYE/AAA) (Fernandes et al., 2008). All of these mutants were purified and behaved 
similar to wild type on a size exclusion column (Figure 1.9C).  
The purified mutants were mixed with Get3 and captured using Ni-affinity beads. All of 
the conserved mutants showed a significant loss in the ability to capture Get3 (Figure 





captured Get3 at a markedly reduced level. As expected, Get5-Ubl-C was unable to 
capture Get3 (lane 8). By reversing the experiment we saw the same pattern of mutant 
Get4/5 capture by Get3 (Figure 1.11C, lanes 2–7). These results center the binding of 
Get3 to the positive N-terminal face of Get4 (Figure 1.11D and Figure 1.12A,B).4  
In our previous study of Get3, we had mutated a number of conserved Get3 surface 
residues that were unable to rescue a Δget3 knockout (Suloway et al., 2009). These 
residues could not be explained by contacts in the Get3 dimer in either the open or closed 
state and many localized to a negative surface (Figure 1.12C–E). We tested several for 
Get4 binding by alanine mutation (Y250, E253, E258, D265, and K297). All of the 
mutants expressed well and behaved similar to wild type on the size exclusion column 
(Figure 1.9D). When wild type Get4/5 was used to capture the Get3 mutants only two 
(Y250A and E253A) showed a significant decrease in binding (Figure 1.11B, lanes 9–13 
compared to 1). These two mutants are near the interface of the Get3 dimer and 
presumably destabilize the closed state (Figure 1.11E). All of the Get3 mutants were able 
to capture Get4/5 (Figure 1.11C, lanes 8–12). The bead bound Get3 is less sensitive to 
nucleotide; therefore, the closed form may be favored despite the mutants. 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Figure 1.11. Binding of Get4/5 to Get3. (A) Tagged wild type Get4/5 and Get3 are 
incubated for 2 h at room temperature then bound to Ni-beads. “D” represents incubation 
in the presence of 2 mM ADP-Mg2+, and “T” in the presence of 2 mM ATP-Mg2+. (B) 
His-tagged Get4/5 and Get3 mutants are incubated in the presence of 2 mM ADP-
Mg2+ as in (A). The YYE/AAA Get4 mutant lacks a TEV cleavage site and is slightly 
smaller than the other tagged mutants. (C) As in (B), using his-tagged Get3. (D) View 
from the N-terminal face of Get4. Mutated residues are displayed as spheres with carbons 
and labels colored based on wild type level (cyan), weak (yellow), or weakest (red) 
interactions with Get3. (E) The closed state of Get3 (PDB ID code 2WOJ) with mutated 




Figure 1.12. Mutants on Get4 and Get3. (A) View from the N-terminal face of Get4 as 
an accessible surface colored from positive (blue) to negative (red) Coulombic charge. 
(B) Side view of Get4/5 as in Figure 1.3B. The mutants used in Figure 1.11B,C are 
displayed as spheres as colored based on wild type (cyan), weak (yellow), or weakest 
(red) binding to Get3 as in Figure 1.11D. (C) Get3 similar to (A) in the closed state (PDB 
ID code 2WOJ) (D) Ribbon diagram of the closed state of Get3 with mutants that had 
previously been shown to have strong phenotypes as spheres. Tested mutants are colored 
as in Figure 1.11E. (E) Ribbon diagram of the open state of Get3 colored as in (D) (PDB 
ID code 3IBG). 
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In Vivo Effects of Get4 and Get5 Mutants 
 To assess the mutants in vivo, we utilized the fact that deletion of either Get4 or Get5 
showed growth phenotypes under stress conditions and tested for rescue by our 
constructs (Hillenmeyer et al., 2008). We rescued the Δget4 sensitivity to temperature 
and copper sulfate by expression of wild type Get4 using the native promoter on a 
plasmid (Figure 1.13A). With this construct, we generated all of the mutants used in the 
binding experiment. All of these mutants were unable to completely rescue the 
phenotype. The poorest rescue was by H33/R37, R42/R45, and YYE/AAA, which are on 
the highly conserved helix α2 (Figure 1.13B). We generated two mutants at the interface 
of the Get4 N- and C-domain (H137A and Y156A) that showed no phenotype (Figure 
1.13). 
The structure of the Ubl domain from the human homologue of Get5, Ubl4a/GDX, has 
been solved by NMR and deposited to the PDB (ID code 2dzi). Using this as a template 
we generated a homology model of Get5-Ubl using SWISS-MODEL and our alignment 
(Figure 1.14A) (Arnold et al., 2006). In ubiquitin isoleucine 44 is highly conserved and 
always involved in protein binding interactions (Hicke et al., 2005). In Get5 homologues, 
this residue is highly conserved as a leucine or methionine (L120) (Figure 1.1B). Based 
on the homology model, we noted that L120 was part of a conserved interface that 
included a number of positively charged residues including the conserved K124, which 
corresponds to the commonly conjugated K48 in ubiquitin (Figure 1.14A–C). Get5 
deletion mutants are viable in rich media but show phenotypes under stress conditions 





Figure. 1.13. Get4 rescue. (A) Spot plate growth assays of YEp-352 derived rescue 
plasmids under control of genomic promoters in the BY4741 Get4::KanMX background. 
Plates consisted of Sc-Ura supplemented with 2 mM CuSO4 and were incubated at 37  °C. 
The panel is generated from a single plate. “KO” represents transformations with empty 
YEp-352 vector and “Rescue” represents wild type Get4. Rescue mutants labels are 
colored based on no (cyan), moderate (yellow), and strong (red) phenotypes. (B) Get4/5-
N with helices shown as cylinders. Sets of mutated residues are shown as sticks with 




not able to fully rescue the Δget5 at 37  °C (Figure 1.14D) despite the protein being stable 
in solution (Figure 1.9C) 
Discussion 
Get4 and Get5 are two highly conserved proteins whose functions have only recently 
begun to be understood. The growing consensus is a direct role for these proteins 
operating upstream of Get3 in the TA protein targeting pathway. Here we have presented 
a structure of the yeast Get4/5-N complex along with a model for the structural elements 
of Get5-Ubl-C. We have shown that the purified Get4/5 complex dimerizes mediated by 
the Get5 C-domain. The Get4 N-terminal face forms part of the recognition interface with 
Get3, apparently preferring to bind to the closed form, and this surface is important in 
vivo. 
Get4 and the N-domain of Get5 form a stable and intimate complex. The fact that Get5-N 
appears to be important in yeast is somewhat surprising considering the absence of this 
domain in Get5 homologues in higher eukaryotes. One might speculate that in higher 
eukaryotes another protein can perform a similar interaction with Get4. An attractive 
option would be another protein that could bridge between Ubl4a and the mammalian 
Get4 homologue. This theoretical protein would contain a Get5-N-like region for binding 
to Get4, a dimerization domain for binding to Ubl4a and possibly a second Ubl. This 
complex would retain many of the features of Get4/5. 
Get3 is a soluble protein that transiently interacts with Get4. In the current model, Get4/5 




Figure 1.14. Get5 model with phenotypic rescue. (A) Ribbons diagram of a homology 
model of the Get5-Ubl-domain generated by sequence threading through the NMR 
structure of human UBL4A (PDB ID code 2DZI) using SWISS-MODEL, color ramped 
from N- (blue) to C-terminus (red). Residues L120 and K124 are displayed as sticks. (B) 
Get5-Ubl oriented as in A and shown as an accessible surface colored from least (purple) 
to most (orange) conserved. (C) As in (B), colored from positive (blue) to negative (red) 
Coulombic charge. (D) Spot plate growth assays in the BY4741 Get5::KanMX 
background, performed as in Figure 1.13. 
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nicely into the model where Get4/5 act as mediators to the ribosome and bind Get3 in a 
state competent for TA protein binding. The dimerization of Get4/5 adds the additional 
possibility that the 2-fold symmetrical Get3 dimer presents a binding site for each of the 
Get4 binding sites in the Get4/5 dimer. A mechanism such as this would lead to 
cooperative binding with a much higher affinity for Get3 in the correct state. 
The results presented here allow us to clarify the role of Get4 and Get5 as intermediaries 
in TA targeting (Figure 1.15). Get4/5 are able to recognize the nucleotide state of Get3 
and localize the closed form of Get3 to the ribosome dependent on an emerging TA 
substrate. Binding of the TA protein to Get3 leads to a conformational change that 
releases the Get3/TA complex from Get4/5 and the ribosome. Sgt2 and cellular 
chaperones either facilitate this transfer of substrate or act as parts of an alternate 
pathway. 
The steps in the Get targeting pathway continue to become clear but there are many 
outstanding questions that remain. The yeast Get4/5 appears to interact with the ribosome 
via Get5 (Fleischer et al., 2006); however, it remains to be demonstrated that this is a 
direct interaction. The role of nucleotide hydrolysis in the targeting pathway is not clear 
and may be involved in fidelity of substrate selection at the ribosome or in release of the 
TA protein at the ER. Finally, although the precise role of dimerization remains to be 
elucidated, the fact that Get4/5 forms dimers is a provocative result in light of the 




Figure 1.15. A model for the role of Get4/5. (1) Dimeric Get4/5 presumably binds the 
ribosome near the exit tunnel. Sgt2 and Ydj1 associate with the Get5-Ubl-C-domains. (2) 
Get3 in the open state is free in the cytoplasm. (3) Get3, in a closed state, is recruited to 
the Get4/5 complex upon ATP binding. (4) Tail-anchored proteins emerge from the 
ribosome and become associated with the Get3/Get4/5 complex. (5) The soluble Get3/TA 




Cloning, expression, and purification of proteins 
The sequences of Get4 (YOR164c) and Get5 (YOL111c) were obtained from the 
Saccharomyces Genome Database, codon optimized for expression in Escherichia coli 
using DNAWorks and synthesized by PCR (Hoover and Lubkowski, 2002). Residues 1–9 
of Get4 were truncated to Met-Gly due to lack of conservation and predicted disorder 
(Figure S1A). The genes were inserted sequentially into a pET33b(+)-derived vector 
(Novagen) and separated by an internal ribosome binding site. The C-terminus of Get4 
was fused to a tobacco etch virus TEV protease cleavage site followed by a hexa-
histidine tag. The proteins were overexpressed in BL21(DE3) (Novagen) grown in 2xYT 
media for 3 h at 37 °C after induction with 0.3 mM IPTG. Cells were lysed using an M-
110L pneumatic microfluidizer (Microfluidics) and purified as a complex by Ni-affinity 
chromatography (Qiagen). The affinity tag was removed by a 3 h TEV protease digest at 
room temperature while dialyzing against 20 mM Tris pH 8.0, 30 mM NaCl and 12 mM 
β-mercaptoethanol. The sample separated into two peaks using a 6 mL Resource Q anion 
exchange column (GE Healthcare). Each peak was further purified using a Superdex 200 
16/60 size exclusion column (GE Healthcare) equilibrated with 5 mM Tris pH 8.0, 
300 mM NaCl and 12 mM β-mercaptoethanol and concentrated to 10 mg⁄mL.  
The Aspergillus fumigatus homologs of Get4 (NCBI sequence XP_747572) and Get5 
(NCBI sequence XP_748165) were cloned, expressed, and purified in the same way as 
the Saccharomyces cerevisiae proteins. Get5 started from the second methionine in the 
Genbank sequence, omitting the first 42 annotated residues, as they were not consistent 
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with our multiple sequence alignments. The sequence used in this study is shown in 
Figure 1.1B. Expression and purification of Get3 were performed as previously described 
(Suloway et al., 2009).  
Mutations and truncations of Get3, Get4, or Get5 were introduced using the Quikchange 
method (Stratagene). All mutants were expressed under identical conditions as the wild 
type Get4/5, purified by Ni-affinity chromatography and cleaved by TEV protease where 
indicated. Analytical size exclusion chromatography was performed using either a 
Superdex 200 10/300 column with a QuadTec UV detector (Biorad) or a Shodex KW 803 
column with a Dawn Heleos MALS detector (Wyatt Technology).  
Formation and detection of complexes between Get3 and Get4/5 
 Complexes were formed by incubating 800 pmol Get3 and 400 pmol Get4/5 for 2 h at 
room temperature in 200 µL of 50 mM HEPES pH 7.3, 100 mM NaCl, 2 mM MgCl2, 30 
mM imidazole and, where indicated, 2 mM ADP or 2 mM ATP. After incubation, the 
reaction was added to 10 µL of gravity settled Ni-NTA agarose beads and mixed. The 
beads were washed twice with 100 µL of the incubation buffer within 1 minute. Bound 
proteins were eluted with 25 µL of incubation buffer containing 300 mM imidazole.  
Limited proteolysis and crystallization of Get4/5 
Crystallization screening was performed using a TTP LabTech Mosquito robot and 
commercially purchased kits (Hampton Research, Qiagen, Molecular Dimensions 
Limited). Adding TLCK treated α-chymotrypsin (Sigma) at a 1∶125 mass ratio to either 
oligomeric state immediately prior to screening, as described (Dong et al., 2007), resulted 
in crystals growing as hexaganol rods within a day at room temperature. Limited 
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proteolysis was performed at room temperature for 15 or 60 minutes on ice and stopped 
by the addition of 0.1 mM PMSF. Six products were separated by a Resource Q column, 
and only the major product, Get4/5-N, crystallized after concentration to 5 mg⁄mL. 
Sequences of the proteolytic fragments were determined using LC/MS with tryptic 
digestion and/or N-terminal sequencing. After refinement of the condition, crystals 
approximately 150 µm in length grew after 3 days at room temperature, although the 
majority had a twist approximately halfway down their length and were unable to diffract 
(Figure 1.2D).  
A small molecule additive screen (Hampton Research) revealed that the addition of 
spermidine aggravated twisting while 10 mM L-proline, trimethylamine-HCL or 
sarcosine yielded three-sided single crystals (Figure 1.2D). Diffracting crystals were 
grown using the hanging drop vapor diffusion method where 1 µL of Get4/5-N at 5 
mg⁄mL in 20 mM Tris pH 8.0, 90 mM NaCl, and 12 mM β-mercaptoethanol was mixed 
with 1 µL of a reservoir of 17% PEG 6000, 0.14 M ammonium sulfate, 0.1 M Bis-tris pH 
5.5, and 10 mM L-proline. Crystals were transferred into 20 µL of reservoir, 
cryoprotected by repeatedly removing and adding reservoir solution supplemented with 
1% increments of glycerol to 10%, and flash frozen in liquid nitrogen. Selenomethionine-
derived protein was expressed following established methods (Van Duyne et al., 1993) 
and purified, crystallized and frozen as described for the native protein. 
Data collection, structure solution, and refinement 
A single wavelength anomalous dataset to 2.8 Å resolution was collected on beam line 9-
2 at the Stanford Synchrotron Radiation Laboratory (SSRL) (Table 1.1). Data were 
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integrated and scaled using XDS (Kabsch, 2010), the space group was determined by 
POINTLESS and the data were merged and converted to amplitudes with 
SCALA/CTRUNCATE (CCP4, 1994). The selenium substructure was determined using 
SHELXD (Sheldrick, 2008) and initial phases, density modification, and model building 
were performed by PHASER (McCoy et al., 2007) and RESOLVE (Terwilliger, 2000) as 
implemented automatically by PHENIX (Adams et al., 2010). The asymmetric unit 
consisted of three copies of Get4/5-N arranged along a distorted 3-fold axis. Chain E was 
the most complete copy of Get4, with continuous electron density observed for residues 
9–299. Similarly, chain F was the most complete copy of Get5-N consisting of residues 
3–56. Manual rebuilding was performed using COOT (Emsley et al., 2010). Difference 
densities in two copies near the N-terminal poles of α3 of Get4 (residues 49–52) that 
were too large for ordered waters were modeled as L-proline. Reciprocal space 
refinement with local NCS restraints was performed using REFMAC v5.6 (Winn et al., 
2003) using the direct single wavelength anomalous dispersion (SAD) target (Skubak et 
al., 2004). A native dataset of comparable quality was collected on beam line 11-1 at 
SSRL, however refinement against the SAD data resulted in a higher quality model 
(determined by R-factors and model geometry) and thus the selenomethionine structure 
was used for deposition into the PDB (ID code 3LKU). The final model had an Rcrys of 
18.2% and an Rfree of 22.4% with residues in the Ramachandran plot in 97.9% preferred, 
2.1% allowed, and 0.0% in the disallowed and restricted regions [COOT (Emsley et al., 
2010)]. Structure figures were prepared using PyMol (Delano, 1998) or UCSF Chimera 




Yeast growth assays  
Knockout strains BY4741 YOR164C::KanMX and BY4741 YOL111c::KanMX were 
purchased from America Type Culture Collection (ATCC) (Winzeler et al., 1999). The 
Get4 rescue plasmid was constructed by PCR amplifying the open reading frame with 
339 bp upstream and 87 bp downstream flanking regions from BY4741 genomic DNA 
and inserting into the YEp-352 shuttle vector (Hill et al., 1986). Similarly, the Get5 open 
reading frame was amplified with 506 bp upstream and 69 bp downstream flanking 
sequence. Mutations were then introduced with the Quikchange method. The parent 
BY4741 and deletion strains were transformed using the LiAc/single-stranded carrier 
DNA/PEG method (Gietz and Schiestl, 2007). Phenotypic rescue was determined by 
growing each transformant in SC-Ura media at 30 °C to an OD600 nm between 1 and 2, 
diluting to 3.85 × 106 cells⁄mL and spotting 4 µL of serial dilutions onto SC -Ura agar 
plates in the presence or absence of 2 mM CuSO4. Plates were then incubated at 37 °C 
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GET5 CARBOXYL-TERMINAL DOMAIN IS A NOVEL DIMERIZATION MOTIF 
THAT TETHERS AN EXTENDED GET4/GET5 COMPLEX 
Abstract 
Tail-anchored transmembrane proteins are targeted to membranes post-translationally. 
The proteins Get4 and Get5 form an obligate complex that catalyzes the transfer of tail-
anchored proteins destined to the endoplasmic reticulum from Sgt2 to the cytosolic 
targeting factor Get3. Get5 forms a homodimer mediated by its carboxyl domain. We 
show here that a conserved motif exists within the carboxyl domain. A high-resolution 
crystal structure and solution NMR structures of this motif reveal a novel and stable 
helical dimerization domain. We additionally determined a solution NMR structure of a 
divergent fungal homolog, and comparison of these structures allows annotation of 
specific stabilizing interactions. Using solution X-ray scattering and the structures of all 
folded domains, we present a model of the full-length Get4/Get5 complex. 
Adapted from 
Chartron, J.W., VanderVelde, D.G., Rao, M., and Clemons, W.M., Jr. (2012). Get5 
carboxyl-terminal domain is a novel dimerization motif that tethers an extended 




The targeted delivery of transmembrane proteins to the proper membrane is a critical 
cellular process. The signal recognition particle pathway delivers the majority of 
transmembrane proteins co-translationally in all organisms. Tail-anchored (TA) proteins 
are important exceptions to this pathway (Shan and Walter, 2005). TA proteins contain a 
single transmembrane helix within 30 residues of the carboxyl terminus, and this feature 
necessitates post-translational targeting. After insertion, the N terminus remains in the 
cytoplasm. TA proteins are found in all membranes exposed to the cytoplasm and have a 
wide variety of roles, such as vesicle fusion, regulating apoptosis, and protein 
translocation (Borgese et al., 2007; Kutay et al., 1993). 
Eukaryotic pathways for TA protein delivery to the ER have been elucidated and are best 
described for yeast [for review, see (Rabu et al., 2009; Simpson et al., 2010)]. The 
majority of TA proteins are targeted via the GET (guided entry of TA proteins) pathway. 
Targeting progresses from the Get4/Get5/Sgt2 sorting complex that loads ER destined 
TA protein onto the ATPase Get3 (Battle et al., 2010; Chartron et al., 2010; Wang et al., 
2010). Mitochondrial TA proteins appear to be initially retained on Sgt2-bound heat-
shock cognate protein chaperones. Get3 then targets the TA protein to the ER membrane 
via Get1/Get2 (Schuldiner et al., 2008). 
Get4 and Get5 form an obligate heterodimer mediated by the amino domain of Get5 
(Get5-N) and the carboxyl domain of Get4 (Chang et al., 2010; Chartron et al., 2010). 
Get4 is an α-helical repeat protein that binds Get3 through a conserved basic face. 
Following the Get5 amino domain in sequence is a ubiquitin-like domain (Get5-Ubl) that 
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mediates interaction with Sgt2 (Chang et al., 2010; Chartron et al., 2011). The carboxyl 
domain of Get5 (Get5-C) is a homodimerization domain, resulting in a heterotetrameric 
Get4/Get5 complex (Chartron et al., 2010). 
A similar pathway for TA targeting exists in mammals. TRC35 and Ubl4A, homologs of 
Get4 and Get5, respectively, form a stable complex with the protein Bag-6/Bat-3/Scythe 
(Mariappan et al., 2010). This Bag-6 complex is required for efficient TA protein 
targeting by transferring them to TRC40, the Get3 homolog, after synthesis is complete 
(Leznicki et al., 2010; Mariappan et al., 2010). It is also involved in the degradation of 
defective nascent polypeptides and the stabilization of hydrophobic segments of proteins 
retrotranslocated from the ER prior to degradation by the proteasome (Minami et al., 
2010; Wang et al., 2011). The human homolog of Sgt2, SGTA, may also interact with 
this complex, suggesting a shared mechanism of TA sorting with yeast (Hegde and 
Keenan, 2011; Winnefeld et al., 2006). 
Structural studies of GET pathway members continue to provide details on the molecular 
series of events that occur in TA targeting. To understand the basis for specificity of 
homodimerization by Get5, we determined both a crystal and solution structure of the 
carboxyl domain of Get5 along with the solution structure of a fungal homolog. These 
structures reveal the nature of the conserved dimerization motif. We characterize the 
oligomeric state of human Ubl4A, which is amendable to the alternate architecture of the 
mammalian complex. Moreover, we use solution small angle X-ray scattering (SAXS) to 
define the overall structure of the full Get4/Get5 heterotetramer, providing the first 




Conservation of the Get5 Carboxyl Domain 
Get5 contains an amino domain, a ubiquitin-like domain, and a carboxyl domain that 
mediates homodimerization (Figure 2.1A) (Chartron et al., 2010). Get5-C, 152–212, 
contains the entire sequence from the end of the Get5-Ubl domain to the carboxyl 
terminus. Residues 152–176 have poor overall conservation in sequence identity or 
length. Residues 177–212 form an ∼35-residue conserved motif that is found in Get5 
homologs from two of the three subphyla of Ascomycota, the largest described fungal 
phylum (Figure 2.2) (James et al., 2006). The motif has greater variability within 
Saccharomycotina than in Pezizomycotina. Taphrinomycotina, the third subphylum that 
includes Schizosaccharomyces pombe, does not appear to have homologs of Get5 that 
contain a carboxyl-terminal domain. 
Ubl4A lacks the amino Get4 binding domain of Get5, with the Ubl domain as the amino 
terminus (Chartron et al., 2010). Ubl4A is well conserved in vertebrates. The carboxyl 
domain of Ubl4A contains the 35-residue dimerization motif seen in Get5 (Figure 2.2). 
The linker between the dimerization motif and the Ubl domain is generally shorter than in 








Figure 2.1. Crystal structure of Get5-C. (A) schematic of the domain organization of 
Get5 and sequence alignment of the carboxyl domain in fungi. Lines indicate flexible 
regions. Sequences are: S. cere, S. cerevisiae; A. goss, Ashbya gossypii; S. scle, 
Sclerotina sclerotiorum; A. fumi, A. fumigatus. Residues that mediate intermolecular 
contacts in both Get5 and AfGet5 dimers are highlighted in red, and residues specific to 
Get5 or AfGet5 are highlighted in blue or green, respectively. (B) Dimerization interface 
of a monomer of Get5-C with σa-weighted 2|Fo|−|Fc| electron density contoured at 1.5σ. 
(C) asymmetric unit of Get5-C. One monomer is color ramped from amino (blue) to 
carboxyl (red) terminus. The 2-fold axis is indicated with a dotted line. Side chains that 






Structure of Get5 Dimerization Motif 
We cloned, expressed, and purified Get5-C for NMR investigation. The main chain 
chemical shifts (1HN, 15NN, 13CCO, 13Cα, 13Cβ, and 1Hα) of residues 152–175 have random 
coil character, whereas those of 179–190 and 194–210 are characteristic of helices 
(Figure 2.3). These helices are designated H1 and H2, respectively. Relaxation rates and 
heteronuclear NOE values also indicate rapid motions for residues 152–175. Consistent 
with this secondary structure,1HN of residues 182–187 and 200–208 were the most 
protected from solvent deuterium exchange whereas residues 152–177 readily exchanged. 
Therefore, we concluded that residues 152–175 were unstructured and not significantly 
contributing to the stability of the folded dimerization domain.5 
Based on these results a truncated version of the carboxyl domain consisting of residues 
175–212 was generated for crystallographic studies. This variant crystallized in space 
group P21 and diffracted to 1.23 Å resolution. Experimental phases were determined by 
the single-wavelength anomalous diffraction technique using an iodide-soaked crystal 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Figure 2.2. Conservation of the dimerization motif within Get5. The sequences shown 
are from the end of the ubiquitin-like domain to the carboxyl terminus of each homolog. 
Secondary structures of S. cerevisiae Get5 and the A. fumigatus homolog are shown as 
red helices above their respective sequences. Secondary structure for H. sapiens Ubl4A is 
predicted using JPRED-3 (Cole et al., 2008) and is shown as blue helices above the 
sequence. Residue numbers above the sequences are from S. cerevisiae, A. fumigatus or 
H. sapiens. Conserved or identical residues within each subphylum are highlighted in 
yellow or green, respectively. Residues that are conserved across all sequences are 
highlighted in blue. Sequences are: S. cer, Saccharomyces cerevisiae; A. gos, Ashbya 
gossypii; D. han, Debaryomyces hansenii; K. lac, Kluyveromyces lactis; A. fum, 
Aspergillus fumigatus; S. scl, Sclerotinia sclerotiorum; P. tri, Pyrenophora triticirepentis; 
A. oli, Arthrobotrys oligospora; H. sap, Homo sapiens; D. rer, Danio rerio; X. lae, 





(Dauter et al., 2000). Two copies of Get5-C are present in the asymmetric unit of the 
native crystal. Unambiguous electron density allowed modeling of residues 175–212 of 
one copy and 175–211 of the second (Figure 2.1B). The structure was refined to 
an Rfree of 0.204. Crystallographic statistics are presented in Table 2.1. 
The two copies of Get5 in the asymmetric unit interact extensively, burying 870 Å2 of 
solvent-accessible surface area (∼25% of total) per monomer and sequester the majority 
of hydrophobic residues (Figure 2.1C). In contrast, the most extensive crystallographic 
contact buries 410 Å2; therefore, the asymmetric unit contains the physiologically 
relevant dimer. 
A 2-fold axis relates one monomer onto the other (Figure 2.1C). The H1 helices pack 
antiparallel to one another. A four-residue linker connects to H2, and the H2 helices cross 
at conserved Gly-207 forming an ∼95° angle. The association between the two subunits 
in the dimer is almost entirely by hydrophobic interactions. The dimer axis is lined by Ile-
182, Leu-185, Leu-204, and Gly-207. Leu-185 and Pro-178 extend from H1 of one copy 
into hydrophobic pockets formed by additional H1 residues the second copy. Asp-181 
and Asn-189 form the only intermolecular hydrogen bond across the dimer.6 
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Figure 2.3. Solution NMR analysis of Get5-C. 15N R1 and R2 relaxation rates, {1H}-
15N heteronuclear NOE, random coil index (Berjanskii and Wishart, 2007) and 
secondary structure probability determined from main-chain chemical shifts using 
TALOS+ (Shen et al., 2009). plotted against amino acid sequence for Get5-C (A) or 
AfGet5-C (B). The greater R1 and lower R2 values of residues 152-175 of Get5-C mean 
this region is tumbling more rapidly than 176-212. Negative {1H}-15N heteronuclear 
NOE values for residues 152-175 indicate rapid (picosecond to nanosecond) motions. 	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Table 2.1. Crystallographic data and model refinement statistics 
 Dataset Native Iodide  
Data collection SSRL BL12-2 Micromax-007 HF 
  Wavelength (Å) 1.0000 1.5418 
  Resolution range (Å) 28.08–1.23 (1.26–1.23)a 26.52–1.60 (1.69–1.60) 
  Space Group P 21 P 2 21 2 
  Cell Parameters 
        a, b, c (Å)  25.02, 46.34, 28.27 25.10, 26.52, 46.17 
      α, β, γ (°) 90.00, 96.90, 90.00 90.00, 90.00, 90.00 
  Unique reflections 18288 4395 
  Completeness (%) 97.9(94.6) 99.6(97.5) 
  Redundancy 4.2(3.9) 12.2(11.2) 
  Rmergeb 0.058(0.609) 0.088(0.605) 
  Mean I/σ(I) 11.6(2.1) 19.5(3.9) 
Refinement   
  Reflections: work/freec 17185/1089  
  Rwork/Rfreed 0.177/0.204  
  Number of atoms   
     Protein 714  
     Water 86  
     Phosphate 5  
Average B-factors (Å2)  
     Protein 13.6  
     Water 24.8  
     Phosphate 33.9  
   r.m.s.d.   
     Bond lengths  (Å) 0.010  
     Bond angles (°) 1.082  
 Ramachandran favorede 100%  
aValues in parentheses are for the highest resolution shell 
b Rmerge = Σhkl Σi |Ii(hkl)−〈I(hkl)〉|/ Σhkl ΣiIi(hkl), where Ii(hkl) is the ith 
observation of reflection hkl and 〈I(hkl)〉 is the weighted average intensity for 
all observations i of reflection hkl. 
cThe free set represents a random 6% of reflections not included in refinement 
dR = Σhkl(||Fobs|−|Fcalc||)/Σhkl|Fobs|, where |Fobs| and |Fcalc| are the observed and 
calculated structure factor amplitudes, respectively. 
ePercentage of residues in Ramachandran plot regions were determined using 




There are several interactions that restrict the conformation of H1 relative to H2 within 
each monomer. Phe-190, which begins the connecting loop, fits in a pocket formed by 
Leu-186, Ala-196, and Val-200 of the same copy (Figure 2.1C). The indole ring of Trp-
179 is normal to the ring of Trp-208 of the same copy, and the side chain of Val-177 fits 
into the resulting pocket. Trp-208 points toward the dimer interface, where the side chain 
of Arg-203 extends from the opposite copy to form a cation–pi interaction. Arg-203 is 
conserved as an arginine or lysine in Saccharomycotina, and Trp-208 is conserved across 
all eukaryotes (Figure 2.2). The side chain of Trp-208 also contacts Val-200 and Leu-204 
of the opposite copy. 
Solution NMR Structure of Get5-C 
We determined the solution structure of Get5-C using NOE-derived and hydrogen bond 
distance restraints, ϕ and ψ dihedral angle restraints, and residual dipolar couplings 
restraints. Residues 152–172 did not converge to a consistent structure due to a lack of 
interresidue NOE-derived distance restraints; therefore, they were omitted in the final 
model calculations. Statistics for the structure and restraints are summarized in Table 2.2, 
and the ensembles of the 10 lowest energy structures are shown in Figure 2.4A. 
The solution structure is very similar to the crystal structure, with an average backbone 
root mean square deviation of 0.94 ± 0.06 Å across residues 177–212 (Figure 2.5A). The 
interaction between Arg-203 and Trp-208 and the interactions between the methyl groups 
of Val-177 with Trp-179 and Trp-208 are maintained in solution (Figure 2.5B). The 
unique environment created by the two aromatic residues is reflected in unusual upfield 
chemical shifts of interacting residues, with Val-177 methyl protons at −0.994 and 
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Table 2.2. NMR structural constraints and structure statistics for the 
10 lowest energy structures 
   Get5-Ca AfGet5-Ca 
No. of restraints   
  NOE-based distance restraintsb   
     Intraresidue (|i – j| = 0) 644 598 
     Sequential (|i – j| = 1) 396 334 
     Medium range (2 ≤ |i – j| < 5) 562 454 
     Long range (|i – j| ≥ 5) 178 158 
     Intermolecular 276 140 
     Ambiguous 824 460 
    Total 2880 2144 
  Dihedral angle restraints (φ/ψ) 132 (66/66) 152 (76/76) 
  Hydrogen bond restraints 96 96 
  Residual dipolar coupling restraints 64 70 
Restraints statistics   
  r.m.s.d. of distance violations   
     NOE restraints 0.11 ± 0.02 Å 0.07 ± 0.01 Å 
     H-bond restraints 0.009 ± 0.001Å 0.009 ± 0.002 Å 
  r.m.s.d. of dihedral violations 1.18 ± 0.06° 0.61 ± 0.05° 
  RDC Q-factors 0.0715 ± 0.004 0.05 ± 0.02 
Coordinate precision r.m.s.d.   
  Backbone 0.24 ± 0.06 Å 0.37 ± 0.07 Å 
  Heavy atom 0.60 ± 0.06 Å 0.69 ± 0.04 Å 
Structural quality   
  Ramachandran statisticsc   
     Most favored regions 84.70% 93.90% 
     Allowed regions 9.30% 4.64% 
     Generously allowed regions 6.00% 0.96% 
     Disallowed regions 0.00% 0.48% 
  WHAT-IF Z-scored   
     Backbone conformation 0.775 ± 0.250 0.537 ± 0.580 
     2nd generation packing quality 7.644 ± 2.380 6.273 ± 2.062 
     Ramachandran plot appearance −2.170 ± 0.359 −0.388 ± 0.339 
     χ1/χ2 rotamer normality 0.514 ± 0.488 −1.883 ± 0.528 
aStatistics are reported for dimers of Get5-C residues 173–212 and AfGet5-
C residues 186–230. 
bA single NOE generates two restraints for atom pairs from each monomer. 
cPercentage of residues in Ramachandran plot regions were determined 
using PROCHECK (Laskowski et al., 1993). 




Figure 2.4. Solution structures of Get5-C and AfGet5-C. (A) and (B), ensembles of 
the 10 lowest energy solution structures of the ordered regions of Get5-C (A) and AfGet5-
C (B). (C) ribbon diagram of AfGet5-C with side chains making intermolecular contacts. 
AfGet5-C is rotated from the orientation in the top of (B) as indicated by the sphere in the 





−0.613 ppm, Arg-205 1Hδ at 1.573 ppm and Gln-205 1Hγ, and a side chain amide proton 
at −0.056 ppm and 4.656 ppm, respectively.7 
Two significant differences exist between the solution and crystal structures, and both 
can be explained by the crystal lattice. First, the loop connecting H1 and H2 is rearranged 
(Figure 2.5C). For the X-ray structure, crystals grew in pH 5.0, and this pH allows Glu-
191 and Asp-193 to form hydrogen bonds with Asp-181 and Glu-202, respectively, from 
two different crystallographic copies. This results in an alternate conformation of the 
loop, predominantly by a rotation of the peptide bond plane between Glu-191 and Gln-
192. The second difference is at the N terminus of the crystal structure, which has a three-
residue cloning artifact prior to residue 175 of the crystallization construct. Leu-175 and 
nonnative Val-173 form hydrophobic contacts with two different crystallographic copies 
(Figure 2.5D), resulting in the terminus turning outward from the helices. In solution, 
residues 173–176 are extended (Figure 2.5A). This full domain results in 1090 Å2 of 
solvent-accessible surface area buried per monomer (∼30% of total). 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Figure 2.5. Comparison of solution and crystal structures of Get5-C (A) Left, the 
ensemble of the 10 lowest energy solution structures of the ordered region of Get5-C. 
Right, the crystal structure of Get5-C. Middle, overlay of solution (magenta) and crystal 
(cyan) structures. (B) The arrangement of Val-177, Trp-179, Trp-208 and Arg-203 in the 
solution (left) and crystal (right) structures. For the solution structure a representative 
model is displayed. (C) The loop connecting H1 and H2 in the solution (left) and crystal 
(right) structures. Two crystallographic copies of the Get5 dimer are colored brown and 
light green. (D) The amino terminus of the Get5-C crystal structure with two 
crystallographic copies of the dimer colored orange and yellow. Val-173 and Asp-174, 




Structure of Get5-C Domain Homolog 
We additionally investigated the carboxyl domain of the Get5 homolog from the 
filamentous fungi A. fumigatus (AfGet5-C). Several structures of other GET pathway 
members have been determined for this organism (Chartron et al., 2011; Suloway et al., 
2009). A. fumigatus is in the subphylum Pezizomycotina, and Get5 homologs from this 
group have conserved features distinct from Saccharomycotina (Figure 2.2). There is 
more conservation in the residues immediately preceding the tryptophan at the amino 
terminus of H1, and there are three additional conserved phenylalanines. We cloned, 
expressed, and purified AfGet5-C residues 159–230, comprising the full sequence of the 
carboxyl domain for NMR investigation. 
Main chain chemical shifts indicated that residues 159–186 are likely random coil 
whereas 212–228 and 195–208 formed helices corresponding to H1 and H2 (Figure 
2.3B). An additional short coil is predicted at residues Ser-190 and Val-191, designated 
H0. We determined the solution structure of AfGet5-C. Residues 159–185 did not 
converge to a consistent structure due to a lack of interresidue NOE-derived distance 
restraints and were omitted from the final structure calculation. Structure and restraint 
statistics are provided in Table 2.2, and the ensembles of the 10 lowest energy structures 
are shown in Figure 2.4B.  
The overall structure of AfGet5-C is similar to the Get5-C (Figure 2.4B,C). However, 
AfGet5-C has an additional turn at the amino terminus of H1, comprising residues Glu-
195, Ala-196, and Pezizomycotina-specific Phe-197 (Figure 2.2). Coil H0 caps the 
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helical bundle on either end, and Val-191 and Val-192 extend into the core. The two other 
conserved phenylalanines, Phe-204, and Phe-222, line the symmetry axis within the 
dimer along with Leu-201 and Ala-225. The dimer interface is homologous to Get5-C, 
with Phe-204 forming interactions that are equivalent to those of Leu-185. Val-191 and 
Phe-197 together occupy a position similar to Pro-178. There is a single intermolecular 
electrostatic interaction made by Arg-208 and Asp-200, similar to the hydrogen bond 
between Asp-181 and Asn-189. The H2 helices cross at an ∼110° angle and cross 
between Phe-222 and Ala-225. This reconfiguration accommodates the aromatic rings of 
Phe-204 and Phe-222 and the side chains extending from H0 in the core. 
AfGet5-C has an arrangement of tryptophans that is distinct from the Val-177/Trp-
179/Trp-208 interaction of Get5 (Figure 2.4C, inset). The extra turn in H1 positions the 
aromatic ring of Phe-197 normal to the ring of Trp-198 and results in upfield shifts of 
5.799 and 5.919 ppm for 1Hδ and 1Hϵ, respectively, of Phe-197. The side chain of Val-
192 occupies a pocket formed by Phe-197, Trp-198, and Trp-226. AfGet5-C does not 
have an intermolecular cation-pi interaction, and the side chain of Trp-226 is flipped 
relative to the equivalently positioned Trp-208; the increased distance of the main chains 
between the two copies prevents any extended side chain interaction to this position. Arg-
203 is not conserved in Pezizomycotina. 
Get5 Carboxyl Domain Is Highly Stable Dimer 
The thermal stabilities of Get5-C and AfGet5-C were determined by circular dichroism 
(CD) spectroscopy (Figure 2.6). Get5-C has a thermal melting curve with a single 





Figure 2.6. Get5-C is a stable dimer. Thermal melting curves of Get5-C (solid line) and 
AfGet5-C (dashed line) measured by CD spectroscopy. 
 
 
Figure 2.7. Refolding of Get5-C and AfGet5-C. (A) and (B). Circular dichroism spectra 
recorded at 25°C before (solid, black) and after (dashed, red) complete denaturation at 
99°C for Get5-C (A) and AfGet5-C (B). In both proteins, the spectra are nearly 
completely overlapping indicating complete refolding. 
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AfGet5-C has a surprisingly similar thermal melting curve and a Tm of 72 °C. After 
heating to 99 °C, both proteins can refold completely (Figure 2.7). 
Mammalian Get5 Homolog Ubl4A Does Not Homodimerize 
We expressed and purified recombinant human Ubl4A from E. coli. Ubl4A, with a 
molecular mass of 20.0 kDa, elutes later from a size exclusion column than a dimeric 
Get5-Ubl-C construct that is lacking the amino-terminal Get4 binding domain (15.9 
kDa), and slightly earlier than the monomeric Get5-Ubl domain alone (10.0 kDa) (Figure 
2.8A). Surprisingly, these data are most consistent with Ubl4A existing as a monomer in 
solution. Alone, Ubl4A is unstable and precipitates over several days when stored at 4 
°C. 
It has been demonstrated previously that Get5 dimers exchange monomers within hours 
at room temperature (Chartron et al., 2010). In that experiment, we were unable to 
demonstrate the formation of a heterodimer between Get5 and AfGet5. We tested whether 
Ubl4A can form heterodimeric complexes with either homolog (Figure 2.8B). A 
heterodimer could be detected with Get5 but not AfGet5, suggesting that the Ubl4A 
dimerization domain is most similar to Get5-C. 
Get4/Get5 Complex Is Extended in Solution 
SAXS can be used to generate low-resolution models of protein complexes in solution 
when high-resolution structures of individual domains are available. We collected SAXS 
data on the full-length Get4/Get5 heterotetramer, which has a molecular mass of 120 






Figure 2.8. Ubl4A can form heterodimers. (A) Size exclusion chromatography of 
Ubl4A (black), Get5- Ubl (red) and Get5-Ubl-C (blue) using a Superdex 200 10/300 
column. Absorbances are normalized against peak values. Cartoons of each construct are 
shown as in Figure 2.1A. (B) Polyhistidine tagged Ubl4A incubated with either AfGet5-
Ubl-C or Get5-Ubl-C for the indicated time, precipitated with Ni-NTA agarose beads, 
eluted and separated by SDS-PAGE. 
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transform, P(r), is characteristic of an elongated particle (Mertens and Svergun, 2010) as 
there is an asymmetric peak that decreases to a large distance in a linear fashion (Figure 
2.9A). Compact particles have a more symmetric, parabolic peak. The radius of gyration 
and maximum particle diameter obtained from this analysis are 68.1 ± 0.1 Å and 240 Å, 
respectively. These values are consistent with the observation that Get4/Get5 appears 
atypically large by size exclusion chromatography (Chartron et al., 2010). An ab initio 
reconstruction using the indirect Fourier transform generates the surface shown in Figure 
2.9B. This surface is the average of 10 individual models and represents the most 
probable volume. 
With high-resolution structures now available for each ordered domain of the Get4/Get5 
complex, rigid body fitting against the SAXS data can generate unbiased models of the 
heterotetramer in solution. The crystal structure of Get4 and Get5-N (Protein Data Base 
ID 3LKU), a homology model of Get5-Ubl generated from the Ubl domain of Ubl4A 
(Protein Data Base ID 2DZI) (Chartron et al., 2010), and the solution structure of Get5-C 
were used for fitting by the program CORAL. This program models flexible termini and 
interdomain linkers as chains of dummy residues (Petoukhov and Svergun, 2005), 
restraining the possible orientations of the rigid domains fit using simulated annealing. 
We performed the calculation eight times. The model with the best fit to the data (Figure 
2.9C, top) is in agreement with the dimensions of the averaged ab initio model (Figure 
2.9B). In all trials there is a similar extended spatial arrangement of the ordered domains, 
although there is variation in the overall rotations of the Get5-Ubl domain and 





Figure 2.9. SAXS of Get4/Get5. (A) Pair–distance distribution function of the 
Get4/Get5 heterotetramer derived from SAXS. (B) Averaged ab initio reconstruction of 
Get4/Get5 shown as a gray surface in two orientations. (C) Rigid body models generated 
by independent simulated annealing calculations using known structures against SAXS 
data. In each model, the two copies of Get5 are colored magenta and orange, and the two 
copies of Get4 are colored cyan and blue. The three top models are shown ranked 
according to χ2 fit to the experimental SAXS curve. 
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axis of the particle (Figure 2.9C). The ab initio model likely reflects an average of these 
orientations rather than a single species. 
Discussion 
Get5 homodimerization is mediated by an ∼35-residue motif within its carboxyl domain. 
Two copies of this motif form a domain with a novel arrangement of four α-helices. The 
sequence of the motif has some similarity to coiled-coils (Chartron et al., 2010); however, 
rather than arranged in a zipper like fashion, hydrophobic residues are buried within a 
small core. Elements of the motif are conserved across the eukaryotic kingdom, such as 
the positions of hydrophobic residues that mediate the dimer interface and the aromatic 
residues toward the beginning and end of the motif (Figure 2.2). Of 13 positions that are 
at the dimer interface, 6 are conserved across eukaryotes (Figure 2.1A and Figure 2.2). 
There is extensive divergence of the remaining sequence, especially at surface positions, 
yet an overall conservation of structure as well as thermal stability. 
The overall solution data of the Get4/Get5 complex points to an extended conformation 
in solution. With this architecture, the two copies of the amino-terminal face of Get4, 
which binds Get3, point outward at opposite ends of the particle. Get5-C presumably 
plays a structural role in this by orienting the Ubl domain that in turn orients Get4. 
Ubl4A is a component of the Bag-6 complex along with Bag-6/Bat-3/Scythe and TRC35. 
This complex is involved in directing TA protein biogenesis (Leznicki et al., 2010; 
Mariappan et al., 2010) and has more recently been implicated in the stabilization of 
proteins retrotranslocated from the ER prior to degradation (Wang et al., 2011). TRC35 is 
	  	  
74 
believed to mask a nuclear localization signal within Bag-6 and modulates the population 
of cytoplasmic and nuclear resident protein (Wang et al., 2011); however, nothing is 
known regarding the physical interactions of components of the complex. Purified Ubl4A 
is an unstable monomer but can form an artificial heterodimer with Get5-Ubl-C. This 
suggests that the carboxyl domain of Ubl4A has the conserved, exposed protein-protein 
interaction face and may mediate its interaction with the Bag-6 complex. We were unable 
to identify a feature in Bag-6 that contained the Get5-C motif; therefore, one might 
expect a unique heterodimeric interaction. The architecture of the Bag-6 complex is 
distinct from the Get4/Get5/Sgt2 complex. Certain steps, such as the recognition of TA 
proteins by SGTA, the binding of SGTA to the Ubl domain of Ubl4A, and the subsequent 
loading of TRC40 are likely mechanistically analogous with yeast. The rearrangement to 
include Bag-6/Bat-3/Scythe could allow interplay between TA targeting pathways, 
protein degradation and apoptosis. 
Oligomerization in biology plays an important role, and there are many examples of 
dimerization domains; however, there are few examples of small (less than 70 residues) 
globular dimerization motifs. We searched for other examples of helix-turn-helix 
homodimers similar to Get5-C in that they are neither intercalated nor have extensive 
coiled-coils. There are four proteins in this category with high-resolution structures 
available. They are the Qua1 domain from STAR proteins (Beuck et al., 2010; Meyer et 
al., 2010) , the protein kinase A (PKA) type Iα and type IIα regulatory subunits (Banky et 
al., 2003; Newlon et al., 1999), and the Siah-interacting protein (SIP) (Santelli et al., 
2005). Of these structures, Get5-C has the shortest sequence and the highest ratio of 
buried to exposed surface area (30% versus 28% for the next most, the crystal structure of 
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the PKA type IIα regulatory subunit) (Gold et al., 2006). It is significantly more 
thermostable than the only other dimer where this was measured, the Qua1 domain, with 
a Tm of 74 °C compared with 63 °C (Beuck et al., 2010). Therefore, this domain is 
currently unique in biology. 
Engineering dimerization into proteins is an important goal (Bolon et al., 2005; Kuhlman 
et al., 2001). Much of this type of work focuses on the use of coiled-coils in the form of 
leucine zippers (Apostolovic et al., 2010). The motif we describe here may provide a 
useful alternative. Recombinant Get5-C expresses very well and is easily purified. The 
35-residue sequence is also amenable to chemical synthesis. The Get4/Get5 complex 
proves that Get5-C is sufficient in maintaining dimers of significantly larger protein 
assemblies. The requirement of only a few key residues suggests that there is ample 
opportunity for protein design to alter stability, specificity, and surface properties. 
It has recently been proposed that TA protein binding to Get3 causes two dimers of Get3 
to assemble into a tetrameric complex (Suloway et al., 2012). This is supported by crystal 
structures of a tetrameric archael Get3 homolog and by SAXS analysis of TA protein-
bound Get3 complexes that show similar overall size and shape. This tetramer has a 
longest dimension of ∼150 Å, which makes it possible for the two copies of Get4 within 
the Get4/Get5 complex to interact with the two different Get3 dimers prior to loading of 
TA proteins. Sgt2, bound to at least one Get5 ubiquitin-like domain (Chartron et al., 
2011), would then be positioned near the hydrophobic cavity created by Get3 (Figure 
2.10). Alternatively, the two copies of Get4 may interact with the two Get3 subunits 
within a single lower order dimer. This necessitates a dramatic conformational change 
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within Get4/Get5 to bring the Get4 N terminus into proximity. Flexibility within Sgt2 
may be amendable with this model. The exact mechanism of TA protein transfer from 
Sgt2 to Get3 awaits further characterization. 
Get5 plays a central role in localizing the various components involved in TA targeting 
forming the nexus of the so-called sorting complex. The unusually stable dimerization 
domain of Get5 is likely critical to the sorting function. It remains unclear whether this 
domain plays a broader role beyond simple dimerization. The novelty of the architecture 






Figure 2.10. Model of the Get4/Get5/Sgt2 sorting complex and its interaction with 
Get3. Schemes are drawn to scale, with the exception of chaperones bound to Sgt2. The 





Cloning, Expression, and Purification 
Get5-C residues 152–212 or 175–212 from Saccharomyces cerevisiae S288C or 159–230 
from Aspergillus fumigatus 118 were amplified from vectors described previously 
(Chartron et al., 2010). The coding sequences were then inserted into a pET33b-derived 
plasmid. Unlabeled proteins were expressed in Escherichia coli BL21(DE3)Star 
(Invitrogen) for 3 h at 37 °C after induction with 250 µM isopropyl-β-D-
thiogalactopyranoside (Affymetrix). Uniformly 15N-labeled proteins were produced using 
N-5052 autoinduction media (Studier, 2005), and uniformly 13C/15N-labeled proteins 
were produced using the method of Marley et al. (2001). Cells were lysed using an S-
4000 sonicator (Misonix) and purified by immobilized metal affinity chromatography 
(Qiagen). The full-length Get4/Get5 complex, Get5-Ubl-C (residues 74–212), 
and AfGet5-Ubl-C (residues 66–230) were prepared as described previously (Chartron et 
al., 2010). (For clarity, residues that are italicized will refer specifically to the A. 
fumigatus homolog.) 
Human Ubl4A was amplified from a cDNA-containing plasmid (ATCC) and inserted 
into a pET33b-derived plasmid. Expression and purification were as for Get5-C. Domain 
swap experiments and pulldown assays were performed as described previously 
(Chartron et al., 2010). Briefly, Get5-Ubl-C or AfGet5-Ubl-C was incubated in 2-fold 
stoichiometric excess with polyhistidine-tagged Ubl4A in 50 mM HEPES, 100 mM NaCl 
and 30 mM imidazole, pH 7.3. Ubl4A was precipitated with nickel-nitrilotriacetic acid-
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agarose beads (Qiagen). The beads were washed twice with incubation buffer and 
proteins eluted with 20 mM EDTA. 
Crystallization, Data Collection, and Structure Determination 
Get5-C residues 175–212 were concentrated to 30 mg/ml in 20 mM sodium phosphate, 
pH 6.1. Crystallization screening was performed using the sitting-drop vapor diffusion 
method with commercially available screens (Qiagen) and a Mosquito robot (TTP 
Labtech). Clusters of plate like crystals grew after 1 week in a 1:1 ratio drop of protein 
solution to a reservoir of 3.4 M ammonium sulfate and 0.1 M sodium citrate, pH 5.0, at 
22 °C. The clusters were broken apart, and individual crystals were transferred to 
reservoir solution supplemented with 10% glycerol for 5 min and then cryopreserved in 
liquid nitrogen. Iodide derivatives were generated by soaking crystals in freshly prepared 
2.9 M ammonium sulfate, 0.5 M ammonium iodide, 0.1 M sodium citrate, and 10% 
glycerol, pH 5.0, for 5 min prior to cryopreservation. 
X-ray diffraction data from a single native crystal were collected on beam line 12-2 at the 
Stanford Synchrotron Radiation Lightsource (SSRL) at 100 K using a Pilatus 6M detector 
and a microbeam. Positions on the crystal were screened for diffraction using an 
automated raster scanning protocol. The best position allowed for collection of a near 
complete dataset to maximum 1.23 Å resolution. Diffraction data from an iodide 
derivative were collected using a Micromax-007 HF rotating copper-anode generator and 
an R-axis IV++ image plate detector (Rigaku) to a maximum 1.6 Å resolution and ∼12-
fold redundancy. Data were integrated, scaled, and merged using XDS (Kabsch, 2010), 
iodide substructure determination, phasing, and initial model building and refinement 
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were performed in PHENIX (Adams et al., 2010), and manual building and model 
refinement were performed using COOT (Emsley et al., 2010). Structure figures were 
prepared using PyMOL (Schrödinger). 
NMR Spectroscopy 
All NMR measurements were collected using a Varian INOVA 600 MHz spectrometer at 
25 °C with a triple resonance probe. Uniformly 13C/15N-labeled Get5-C residues 152–212 
or AfGet5-C residues 159–230 were concentrated to a monomer concentration of 3.5 
mM in 20 mM sodium phosphate, pH 6.1. Chemical shift assignments were determined 
using standard triple-resonance experiments (Sattler et al., 1999). Data were processed 
using either TopSpin (Bruker) or NMRPipe (Delaglio et al., 1995) and analyzed using 
CCPN (Vranken et al., 2005). The PINE web server aided initial assignments (Bahrami et 
al., 2009). Distance restraints were derived from 13C- and 15N-edited NOESY spectra. An 
asymmetrically labeled dimer of AfGet5-C was prepared by mixing 4 mM unlabeled 
protein with 2 mM uniformly 13C/15N-labeled protein and incubating at room temperature 
for 3 days. Intermolecular distance restraints were then determined using a 13C/15N-
filtered 13C-edited NOESY spectrum. 
HN-N residual dipolar couplings were measured using the IPAP-HSQC experiment. A 2.5 
mM solution of 15N-labeled Get5-C was aligned in a 4% strained polyacrylamide gel, and 
a 2 mM solution of 15N-labeled AfGet5-C was aligned in a 5% strained polyacrylamide 
gel (Chou et al., 2001). 
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Solution Structure Determination 
ARIA2.3 was used for automated NOE cross peak assignment and structure calculation 
with hydrogen bond, dihedral and residual dipolar coupling-derived restraints (Rieping et 
al., 2007). Every NOE cross peak was treated ambiguously as an inter- or intramolecular 
contact, with initial sets of unambiguous intermolecular contacts determined by 
constraints imposed by secondary structure (Bardiaux et al., 2009). For AfGet5-C, 
experimentally determined intermolecular restraints were also utilized. Restraints for ϕ/ψ 
dihedral angles were predicted from chemical shifts using TALOS+ (Shen et al., 2009). 
An energy term is included to maintain symmetry within each model. Hydrogen bond 
restraints were initially assigned to the amide protons most resistant to deuterium 
exchange. After structure calculation, additional hydrogen bonds that were supported by 
the ensemble of models were added within the helical segments and the calculations 
repeated. The initial structures were also used to determine the axial and rhombic 
components of the alignment tensors with the program REDCAT (Valafar and 
Prestegard, 2004). Residual dipolar couplings were added as restraints during subsequent 
calculations. A log-harmonic energy potential was used during the second Cartesian 
cooling phase of the simulated anneal protocol with automatic determination of weights 
for NOE-derived and hydrogen bond distance restraints (Nilges et al., 2008). One 
hundred models were generated in the final iteration of ARIA, and the 10 lowest energy 
models were selected for refinement in explicit water. 
SAXS 
Multiple concentrations of S. cerevisiae Get4/Get5 were prepared as described previously 
(Chartron et al., 2011), with dialysis against 50 mM Tris, 300 mM NaCl, and 5 mM 2-
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mercaptoethanol, pH 8.0. Data were collected at SSRL beam line 4-2 using a Rayonix 
MX225-HE detector, 1.13 Å wavelength X-rays, and a detector distance of 2.5 m for a 
momentum transfer range of 0.0055–0.3709 Å−1. Data were processed using 
MARPARSE (Smolsky et al., 2007), and Guiner analysis was performed with PRIMUS 
(Konarev et al., 2003). The distance distribution function was determined with GNOM 
(Svergun, 1992). Ten independent ab initio models were generated using DAMMIF 
(Franke and Svergun, 2009) and real space data. These were superposed, averaged, and 
filtered using DAMAVER (Volkov and Svergun, 2003). High-resolution structures of 
Get4 and Get5 components were used as input into the program CORAL (Petoukhov and 
Svergun, 2005) for rigid body fitting with reciprocal space data. All calculations used 
imposed 2-fold symmetry. 
Circular Dichroism Spectroscopy 
Thermal denaturation measurements were collected using an Aviv 62A DS circular 
dichroism spectrometer. Get5-C or AfGet5-C at 10 µM in 20 mM sodium phosphate, pH 
7.5, was heated from 25 to 99°C in 1 °C increments, and ellipticity was measured at 227 
or 221 nm, respectively. Fractions of unfolded and folded protein were approximated 
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A STRUCTURAL MODEL OF THE SGT2 PROTEIN AND ITS INTERACTIONS 
WITH CHAPERONES AND THE GET4/GET5 COMPLEX 
Abstract 
The insertion of tail-anchored transmembrane (TA) proteins into the appropriate 
membrane is a post-translational event that requires stabilization of the transmembrane 
domain and targeting to the proper destination. Sgt2 is a heat-shock protein cognate 
(HSC) co-chaperone that preferentially binds endoplasmic reticulum–destined TA 
proteins and directs them to the GET pathway via Get4 and Get5. Here, we present the 
crystal structure from a fungal Sgt2 homolog of the tetratricopeptide repeat (TPR) 
domain and part of the linker that connects to the C-terminal domain. The linker extends 
into the two-carboxylate clamp of the TPR domain from a symmetry-related molecule 
mimicking the binding to HSCs. Based on this structure, we provide biochemical 
evidence that the Sgt2 TPR domain has the ability to directly bind multiple HSC family 
members. The structure allows us to propose features involved in this lower specificity 
relative to other TPR containing co-chaperones. We further show that a dimer of Sgt2 
binds a single Get5 and use small angle X-ray scattering to characterize the domain 
arrangement of Sgt2 in solution. These results allow us to present a structural model of 




Chartron, J.W., Gonzalez, G.M., and Clemons, W.M., Jr. (2011). A structural model of 
the Sgt2 protein and its interactions with chaperones and the Get4/Get5 complex. J. Biol. 
Chem. 286, 34325-34334. 
Introduction 
The eukaryotic cell is a complex environment of multiple membrane-bound organelles, 
each with a unique set of resident integral membrane proteins. Biogenesis of these 
proteins requires mechanisms for targeting and insertion into the correct membrane. For 
the majority destined to the ER membrane, this is accomplished via the signal recognition 
particle pathway (Walter and Johnson, 1994). Major exceptions to this rule are tail-
anchor transmembrane (TA) proteins that are defined topologically by a single 
transmembrane helix within 30 residues of the C-terminus. Examples are found in all 
membranes exposed to the cytoplasm (Borgese et al., 2007; Kutay et al., 1993). A 
dedicated targeting pathway for ER destined TA proteins has been elucidated and is 
called the GET pathway (Guided Entry of TA proteins) in yeast (Schuldiner et al., 2008). 
The central player is Get3, a cytosolic ATPase that sequesters the transmembrane 
segment of a newly synthesized TA protein for targeting. A multiprotein complex 
consisting of Get4/Get5 and Sgt2 loads the TA protein onto Get3 (Wang et al., 2010). 
Get4 is an α-helical repeat protein that forms an obligate dimer with the N-terminal 
domain of Get5 (Bozkurt et al., 2010; Chang et al., 2010; Chartron et al., 2010), which 




Sgt2, the small glutamine-rich tetratricopeptide repeat (TPR) containing protein (SGT in 
mammals), is a 38-kDa protein highly conserved across eukaryotes (Kordes et al., 1998). 
It consists of an N-terminal homodimerization domain, a TPR domain composed of three 
TPR repeats, and a C-terminal domain that is rich in glutamine and methionine (Liou and 
Wang, 2005; Tobaben et al., 2003; Worrall et al., 2008). The Sgt2 dimer has a larger 
hydrodynamic radius than expected for a globular protein suggesting an extended 
conformation (Liou and Wang, 2005; Worrall et al., 2008). SGT interacts with a variety 
of proteins, notably heat-shock proteins and their cognates (referred to here in general as 
HSC) such as Hsc70 and Hsp90, which bind directly to the TPR domain (Angeletti et al., 
2002; Liou et al., 2007; Liou and Wang, 2005; Worrall et al., 2008). SGT binding to 
HSCs appears to modulate the chaperone ATPase activity and folding rates dependent on 
other HSC co-chaperones. Binding to Hsc70 decreases ATPase activity and protein 
folding rates, whereas a neuronal Hsc70 complex, including SGT and cysteine string 
protein, stimulates ATPase activity (Angeletti et al., 2002; Tobaben et al., 2001; Wu et 
al., 2001). SGT also binds a number of viral proteins, and, in one case, the interaction 
was mediated by the TPR domain (Callahan et al., 1998; Cziepluch et al., 1998; Fielding 
et al., 2006). The C-terminal domain of SGT is capable of binding hydrophobic regions 
of protein, such as the N-terminal signal sequence of myostatin and in vitro translated 
type 1 glucose transporter (Liou and Wang, 2005; Wang et al., 2003). 
The initial links between Sgt2 and Get5 were from proteome-wide yeast two-hybrid and 
tandem-affinity purification assays (Krogan et al., 2006; Uetz et al., 2000). Additional 
yeast two-hybrid and pulldown assays demonstrated that an N-terminal construct of Sgt2 
was necessary and sufficient for binding to Get5, and consequently Get4, in an 
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interaction also dependent on the Ubl domain of Get5 (Chang et al., 2010; Liou et al., 
2007). A direct role for Sgt2 in the TA targeting pathway was shown by two independent 
genetic interaction analyses indicating a strong functional connection with other GET 
pathway members (Battle et al., 2010; Costanzo et al., 2010). Both demonstrated TA 
protein mislocalization in Sgt2 deletion strains, and Battle et al. (2010) proposed that 
Sgt2 acts functionally upstream of Get5 and the other GET members. Most recently, it 
has been shown using an in vitro translation system that Sgt2 can bind to ER destined TA 
proteins directly through the C-terminal hydrophobic-binding domain. With the aid of 
Get4/Get5, the TA protein is then transferred to Get3 (Wang et al., 2010). TA proteins 
destined to the mitochondria do not bind Sgt2 directly but are bound to TPR domain-
associated chaperones. 
TPR domains are defined by a variable number of two-helix, 34-residue motifs and 
frequently mediate protein-protein interaction (D'Andrea and Regan, 2003). A subclass 
acts as co-chaperones of HSCs by regulating nucleotide hydrolysis cycles, physically 
linking multiple HSC families, and/or connecting protein-folding pathways with alternate 
pathways such as ubiquitination and degradation (Meacham et al., 2001). Examples are 
found in protein phosphatase 5, Hsp organizing protein (HOP in human, Sti1 in yeast) 
and C-terminus of Hsc70 interacting protein (CHIP) (Das et al., 1998; Scheufler et al., 
2000; Zhang et al., 2005). This TPR subclass is composed of three repeats followed in 
sequence by a C-terminal capping helix and recognizes the C-terminal residues of the 
HSC, exemplified by IEEVD in Hsc70 and MEEVD in Hsp90. Five conserved residues 
from the TPR domain mediate this interaction forming a motif named the two-
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carboxylate clamp, based on the recognition of the terminal acidic residue and the main-
chain carboxylate (Scheufler et al., 2000). 
Here we report the crystal structure of the Sgt2 TPR domain from the filamentous 
fungus Aspergillus fumigatus (AfSgt2). A crystallographic contact generates a 
serendipitous interaction that mimics the carboxyl sequence of many HSCs binding to a 
TPR co-chaperone. Based on a structural analysis, we demonstrate biochemically that the 
Sgt2 TPR domain in Saccharomyces cerevisiae (Sgt2) can directly bind to at least four 
different HSC families. We also test the potential stoichiometry between Sgt2 and Get5 
and characterize the structure of Sgt2 in solution, allowing us to present a structural 
model for the higher order complex between chaperones, Sgt2 and Get4/Get5. 
Results 
Crystal Structure of a Fungal Sgt2 TPR Domain 
We expressed the TPR and C-terminal domains of the A. fumigatus homolog of Sgt2 
(AfSgt2), corresponding to residues 109–341, in E. coli and purified it using nickel-
nitrilotriacetic acid affinity chromatography. There was an extensive range of proteolysis, 
and two major species could be resolved by SEC (Figure 3.1). The smaller protein is a 




Figure 3.1. Purification of AfSgt2-TPR-C. (A) Size exclusion chromatography of 
AfSgt2-TPR-C after Ni-affinity chromatography using a Superdex 75 16/60 column. (B) 
SDS-PAGE of the region indicated in (A) with elution volume indicated per lane. 
Fractions labeled in red were used for crystallization trials without further purification. 
The major band has a molecular weight of 17,547 Da by mass spectrometry and migrates 
slower than the molecular weight standards on the gel. 
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molecular mass of residues 109–267. This protein yielded orthorhombic crystals in space 
group F222 that diffracted to a maximum of 1.72 Å resolution. The crystal structure was 
solved by molecular replacement using the human SGT α-isoform TPR domain (SGTA) 
(Dutta and Tan, 2008) as a search model. A single copy of the TPR domain (AfSgt2-TPR) 
was located in the asymmetric unit (Figure 3.2A). Electron density extending from the C-
terminal helix of the TPR domain could be modeled as 21 residues of the linker 
connecting to the C-terminal domain. Overall, unambiguous electron density throughout 
the entire chain allowed residues 109–254 to be modeled and refined to an Rfactor of 0.168 
and an Rfree of 0.208. Complete crystallographic statistics are shown in Table 3.1. 
The AfSgt2-TPR has 38% sequence identity and 60% similarity to the SGTA TPR 
domain and shares an architecture consisting of three TPR repeats comprised by helices 
α1–α6 with a “capping” helix, α7 (Figure 3.2A,E). Like other domains composed of three 
TPR repeats, these seven helices are arranged in a right-handed supercoil (D'Andrea and 
Regan, 2003) resulting in a concave surface lined by α1, α3, α5, and α7. The Cα root 
mean square deviation between the TPR domains of the SGTA and AfSgt2 is 1.2 Å. 
Relative to the truncated SGTA construct, α7 is extended by five residues, and the angle 
formed between α6 and α7 is increased by ∼10° (Figure 3.2B). Unlike the SGTA crystal 
structure, which lacks extensive intermolecular contacts, AfSgt2-TPR forms a 
crystallographic dimer with a symmetry-related copy, burying 2108 Å2 of solvent-
accessible surface area (Figure 3.2A, inset). This interface is mediated by the α7 helices, 
which pack head to tail against one another, and residues 240–254 of the linker to the C-








Figure 3.2. Crystal structure of AfSgt2 TPR domain. (A) The asymmetric unit shown 
as a ribbons diagram with color ramped from the N (blue) to C (red) termini. The region 
in gray is a cloning artifact. The crystallographic dimer is inset. (B) AfSgt2-TPR as in (A) 
superposed on human SGTA TPR domain (gray, PDBID 2VYI). (C) Superposition of 
AfSgt2 and bound C-terminal linker (rainbow, magenta carbons) onto Hsc70 peptide-
bound HOP TPR1A (gray, cyan carbons, PDBID 1ELW). (D) AfSgt2 TPR groove with a 
1σ 2|Fo|−|Fc| simulated annealing omit map of the C-terminal linker of AfSgt2 (gray 
carbons). Hydrogen bonds to conserved two-carboxylate clamp residues (magenta 
carbons) are indicated as black dashes. Residues are labeled based on the AfSgt2 
sequence. Sgt2-specific residues are shown as cyan carbons. The FAA mutant positions 
are underlined. (E) Alignment of the sequence observed in the crystal structure. 
Sequences are: Af, A. fumigatus; Sc, S. cerevisiae; Ce, C. elegans; Hs, Homo sapiens; T1, 
H. sapiens HOP TPR1; T2, H. sapiens HOP TPR2a. The numbering above is from A. 
fumigatus. Residues predicted to be involved in substrate specificity are marked with 
asterisks. The locations of the FAA mutations are indicated with arrowheads. Two-
carboxylate clamp residues and conserved Sgt2 residues are highlighted in magenta and 
cyan, respectively. Further TPR conserved residues are highlighted in red. The C-
terminal linker bound in the TPR groove is highlighted in gray. 
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conformation. This includes a well-ordered interaction between two acidic side chains 
(Glu-239 to Asp-194) outside the groove that is unlikely to occur in vivo and may be 
stabilized by the low pH of crystallization. 
Fortuitously, the sequence of residues 240–247 in AfSgt2, PPADDVDD, resembles the 
C-terminal residues of Hsp70 and Hsp90 homologs, exemplified respectively in yeast by 
PTVEEVD in Ssa1 and TEMEEVD in Hsc82. These sequences are recognized by a 
variety of TPR domains containing a two-carboxylate clamp that anchors the EEVD 
motif (Scheufler et al., 2000). Hsp70/Hsp90 Organizing Protein (HOP) contains three 
TPR domains designated TPR1, TPR2a, and TPR2b. TPR1 specifically binds Hsc70, 
whereas TPR2a binds Hsp90, and the crystal structures of these interactions have allowed 
an understanding of determinants of substrate specificity in TPR domains (Odunuga et 
al., 2003; Scheufler et al., 2000). The main chain conformation of the C-terminal linker 
region of AfSgt2 in our crystal structure is identical to that of the GPTIEEVD peptide 
bound to HOP TPR1 (Figure 3.2C). The two-carboxylate clamp is composed of five 
highly conserved residues that make hydrogen bonds to the main chain of the EEVD 
motif. In AfSgt2, Arg-187 (Arg-175; for clarity when referencing the structure A. 
fumigatus numbering will be used and S. cerevisiae sequence numbering will be provided 
in parenthesis) and Lys-183 (Arg-171) interact with the carbonyl of Asp-244 and Arg-
187 (Arg-175) makes an additional contact to the carbonyl of Asp-243 (Figure 3.2D). 
Asn-122 (Asn-110) extends from α3 to form a hydrogen bond with Asn-153 (Asn-141) 
from α5, and these two asparagines hydrogen bond with the amide and carbonyl of Asp-
246. Lys-118 (Lys-106) hydrogen bonds with the carbonyl of Asp-247, the equivalent 
position of the terminal carboxyl of Hsp70/90. In addition to these five canonical 
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residues, Tyr-181 (Tyr-169), conserved across eukaryotes, forms a hydrogen bond with 
the side chain of Asp-246 (Figure 3.2D,E). 
The TPR Domain of Sgt2 Is a General HSC Binding Interface 
Sgt2 is physically linked with several families of heat-shock proteins. Hsp70 homologs 
Ssa1 and Ssa2, Hsp110 homologs Sse1 and Sse2, the Hsp90 homolog Hsc82, and the 
Hsp100 homolog Hsp104 co-purify with Sgt2 from yeast lysate, and all of these 
interactions are abolished by mutation of residues in the two-carboxylate clamp 
(Costanzo et al., 2010; Wang et al., 2010). TPR domain containing co-chaperones often 
have specificity for different HSCs; therefore, we asked if Sgt2 can either bind each of 
these chaperone families directly or if co-immunoprecipitation of certain families were 
mediated by sub-complexes between chaperones. For example, Sse1 can form a stable 
complex with Ssa1 (Shaner et al., 2005). SGT and a homolog from C. elegans can bind 
directly to either Hsp70 or Hsp90 (Angeletti et al., 2002; Liou and Wang, 2005; Worrall 
et al., 2008). Using a nickel affinity pulldown assay, purified Ssa1 and Hsc82 bind 
directly to a polyhistidine-tagged TPR domain of Sgt2 (Figure 3.3A lanes 1-2 and 4-5). A 
triple mutant of the Sgt2-specific Y169F and the two-carboxylate clamp residues R171A 
and R175A (designated “FAA” corresponding to AfSgt2 numbering Y181/K183/R187 
(Figure 3.2D,E), reduced binding to background levels (Figure 3.3A, lanes 3 and 6). 
Hsp104 has a C-terminal sequence of MEIDDDLD and binds to the two-carboxylate 
clamp in Cpr7 and the TPR1 domain of Sti1 (Abbas-Terki et al., 2001). The C-terminal 






Figure 3.3. Sgt2 binds multiple chaperone families. (A) SDS-PAGE of nickel affinity 
pulldown assays of Ssa1, Hsc82, Sse1, or Hsp104 in the absence of Sgt2 (−), with wild 
type polyhistidine-tagged Sgt2-TPR (WT) or polyhistidine-tagged Sgt2-TPR-FAA 
(FAA). (B–D) Hydrophobic binding pocket on the TPR groove (cyan) with bound 
peptides (magenta) of AfSgt2-TPR with symmetry molecule (B), H. sapiens HOP TPR1 
with Hsp70-derived peptide (PDB ID 1ELW) (C), and H. sapiens HOP TPR2A with 
Hsp90-derived peptide (PDBID 1ELR) (D). 
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Sse1 and Hsp104 bind to the TPR domain of Sgt2 dependent on the two-carboxylate 
clamp (Figure 3.3A, lanes 7–12). 
The structural basis for TPR domain specificity has been well characterized in HOP/Sti1. 
The TPR1 domain of HOP/Sti1 binds Hsp70 and Hsp100, whereas the TPR2A domain 
binds Hsp90 (Abbas-Terki et al., 2001; Scheufler et al., 2000). The identity of the 
hydrophobic residues preceding the EEVD terminus of Hsp70 and Hsp90 is critical for 
specific binding (Brinker et al., 2002). Structure-guided mutational analysis determined a 
set of TPR residues that impact specificity, in particular TPR residues equivalent to 
positions Met-125 (Met-113), Ser-159 (Ser-147), and Ala-160 (Ser-148) in AfSgt2 
(Figures 3.2E and 3.3B) (Odunuga et al., 2003). In HOP-TPR1, these positions are 
occupied by Leu-15, Ala-49, and Lys-50, and the isoleucine of the Hsp70 GPTIEEVD 
sequence fits between the alanine and lysine side chains on α3 (Figure 3.3C). 
Alternatively, in HOP-TPR2a, the respective positions are occupied by Tyr-236, Phe-270, 
and Glu-271, and the methionine of the Hsp90 MEEVD sequence is found between α3 
and α1 interacting with the tyrosine and glutamate (Figure 3.3D). A structure of HOP-
TPR2a bound with non-cognate Hsp70-derived peptide shows that the isoleucine is not 
accommodated and becomes solvent exposed (Kajander et al., 2009). In contrast with the 
HOP/Sti1 TPR domains, these positions in Sgt2 create an open pocket that we predict 
accommodates a wider range of substrates (Figure 3.3B). Met-125 (Met-113) is 
conserved across the eukaryotic kingdom; Ser-159 (Ser-147) and Ala-160 (Ser-148) are 
highly conserved in fungi (Figure 3.2E). Higher eukaryotes have a conserved basic 
residue at position 160, perhaps indicating variation in specificity. Additionally, Ala-155 
	  	  
98 
(Ala-143), Ala-156 (Ala-144), and Ala-157 (Ala-145) are strictly conserved in Sgt2 and 
complete the substrate interacting face of α3 (Figures 3.2E and 3.3B). 
Another characterized example of binding to multiple heat-shock protein families is the 
C-terminal TPR domain of Hsp70 interacting protein, CHIP, which can bind either Hsp70 
or Hsp90. Structures with peptides derived from either chaperone show that, rather than 
binding in an extended conformation, the bound peptide kinks immediately prior to the 
EEVD motif to position the upstream isoleucine or methionine into a large hydrophobic 
pocket lined by α5, α6, and α7 that is unique to CHIP (Wang et al., 2011; Zhang et al., 
2005). 
The Sgt2 Dimer Binds a Single Copy of Get5 at a Canonical Ubl Interface 
Yeast two-hybrid assays (Chang et al., 2010; Liou et al., 2007) and analytical SEC (Wang 
et al., 2010) indicated that the N terminus of Sgt2 and the Ubl domain of Get5 are 
necessary for binding between these two proteins; however, molecular details of this 
interaction remain to be defined. We used a nickel affinity pulldown assay to further 
characterize the complex. Residue ranges of the domains of Sgt2 and Get5 are defined in 
Figure 3.4A. Polyhistidine-tagged Get4/Get5 can bind Sgt2 (Figure 3.4B, lane 2), as well 
as Get4/Get5ΔC (Figure 3.4B, lane 3), indicating that dimerization of Get4/Get5 is not 
essential for the interaction. Further deletion of the Ubl domain abolishes binding to Sgt2 
(Figure 3.4B, lane 4). We previously identified a double mutant of Get5, L120A/K124A, 
that resulted in incomplete rescue of a Get5 deletion strain and is predicted to disrupt a 
conserved binding interface in ubiquitin-like domains (Chartron et al., 2010; Hicke et al., 






In the absence of Get4, recombinant Get5 is unstable and prone to forming inclusion 
bodies or susceptible to proteolysis (Chartron et al., 2010; Liou et al., 2007; Wang et al., 
2010). Removing the N-terminal Get4 binding domain results in a stable Get5-Ubl-C 
(Chartron et al., 2010), which is capable of binding to Sgt28(Figure 3.4B, lane 6). We 
generated a construct of the N-terminal 72 residues of Sgt2. This minimal domain alone 
was sufficient to bind to Get4/Get5 (Figure 3.5A). From this assay, we conclude that the 
interaction between Get4/Get5 and Sgt2 is predominantly between the Ubl domain of 
Get5, and the N-terminal domain of Sgt2 and is mediated by a canonical binding 
interface. 
We next investigated the stoichiometry of the interaction between Sgt2 and Get5. After 
formation, complexes of Sgt2 and Get5 are stable and can be purified from unbound 
protein by SEC (Figure 3.6). Purified complexes are stable upon further SEC and were 
subjected to SEC coupled with MALLS for molecular weight determination (Figure 3.4C 
and Table 2). The Sgt2-N dimer possibly has two unique binding interfaces; therefore, up 
to two copies of Get5-Ubl might be expected to bind. However, only a single higher 
weight peak was observed after incubation with a 3-fold stoichiometric excess of Get5-
Ubl (Figure 3.6). The MALLS molecular weight of this complex was 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Figure 3.4. The Sgt2-Get4/Get5 complex. (A) Schematics indicating residue ranges of 
domains described in text with corresponding letter abbreviations. (B) SDS-PAGE of 
nickel affinity pulldown assays. Get4 and Get5 are abbreviated as 4 and 5, respectively, 
with “h” indicating the polyhistidine-tagged protein. (C) SEC-MALLS of Sgt2 and 
Get4/Get5 complexes. Traces are normalized to maximum differential refractive index. 
Horizontal lines are experimentally measured molecular weight (right axis). Proteins 
added in 3-fold stoichiometric excess to generate complexes are Get5-Ubl (top), Sgt2-N 





Figure 3.5. Sgt2 interactions. (A) Nickel affinity capture of Sgt2-N (residues 1-72) by 
poly-histidine tagged Get4/Get5. (B) Nickel affinity capture of indicated protein 
mixtures. The lanes indicated with the horizontal bar are 1/10 the total amount of protein 




Figure 3.6. Formation of the Sgt2-N/Get5-Ubl complex. Size exclusion 
chromatography was performed with a Superdex 75 16/60 column. The top 
chromatogram is Sgt2-N alone and the bottom is Sgt2-N incubated with a three-fold 
stoichiometric excess of Get5-Ubl. Get5-Ubl does not contain tryptophan or tyrosine but 
absorbs at 214 nm. 
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most consistent with an Sgt2-N dimer and a single copy of Get5-Ubl (Figure 3.4C, top, 
and Table 3.2). Similarly, when Sgt2-N-TPR was incubated with excess Get5-Ubl the 
determined molecular weight of the resulting complex was in closer agreement with a 
single bound copy of Get5-Ubl than two copies. Under the conditions tested here, we did 
not detect Sgt2 binding to more than one copy of Get5.	   
 
When Get5-Ubl-C was incubated with excess Sgt2-N, the resulting complex had a 
determined molecular mass of 57.88 kDa (Figure 3.4C, middle). A complex of a Get5-
Ubl-C dimer with a single Sgt2-N dimer has an expected molecular mass of 49.4 kDa and 
also with two Sgt2-N dimers of 65.2 kDa. When Get4/Get5 was incubated with excess 
Sgt2-N-TPR, the resulting complex had a molecular mass of 186 kDa, a value closer to a 
single copy of the Get4/Get5 dimer with a single copy of the Sgt2-N-TPR dimer (Figure 
3.4C, bottom). Although full-length Sgt2 can interact with Get4/Get5 (Figure 3.4B), the 
same sample by SEC showed no higher peaks relative to each protein run individually. 
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This could suggest a conformational change resulting in a similar hydrodynamic radius 
for the complex relative to the individual proteins; however, it is more likely that the 
complex simply was not stable by this method. It is possible that steric clashes between 
Get4 and the Sgt2-C domain, or increased entropic costs, reduce the binding affinity. 
Ydj1 Does Not Directly Bind the Sgt2-Get4/Get5 Complex 
The yeast DnaJ homolog Ydj1 is reported to bind Get5, which mediates a genetic 
interaction between Ydj1 and Sgt2 (Liou et al., 2007). In that study, recombinant Get5, in 
the absence of Get4, formed an in vitro complex with Ydj1. We tested whether Ydj1 
binds to purified Get4/Get5 but did not see any enrichment in a pulldown assay, nor 
could we detect binding with the addition of Sgt2 or Ssa1 (Figure 3.5B). The N-terminal 
domain of Get5 causes the protein to aggregate in the absence of Get4, and we propose 
that Ydj1 binds in response to this aggregation. Rather than directly interacting with Sgt2, 
Get4, or Get5, the genetic linkage is likely due to the role of Ydj1 in regulating Ssa1. It is 
noteworthy that Sis1, the other DnaJ homolog in yeast, co-immunoprecipitates with Sgt2 
dependent upon two-carboxylate clamp (Wang et al., 2010). 
SAXS of Sgt2 
Sgt2 is a multidomain dimeric protein with an extended conformation whose domain 
arrangement is unknown. Small angle X-ray scattering (SAXS) allows determination of 
particle size, analysis of flexibility, and ab initio determination of low-resolution 
structure. This allows modeling of higher order assemblies when coupled with high-
resolution structures of individual domains. SAXS was performed on Sgt2 using the 
constructs indicated in Table 3.2. Values for radius of gyration (Rg) and the maximum 
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particle distance (Dmax) were obtained from the indirect Fourier transform processed in 
GNOM. We generated ab initio models of Sgt2-N and Sgt2-N-TPR using GASBOR 
(Svergun et al., 2001), which uses dummy residues restrained with simulated chain 
connectivity to fit experimental data. A total of 20 independent models was generated for 
each construct, and these were superposed, averaged, and filtered using DAMAVER 
(Volkov and Svergun, 2003). The resulting model represents the most probable volume 
shared by the individual models. Sgt2-N was reconstructed as a somewhat spherical 
particle, in agreement with the p(r) function, which has a single peak that smoothly 
approaches zero (Figure 3.7A,B). The p(r) function of Sgt2-N-TPR is indicative of 
multiple folded domains as it has more than one peak (Figure 3.7C). Sgt2-N-TPR 
reconstructed as a curved tubular shape, with two volumes, appropriately sized for TPR 
domains, extending out from the dimerization domain in the same plane (Figure 3.7D). 
We additionally modeled Sgt2-N-TPR with the program BUNCH, which allows fitting to 
multiple SAXS curves in cases where scattering from truncations are available, and it 
also fits high resolution structures as rigid bodies (Petoukhov and Svergun, 2005). In this 
case, the fit utilized the TPR crystal structure and Sgt2-N curve in addition to the Sgt2-N-
TPR curve. Unknown regions were generated ab initio as dummy residues. The resulting 
models are in agreement with the averaged GASBOR model (Figure 3.7E). The 
orientation of the TPR domain groove is not resolved by SAXS; it may be resolution-
limited or averaged due to flexibility in the inter-domain linker. Importantly, the angle 
formed between the TPR domains and the N-domain, as well as the end-to-end distance 






Figure 3.7. SAXS of Sgt2-N and Sgt2-N-TPR. (A) and (C) Experimental SAXS curve 
(black), fits of the best GASBOR (red) and BUNCH (blue) models and pair-probability 
functions (inset) for Sgt2-N (A) and Sgt2-N-TPR (C). (B) and (D) ab initio 
reconstructions of 20 averaged and filtered GASBOR models of Sgt2-N (B) and Sgt2-N-
TPR (D). Bottom images are rotated relative to top images. (E) Four example BUNCH 
models. Blue regions were fit to both Sgt2-N and Sgt2-N-TPR data, while red regions 
were fit to only Sgt2-N-TPR. 
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From primary sequence, Sgt2-TPR-C is expected to have high flexibility, and the shape 
of the Kratky plot is characteristic of a partially folded protein as intensity plateaus to a 
nonzero value as Q increases (Doniach, 2001) (Figure 3.8A). The program EOM 
interprets SAXS data of flexible proteins by selecting ensembles of structures to fit 
scattering from a large, diverse pool of structures (Bernado et al., 2007). The AfSgt2-TPR 
crystal structure was linked with 10,000 random Cα models of the C-terminal domain. An 
ensemble of 50 structures was fit to the data (Figure 3.8B). The Rg and Dmax distributions 
(Figure 3.8C,D) of the fitted structures have similar center and shape to the entire random 
pool of structures, indicating unrestricted flexibility between the TPR and C-terminal 
domains. 
We further used SAXS to confirm the stoichiometry between Sgt2 and Get5. Using data 
for the purified Sgt2-N/Get5-Ubl complex, the molecular envelope was reconstructed 
with the program DAMMIF (Figure 3.9A,B). DAMMIF uses dummy atoms to fill a 
volume that satisfies the SAXS curve and, unlike GASBOR, does not require total 
residue number as an input, reducing bias of the complex stoichiometry. The averaged 
model is ellipsoidal, with a long dimension of ∼60 Å. This can only be fit with the 40 Å 
diameter reconstruction of the Sgt2-N dimer (Figure 3.7B) and a single Get5-Ubl of 







Figure 3.8. SAXS of the flexible Sgt2-TPR-C. (A) Kratky plot; (B) experimental SAXS 
curve of Sgt2-TPR-C (black) with EOM fit (red); (C) and (D) Rg and Dmax distributions, 
respectively, for 10,000 random C-domain models relative to the TPR domain (dashed 
lines) versus 50 models fit to experimental data (solid lines). Correlation suggests 






Figure 3.9. SAXS of an Sgt2/Get5 complex. (A) Experimental SAXS curve (black) 
versus fit of the best DAMMIF model (red). The pair-probability function of Sgt2-
N/Get5-U is inset. (B) Filtered average of 20 DAMMIF models. (C) Filtered average 
GASBOR model of Sgt2-N (blue spheres) and space filling model of a homology model 





The mechanism for the sorting of TA proteins among the variety of target membranes is 
only beginning to be understood. Sgt2 appears to selectively bind ER destined TA 
proteins transferring these substrates with the aid of Get4/Get5 to Get3. Sgt2 contains a 
TPR domain that physically links the GET pathway to other chaperone pathways. 
Although other characterized TPR domain-containing co-chaperones are limited in their 
binding to one or two heat-shock protein families, we demonstrate here that the Sgt2 TPR 
domain can bind directly to members of at least four families. This promiscuity is 
explained by the structure of the Sgt2 TPR domain. A phylogenetic analysis of TPR 
domain sequences indicated that the Sgt2 TPR domain is most similar to the HOP 
domains (Schlegel et al., 2007) and, indeed, in our structure, bound peptide adopts an 
identical conformation. The determinants of substrate specificity include the conserved 
binding pocket formed by residues Met-125 (Met-113), Ala-155 (Ala-143), Ala-156 
(Ala-144), Ala-157 (Ala-145), Ser-159 (Ser-147), and Ala-160 (Ser-148). This wider 
pocket is sterically less restrictive than the HOP TPR domains presumably allowing for 
the binding of non-canonical two-carboxylate clamp substrates such as the EGDVDMD 
of Sse1. Moreover, human SGTA TPR can interact with an internal stretch in the 
androgen receptor that does not contain a clear binding motif suggesting an even broader 
specificity (Buchanan et al., 2007). In addition to the five two-carboxylate clamp 
residues, a conserved tyrosine contributes a hydrogen bond to the side chain of the 
residue corresponding to the terminal residue in Hsp70 or Hsp90. It is possible that this 
further stabilizes binding to longer sequences. 
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Is it simply fortuitous that the linker following the AfSgt2 TPR contains the sequence 
PPADDVDD, resembling an HSC termini? Evidence for a possible functional role is that 
the sequence is conserved in the Eurotiomycetes family, of which A. fumigatus is a 
member, and S. cerevisiae Sgt2 contains the related sequence SRDADVDA (Figure 
3.2E). Unfortunately, similar regions are not found more broadly in other fungal 
homologs, and there are no comparable sequences found in higher eukaryotes. This does 
not rule out family-specific specialization, perhaps binding other co-chaperones; 
however, it makes a general conserved role for this sequence unlikely. 
Sgt2 forms a direct complex with Get4/Get5 mediated by the dimerization domain of 
Sgt2 and the Ubl domain of Get5. Despite possible symmetry of Sgt2-N, only a single 
copy of Get5-Ubl can bind with high affinity. The Vps9-CUE domain is a homodimeric 
α-helical domain that binds ubiquitin at its symmetry axis and undergoes a 
conformational change that breaks symmetry to resemble a ubiquitin-associating domain 
(Shih et al., 2003). The Sgt2/Get5 complex may undergo similar rearrangements. 
Alternatively, binding of one copy may simply occlude a second binding site. The 
inability of Sgt2 to bind a second Ubl domain creates a potential for the Get4/Get5 dimer 
to bind two dimers of Sgt2. In vitro, complexes between the minimal binding domains are 
stable indefinitely; however, as additional domains are included only a single dimer of 
Sgt2 can bind Get4/Get5, and the full-length proteins do not form a complex stable over 
SEC. This leaves the overall in vivo stoichiometry ambiguous. It is likely that other 
factors, such as the Get4 to Get3 interaction, may result in a dynamic complex. 
	  	  
112 
Based on the data we present here, we can suggest an updated model for the role of Sgt2 
in TA targeting and an overall structure of the Sgt2/Get4/Get5/HSC complex (Figure 
3.10). The SAXS analysis of Sgt2-N-TPR suggests that the TPR domains have 
independent motion. Coupled with the observations that N-domain deletions still bind 
both HSC and TA proteins (Wang et al., 2010), we conclude that the two Sgt2-TPR-C 
domains act independently. This would allow for the Sgt2 dimer to bind multiple HSCs 
simultaneously. The dimerization domain of Sgt2 would bind one Ubl of the Get4/Get5 
heterotetramer. Sgt2 will sequester an ER-bound TA and deliver it specifically to Get3. 
This work allows us to speculate on the interplay of HSCs and the GET pathway. The 
low specificity for HSC families suggests that Sgt2 can interact with unfolded proteins 
distributed among the majority of protein folding pathways in the cell. This may allow 
Sgt2 to act as a general recovery pathway for TA proteins through its TPR domain, 
consistent with a recent observation that the TPR domain is not essential for targeting of 
certain substrates by Get3 under low stress conditions (Kohl et al., 2011). Perhaps more 
prominently, given the genetic role of Sgt2 in the GET pathway, Sgt2 uses the TPR 
domain to couple multiple folding pathways with TA targeting. This would allow TA 
substrates with a variety of folding needs to enter the GET pathway. Combined, this 
suggests two possible routes for TA proteins through Sgt2: either HSCs bind the TA 






Figure 3.10. Model for the Sgt2/Get4/Get5/HSC complex. Sgt2 (purple) is bound to 
Get4/Get5 via the Ubl domain (green). TA protein (red) transmembrane domain may 
initially be in complex with an HSC (e.g., with Ssa1, yellow) with subsequent binding to 
the Sgt2-TPR and transfer to Sgt2-C. Alternatively, the transmembrane domain initially 
binds to Sgt2-C and chaperones required for substrate stabilization are bound to the Sgt2-
TPR. The complex then releases the TA protein to Get3. 
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recruited to either aid in folding or to act as acceptors if the TA protein is not ER 
destined. 
TA proteins are diverse with the majority specifically targeted to either the ER or 
mitochondria. For those destined to the ER, both the GET pathway and Hsp70 operate 
post-translational targeting pathways, the former being critical as TA hydrophobicity 
increases (Rabu et al., 2008). Targeting of TA proteins to the mitochondria is less 
characterized. It has been suggested that this may only depend on Hsp70/90-mediated 
targeting to the co-chaperone TPR receptors on the mitochondria (Abell and Mullen, 
2011; Borgese and Fasana, 2011). This type of targeting could be more general as co-
chaperone TPR receptors exist on every organelle (Kriechbaumer et al., 2012; Schlegel et 
al., 2007). These overlapping or alternative pathways may allow delivery independent of 
the GET pathway, possibly explaining why none of the individual GET components are 
essential under optimal conditions. All of this would suggest an important role for co-
chaperone TPR proteins in delivery of TA proteins. Sgt2 would be the central co-
chaperone acting as a sortase to optimize correct delivery to the GET pathway. If so, TA 
targeting by Sgt2 may be more akin to panning for gold, retaining substrate proteins for 




Cloning, Expression, and Purification 
Get4/Get5 was prepared as previously described (Chartron et al., 2010). Sgt2, Ssa1, Sse1, 
Hsc82, and Hsp104 were amplified from genomic DNA isolated from S. cerevisiae strain 
S288C (AfSgt2 from A. fumigatus strain 118, ATCC) and ligated into pET33b-derived 
vectors that added N-terminal hexahistidine tags separated by a tobacco etch virus 
protease site. Truncations were prepared by using QuikChange mutagenesis (Stratagene). 
Except for the crystallography, all experiments used Sgt2 and its variants from the S. 
cerevisiae homolog. 
Sgt2 variants were expressed in Escherichia coli BL21(DE3)Star (Invitrogen). Cells were 
lysed by sonication, and proteins were purified by nickel affinity chromatography 
(Qiagen). Proteins were digested with tobacco etch virus protease for 3 h at room 
temperature, and uncut protein and protease were removed by incubation with nickel-
nitrilotriacetic acid-agarose beads. Proteins were further purified by size-exclusion 
chromatography (SEC) using Superdex 200 or Superdex 75 (GE Healthcare) and 
concentrated to 10–20 mg/ml in 20 mM Tris, 100 mM NaCl, 5 mM 2-mercaptoethanol, 
pH 8.0. The molecular weight of the AfSgt2 truncation product was determined by 
LC/MS at the Protein/Peptide MicroAnalytical Laboratory at Caltech. 
Ssa1, Sse1, Hsc82, and Hsp104 were expressed in Rosetta(DE3) (Novagen), lysed by 
sonication in 50 mM K-HEPES, 300 mM KCl, 20 mM imidazole, 5 mM 2-
mercaptoethanol, and 0.1% Triton X-100, pH 8.0 and purified by nickel affinity 
chromatography. Proteins were dialyzed against a buffer containing 0.1 mM EDTA 
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during cleavage by tobacco etch virus protease and further purified by anion-exchange 
chromatography (ResourceQ, GE Healthcare) and SEC. Proteins were concentrated to 
10–20 mg/ml in 20 mM K-HEPES, 100 mM KCl, 5 mM 2-mercaptoethanol, pH 8.0. 
Pulldown Assays 
Binding reactions between Get4/Get5 and Sgt2 were performed in 50 µl of a 10% slurry 
of nickel-nitrilotriacetic acid-agarose in a binding buffer of 20 mM Tris, 100 mM NaCl, 
40 mM imidazole, pH 8.0. Per reaction, 8 µM of each protein was mixed for 10 min at 
room temperature. The resin was washed three times with 100 µl of binding buffer and 
eluted with binding buffer supplemented with 20 mM EDTA. Reactions between Ssa1, 
Sse1, Hsc82, and Hsp104 with the Sgt2 TPR domain were performed in 50 µl of 20 
mM K-HEPES, 100 mM KCl, 20 mMimidazole, 5 mM MgCl2, 5 mM ADP, 5 mM 2-
mercaptoethanol, pH 7.5. 50 µM His-TPR domain were incubated with 5 µM chaperone 
on ice for 2 h and then added to 5 µl of nickel-nitrilotriacetic acid-agarose. The resin was 
washed twice with 100 µl of binding buffer and eluted with binding buffer with 300 
mM imidazole. 
SEC with MALLS 
Complexes between Sgt2 and Get4/Get5 were formed in 20 mM Tris, 100 mMNaCl, 5 
mM 2-mercaptoethanol, pH 7.0, and resolved by SEC using Superdex 200 or Superdex 
75. To generate saturated complexes, 3-fold stoichiometric excesses of the smaller 
protein were used. Complex peaks were confirmed by SDS-PAGE, concentrated to 10 
mg/ml, and separated on a Shodex KW-804 column with multiangle laser light scattering 
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(MALLS) data collected by a DAWN HELEOS and Optilab rEX detector. Data were 
processed with ASTRA (Wyatt). 
Crystallization 
Crystallization screening was performed using the sitting drop vapor-diffusion method 
with commercially available screens (Hampton Research, Qiagen, Molecular 
Dimensions) set up by a Mosquito robot (TTP Labtech) then incubated at room 
temperature. A proteolytic product of AfSgt2 crystallized after 1 week as rectangular 
prisms against a reservoir of 25% PEG 1500 and 0.1 MMES/malic acid/Tris buffer, pH 
4.0 (PACT Premier condition 37), with dimensions of ∼50 × 50 × 25 µm. They were 
soaked in reservoir solution with glycerol added to 10% for 15 min, surrounded with 
perfluoropolyether PFO-X175/08 (Hampton Research) and flash frozen in liquid 
nitrogen. 
Data Collection, Structure Solution, and Refinement 
X-ray diffraction data were collected on beam line 12-2 at the Stanford Synchrotron 
Radiation Laboratory (SSRL) using a Pilatus 6M pixel array detector at 100 K. A 
complete dataset was collected from a single crystal to 1.72 Å resolution. Data were 
integrated, scaled, and merged using MOSFLM (Battye et al., 2011) and SCALA (Evans, 
2006). Phases were determined by molecular replacement using the crystal structure of 
human SGT (PDB ID 2VYI) as a search model by PHASER (McCoy et al., 2007), and 
the model was rebuilt using RESOLVE (Terwilliger, 2004). The model was refined using 
COOT (Emsley et al., 2010) and PHENIX (Adams et al., 2010). Secondary structure-
matching root mean square deviation values were obtained using COOT. Solvent-
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accessible surface area between copies was calculated using PISA (Krissinel and 
Henrick, 2007). Structure figures were prepared using PyMOL (Delano, 1998). 
Small Angle X-ray Scattering 
Samples were concentrated to 25 mg/ml and filtered through 0.22 µm membranes. 
Overnight dialysis was performed against 50 mM Tris, 100 mM NaCl, 5 mM 2-
mercaptoethanol, pH 8.0. Dilutions to 1, 2, 5, and 10 mg/ml were made using the 
dialysate, and concentrations were determined using an ND-1000 spectrophotometer 
(Nanodrop Technologies) and theoretical extinction coefficients derived from protein 
sequences. 
Data were collected at SSRL beam line 4-2 using a Rayonix MX225-HE detector, 1.13 Å 
wavelength X-rays, and a detector distance of 2.5 m. For each concentration, 20 
exposures of 1 s were collected covering a momentum transfer range of 0.0055–0.3709 
Å−1. Data were reduced, averaged, and buffer-subtracted using MARPARSE (Smolsky et 
al., 2007). Extrapolation to infinite dilution and merging were performed with PRIMUS 
(Konarev et al., 2003). Guiner analysis was performed using AutoRG, and distance 
distribution functions were determined with GNOM (Svergun, 1992). Ab initio 
reconstructions were performed using software available in the ATSAS package 
(Konarev et al., 2006). Sgt2-N and Sgt2-N-TPR were reconstructed with imposed 2-fold 
symmetry as an additional constraint on the data. Sgt2-N/Get5-Ubl was reconstructed 
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STRUCTURES OF THE SGT2/SGTA DIMERIZATION DOMAIN WITH THE 
GET5/UBL4A UBL DOMAIN REVEAL A NOVEL INTERACTION THAT FORMS A 
CONSERVED DYNAMIC INTERFACE  
Abstract 
In the cytoplasm, the correct delivery of membrane proteins is an essential and highly 
regulated process. The post-translational targeting of the important tail-anchor membrane 
(TA) proteins has recently been under intense investigation. A specialized pathway, 
called the GET pathway in yeast and the TRC pathway in vertebrates, recognizes ER 
targeted TA proteins and delivers them through a complex series of handoffs. An early 
step is the formation of a complex between Sgt2/SGTA, a co-chaperone with a presumed 
ubiquitin-like-binding domain (UBD), and Get5/Ubl4a, a ubiquitin-like domain (UBL) 
containing protein. We structurally characterize this novel UBD/UBL interaction for both 
the yeast and human proteins. This is supported by biophysical studies that demonstrate 
that complex formation is mediated by electrostatics generating an interface that has high 
affinity with rapid kinetics. In total, this work provides a refined model of the interplay of 
Sgt2 homologs in TA targeting. 
Adapted from 
Chartron, J.W., VanderVelde, D.G., and Clemons, W.M., Jr. (2012). Structures of the 
Sgt2/SGTA dimerization domain with the Get5/Ubl4a UBL domain reveal a novel 




Two homologous pathways have been elucidated for the targeting of TA proteins to the 
ER (recently reviewed in Chartron et al., 2012a; Hegde and Keenan, 2011). The best 
characterized is the fungal GET pathway (Guided Entry of TA proteins). In its simplest 
form, a TA sorting complex comprising Sgt2, Get4, and Get5 (alternatively name Mdy2) 
facilitates the loading of a TA substrate onto the Get3 ATPase. The Get3/TA complex is 
targeted to the ER where the TA is released for insertion by the membrane proteins Get1 
and Get2. Vertebrates have a related system, referred to as the TRC pathway 
(Transmembrane domain Recognition Complex). In this case, the sorting complex 
similarly contains the proteins TRC35 and Ubl4a/Gdx, homologs of Get4 and Get5 
respectively; however, they form a three-component complex with the protein Bag6. 
From here, the TA is handed to a Get3 homolog, TRC40, that delivers the protein to 
WRB, a homolog of Get1.  
Sgt2, a heat-shock protein (HSP) co-chaperone, facilitates the first committed step in TA 
protein targeting. It recruits a variety of HSP families via an internal tetratricopeptide 
repeat (TPR) domain (Chartron et al., 2011; Wang et al., 2010). The Sgt2 C-terminal 
domain can bind to sequences of six or more hydrophobic residues (Liou and Wang, 
2005) including ER destined TA proteins, which are then handed to Get3 (Wang et al., 
2010). Mitochondrial TA proteins, which can also co-purify with the Sgt2/Get4/Get5 
complex, are associated with bound HSPs and are not transferred to Get3. The role of 
Sgt2 in sorting between target organelles is supported by the mislocalization of ER 
resident TA proteins to the mitochondria in Δsgt2 cells (Costanzo et al., 2010). The C-
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terminal domain, rich in asparagine, glutamine and methionine, contains only a short 
conserved sequence and is weakly predicted as helical. Sgt2 is flexible, especially 
between the TPR and C-terminal domains (Chartron et al., 2011; Liou and Wang, 2005). 
A small N-terminal homodimerization domain (Sgt2-N) mediates the association with 
Get5, where a dimer of Sgt2 binds a single copy of Get5 (Chang et al., 2010; Chartron et 
al., 2011; Liou et al., 2007).  
Get4 and Get5 form an adaptor required for the transfer of TA proteins from Sgt2 to Get3 
(Wang et al., 2010). Get4 forms a complex via the N-terminal domain of Get5 and 
sequesters a nucleotide bound Get3 (Bozkurt et al., 2010; Chang et al., 2010; Chartron et 
al., 2010). Get5 has a central ubiquitin-like domain (Get5-UBL) that binds Sgt2-N and a 
C-terminal homodimerization domain, resulting in an extended Get4/Get5 
heterotetrameric complex (Chartron et al., 2010; Chartron et al., 2012b). Disruption of 
the Get5-UBL/Sgt2-N interaction leads to incomplete rescue of Δget5 growth defects 
under stress conditions (Chartron et al., 2010; Liou et al., 2007). Moreover, the TA 
protein transfer reaction is competed by excess Get5, which cannot alone form a 
productive complex with Get3 (Wang et al., 2010). These results underscore the 
importance of the physical interaction between Sgt2 and the Get4/Get5 complex. The 
molecular details of the transfer of TA proteins, including energetic requirements and the 
in vivo stoichiometry of Sgt2, Get4/Get5 and Get3 over the course of the hand off, remain 
to be established. 
The yeast Get4/Get5/Sgt2/HSP complex has also been dubbed the TRC (Wang et al., 
2010). An analogous complex to Get4/Get5/Sgt2 exists in vertebrates; however, with 
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different organization and additional functions. The homologs of Get4 and Get5, named 
TRC35 and Ubl4a, along with Bag6 (alternatively named Bat-3 or Scythe) form the Bag6 
complex (Mariappan et al., 2010). Bag6 is a large, ~1100-residue protein with an N-
terminal UBL domain, a C-terminal BAG domain, and internal proline rich regions. 
SGTA, the homolog of Sgt2, associates with Bag6 through its N-terminus (Winnefeld et 
al., 2006) and Ubl4A is postulated to bridge this interaction (Chartron et al., 2012a; 
Hegde and Keenan, 2011). The Bag6 complex has the ability to load TA proteins onto 
TRC40 (Leznicki et al., 2010; Mariappan et al., 2010). In addition, it is involved in the 
degradation of mislocalized membrane and other defective proteins (Hessa et al., 2011; 
Minami et al., 2010; Wang et al., 2011).  
Here we use a combination of structural biology and biochemistry to define the 
interaction between Sgt2 and Get5 homologs. We present the first structures of the Sgt2-
N and SGTA-N homodimerization domains and characterize them as a new class of 
UBDs. Further, we solve the structure of the Get5-UBL demonstrating it as a novel UBL. 
Finally, we determined the structure of a complex between the Sgt2-N dimer and the 
Get5-UBL revealing an interaction strongly influenced by electrostatics. We use a variety 
of methods to demonstrate that this interaction has high affinity with rapid binding 
kinetics. This provides critical context for understanding the Sgt2/Get4/Get5 complex. 





The structures of Sgt2 and SgtA dimerization domains 
The Sgt2-N domain is both a homodimerization domain and a binding platform for the 
Get5-UBL domain. This provides the physical link between the Sgt2 chaperone complex 
and the GET pathway. Sgt2-N does not have sequence homology to known structures or 
other characterized UBDs. To understand how these dual functions are accomplished, we 
first determined the structure of S. cerevisiae Sgt2-N homodimer using solution NMR. 
Statistics for NMR structure calculations are in Table 4.1. A monomer of Sgt2-N consists 
of three helices (Figure 4.1A–C). The first two helices are of similar length and mediate 
homodimerization, forming a four-helix bundle with 2-fold symmetry, consistent with the 
postulated coiled-coil (Tobaben et al., 2003). A third, shorter helix packs against either 
side of the bundle away from the dimer interface. The residues C-terminal to this helix 
give weaker signals than the helical region in all NMR experiments and only partial 
chemical shift assignments were possible. This is due to different rates of motion relative 
to the rest of the protein rather than proteolysis, as signals for the terminal residues are 
observed. The few NOE derived contacts observed in this sequence restrain it in partially 
folded conformations (Figure 4.1C).  
The symmetry axis places the equivalent helices from each subunit head-to-tail resulting 
in two unique surfaces. We designate the surface comprised of the α2 helices the Get5 
binding surface, and the opposite comprised of the α1 helices the α1 surface (Figures 
4.1A and 4.2A,B). The dimer contacts in α2 are made by conserved small residues 
(Ser32, Ala36, Cys39, and Ala43), resulting in close packing between the main chains of 
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Table 4.1. NMR structural constraints and structure statistics 
   Sgt2-N Get5-UBL 
No. of restraintsa,b     NOE-based distance restraints        Intra-residue (|i − j| = 0) 1008 663 
     Sequential (|i − j| = 1) 580 271 
     Medium range (2 ≤ |i − j| < 5) 730 183 
     Long range (|i − j| ≥ 5) 348 334 
     Inter-molecular (homodimer) 120  -  
     Ambiguous 716 321 
    Total 3502 1772 
  φ + ψ dihedral angle restraints 240 124 
  Hydrogen bond restraints 100 52 
  Residual dipolar coupling restraints 88  -  
     Magnitude (Da) 7.0  -  
     Rhombicity (R)  0.54  -  
Restraints statistics     r.m.s.d. from experimental distance restraints 0.008 ± 0.001 Å 0.018 ± 0.002 Å 
  r.m.s.d. from experimental dihedral restraints 0.3 ± 0.1° 0.5 ± 0.1° 
 Cross-validated RDC Q-factorsc, (No. used for validation) 0.11 ± 0.03 (18) - 
   Model Statistics 
     Residue Ranged 5-56 (x2) 73-149 
Coordinate precision r.m.s.d. 
    Backbone 0.33 ± 0.07 Å 0.34 ± 0.09 Å 
  Heavy atom 0.73 ± 0.08 Å 0.74 ± 0.09 Å 
Structural quality 
    Ramachandran statisticse 
       Most favored regions 99.00% 83.10% 
     Allowed regions 1.00% 15.60 % 
     Generously allowed regions 0.00% 0.00% 
     Disallowed regions 0.00% 1.70%g 
  WHAT-IF Z-scoref 
       Backbone conformation 1.306 ± 0.417 −1.428 ± 0.327 
     2nd generation packing quality 5.440 ± 1.865 5.730 ± 2.413 
     Ramachandran plot appearance 0.169 ± 0.418 −3.309 ± 0.319 
     χ1/χ2 rotamer normality −1.610 ± 0.588 −3.189 ± 0.537 
aFor Sgt2-N, a single NOE generates two restraints for atom pairs from each monomer.  
bStructures were calculated using the full sequence of the protein. 
cQ-factors were calculated with PALES using RDCs omitted from structure calculations (Zweckstetter and Bax, 
2000) 
dValidation was performed over the ordered sequence of the protein. 
eRamachandran statistics calculated by PROCHECK (Laskowski et al., 1993) 
 fZ-scores were calculated by WHAT-IF (Vriend and Sander, 1993). Positive scores are better than average and 
negative scores are worse 
gK85, which follows cis P84, is the only residue in the disallowed region. TALOS dihedral angle restraints were 




Figure 4.1. Atomic structure of the Sgt2-N/SGTA-N dimerization domain. (A) 
Solution NMR structure of S. cerevisiae Sgt2-N orientated to show the conserved binding 
face. The cartoon diagram of a representative structure is color ramped from N- to C-
terminus (blue to red) for each subunit of the dimer. Conserved residues are shown as 
sticks with noncarbon atoms colored. (B) Similar to (A) rotated 90° forward looking 
down the bundle axis. Interior small (magenta) and bulky (gray) residue side chains are 
highlighted as sticks. (C) Ribbon diagram of the overlaid ensemble of the ten lowest-
energy NMR structures rotated 90° to the right relative to (B). One subunit is color 
ramped and one is in gray. (D) Surface representation of the binding face highlighting 
exposed hydrophobicity. The surface is color ramped from 0 (gray) to 4.5 (green) on the 
Kyte-Doolittle hydrophobicity scale (Kyte and Doolittle, 1982). (E) Surface 
representation of the binding face showing surface charge. The surface is color ramped 
based on electrostatic potential colored from negative (red) to positive (blue). (F) X-ray 
crystal structure of human SGTA-N aligned to Sgt2-N (gray) similar to (A). (G) 
Sequence alignment of Sgt2-N homologs. The species are Scer (S. cerevisiae), Afum 
(Aspergillus fumigatus), Dmel (D. melongaster) and Hsap (H. sapiens). Alignment and 
residue coloring are based on ClustalX output (Larkin et al., 2007). Numbering and 
secondary structure (rectangles for helices) are indicated above or below the 
corresponding sequence. Mutations tested in Figure 4.5 are highlighted in the numbers 




Figure 4.2. Comparison of the structures of Sgt2-N and SGTA-N. (A) View of the α1 
surface. Sgt2-N is color ramped from N- (blue) to C- (red) termini, as in Figure 4.1A. (B) 
Surface representation of the α1 surface of Sgt2-N. The surface is color ramped from 0 
(gray) to 4.5 (green) on the Kyte-Doolittle hydrophobicity scale. (C) SgtA-N was co-
expressed and co-purified with affinity tagged Ubl4A-UBL. Shown here is the size 
exclusion chromatogram of the separation of excess Ubl4A-UBL from Ubl4A-UBL in 
complex with SGTA-N. Coomassie stained SDS-PAGE of indicated 1 ml fraction ranges 
is shown below. The complex peak was used for crystallization trials, although only 
crystals of the co-purified SgtA were obtained. (D) Hydrophobic representation of the 
Ubl4A-UBL binding surface of SGTA-N, colored as (B). (E) Comparison of the crystal 
structures of SGTA-N with fully reduced C38 (magenta), single (cyan) or double (green) 
β-mercaptoethanol covalent adducts. (F) Overlay of the reduced (magenta) and fully 
oxidized (green) SGTA-N structures. The view is of the α1 surface. Along with the 
reconfiguration of the C-terminal residues, the packing of α1 is altered in the covalently 
modified structures.  
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the two subunits (Figure 4.1B). Cys39 and Val35 make a small hydrophobic surface at 
the center of the Get5 binding face (Figure 4.1A,D). The partially exposed Cys39 is 
strictly conserved across eukaryotes; Val35 is fully solvent exposed and is conserved as 
either valine or isoleucine. Despite the close proximity of the Cys39 sulfhydryl groups 
(5.3 ± 0.4 Å sulfur-sulfur distance), the Cβ shifts of 27.819 ppm argue against disulfide 
bond formation, even after incubation for several months (Sharma and Rajarathnam, 
2000).  The conserved acidic residues Asp28 and Glu31 and the conserved positioning of 
Glu42, Glu47 and Glu49 result in a negatively charged ring surrounding the hydrophobic 
patch (Figure 4.1A and E). 
The helices of the α1 surface are held further apart than the α2 interface by the 
interlocking of large hydrophobic side chains (Figures 4.1B and 4.2A). This results in an 
exposed hydrophobic surface that is protected, to some extent, from solvent by the 
partially folded carboxyl terminal linker (Figure 4.1C and 4.2B). When an Sgt2-N variant 
with this linker deleted is purified, it forms a higher order oligomer, likely due to 
aggregation at this face (data not shown).  
We also investigated the N-terminal domain of human SGTA (SGTA-N). The domain 
was co-expressed and purified with an affinity tagged UBL domain of Ubl4A (Ubl4a-
UBL), demonstrating a stable complex that could be separated from excess Ubl4A 
(Figure 4.2C). We attempted to crystallize this complex; however, in the three resulting 
distinct crystal structures, only density for SGTA-N was observed. Structures were 
determined by molecular replacement using Sgt2-N at 1.35-1.45 Å resolutions. The 
structures differ predominantly by a post purification oxidation of the conserved cysteine 
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with buffer components (Figure 4.2E,F). Crystallographic data collection and refinement 
statistics are provided in Table 4.2. SGTA-N shares the four-helix bundle topology with 
Sgt2-N (Figure 4.1F). As expected from the solution data, the cysteine sulfhydryl groups 
do not form a disulfide bond between subunits.  
As was the case for structures of the Sgt2/SGTA-TPR domains (Chartron et al., 2011; 
Dutta and Tan, 2008), Sgt2-N and SGTA-N have very similar architecture with an 
r.m.s.d. of 1.24 ± 0.07 Å over equivalent Cα atoms (Figure 4.1F). The sequences have 
high homology (Figure 4.1G) and all of the general features are conserved including the 
hydrophobic patch surrounded by charge at the binding face (Figures 4.1F and 4.2D). 
One notable difference is that SGTA-N does not have a third α-helix. The residues that 
would correspond to α3 are disordered or involved in non-physiological crystallographic 
contacts. 
The structure of the Get5-UBL domain 
The UBL of Get5 and Ubl4A have a number of features that make them unique compared 
to other UBLs with high homology to ubiquitin. Get5 binds Sgt2 via its UBL and this 
interaction includes Leu120, the equivalent of Ile44 of ubiquitin (Chang et al., 2010; 
Chartron et al., 2011). The solution NMR structure of the Ubl4A-UBL domain showed 
that it has the expected ubiquitin fold (Figure 4.3A) (PDBID:2DZI, RIKEN Structural 
Genomics Initiative). Get5-UBL has several small sequence insertions suggesting some 
structural differences (Figure 4.3F); therefore, to fully characterize the yeast system, we 
determined the structure of the Get5-UBL domain. Initially, we solved a structure by 





Figure 4.3. Atomic structure of the Get5-UBL/Ubl4A-UBL domain. (A) Ribbon 
diagram of the human Ubl4A-UBL domain solution structure (PDBID: 1DZI). Residues 
equivalent to those tested in Figure 4.5 are highlighted as sticks in (A)-(C). (B) X-ray 
crystal structure of the S. cerevisiae Get5-UBL domain. The cartoon of chain A is color 
ramped between termini. (C) Overlay of a representative structure of ubiquitin (red) is 
shown (PDBID:1UBQ) as a ribbon diagram with Get5-UBL (light blue). (D) Surface 
representation highlighting exposed hydrophobicity of Get5 and ubiquitin as in Figure 
4.1D. (E) Surface representation showing surface electrostatic potential of Get5 and 
ubiquitin as in Figure 4.1E. (F) Sequence alignment of Get5-UBL homologs. Sequences 
are displayed similar to Figure 4.1G. In addition, beta-sheets are shown as arrows, Drer is 
Danio rerio, and the residues equivalent to the important ubiquitin residues Ile44 and 




Figure 4.4. Comparison of the structures of Get5-UBL and Ubl4A-UBL. (A) Overlay 
of the backbone nitrogen and carbon atoms of the ensemble of the 10 lowest energy 
NMR structures of Get5-UBL (blue) and the three copies of the Get5-UBL in the 
asymmetric unit of the crystal structure (green). Chain A is used in figures and in 
discussion of the Get5-UBL structure. (B) The three molecules found in the asymmetric 
unit of the Get5-UBL crystal structure with Leu120 shown as spheres for reference. (C) 
Overlay of the main-chain atoms of the crystal structure of Get5-UBL (carbons color 
ramped blue to red from N- to C-terminus) and a representative structure of Ubl4A-UBL 
(magenta carbons). Insertions in Loops 1, 3, and 6 of Get5-UBL cause most of the 




diffracted to 2.4 Å. We were able to obtain phases by molecular replacement using the 
Get5-UBL solution structure. Three copies of Get5-UBL were present in the asymmetric 
unit (Figures 4.3B and 4.4B). They have an average r.m.s.d. of 0.75 Å over main chain 
atoms. Statistics for the solution structure calculations and crystallographic data 
collection and refinement are presented in Tables 4.1 and 4.2, respectively. The solution 
and crystal structures are very similar with an average main chain r.m.s.d. of 1.23 Å 
(Figure 4.4A), with most variation in loops 1 and 5.  
While overall the structures from Get5 and Ubl4A are similar, there are a few differences 
due to insertions (Figure 4.4C). Based on the structures and sequences of other animal 
homologs, Get5-UBL has a two-residue insertion around Pro84 in Loop 1. Pro84 is cis 
allowing for a tight turn, and there is no detectable cis to trans isomerization by NMR. 
There are two additional insertions in Get5-UBL, His113 in Loop 3, and Ala141 that 
causes a short coil-like turn to extend at the end of Loop 6. Despite these differences, the 
surface elements on the face of the β-sheet are conserved between Get5 and Ubl4A 
(Figure 4.3A,B). 
Most UBLs share some functional roles with ubiquitin. They occur either as independent 
units known as Type I UBLs that can be conjugated onto other proteins or as Type II 
UBLs that are domains in larger proteins that frequently mediate binding to the 
proteasome	  (Jentsch and Pyrowolakis, 2000). Get5 falls into the latter class but does not 
associate with the 20S proteasome or polyubiquitin chains (Hu et al., 2006; Saeki et al., 





Get5 homologs from ubiquitin. Comparing Get5-UBL to ubiquitin, the two most 
significant structural differences are the conformations of Loop1 and Loop6 (Figure 
4.3C). Ubiquitin is noted for the hydrophobic “I44 patch.” In Get5, the conformations of 
Loop1 and Loop6 significantly reduce the size of the equivalent patch (Figure 4.3D). 
Moreover, the surface charge of both proteins around the I44 patch has a positive charge; 
however, it is significantly more pronounced in Get5 (Figure 4.3E). 
Characterization of the putative interface between Sgt2-N and Get5-UBL 
We previously demonstrated that only a single copy of Get5-UBL binds to dimeric Sgt2-
N and the double mutation L120A/K122A prevents complex formation (Chartron et al., 
2011). We decided to probe the interaction further using isothermal titration calorimetry 
(ITC) of wild type and mutant proteins (Figure 4.5 and 4.6). All of the variants behaved 
similarly to wild type during purification (data not shown). Sgt2-N and Get5-UBL 
interact with 10-8 M affinity independent of which protein is used as a titrant. The 
interaction is slightly exothermic, releasing approximately 1.4 kcal/mol. The Get5-UBL 
L120A mutation has a thousand fold lower binding affinity consistent with the 
significance of this position in UBLs. The Get5-UBL L120I mutant bound Sgt2-N with 
similar affinity to wild type. This is surprising considering that a leucine at this position is 
completely conserved, in contrast to the isoleucine in most UBLs. Mutations of three 
other nearby hydrophobic residues that compose part of the hydrophobic patch, G123Y, 
V125A, and M147A also significantly lowered the binding affinity.  
The complementing surface charge of the two proteins suggests that a significant 










Figure 4.5. Importance of conserved residues of both Sgt2 and Get5 at the putative 
binding interface by ITC. The table is a summary of the data obtained by ITC where 
mutants were tested for binding affinity. Wild type is represented by “wt.” Mutations 
tested are colored based on the loss of binding affinity (red; strong effect, orange; 
moderate effect, yellow; mild effect, blue; no significant effect). On the right, mutations 





Figure 4.6. Isothermal titration calorimetry. Representative ITC isotherms for the 
interaction between Sgt2-N and Get5-UBL. Raw data are shown in the top panel of each 
trial as the power input to the sample cell over time. Integrated data are shown in the 
bottom panels in terms of total energy required for equilibration as a function of molar 
ratio. Data using Get5-UBL as a titrant were corrected for heat of dilution of the protein. 
Note that trials are individually scaled to demonstrate the quality of fits. The top row 
utilized Get5-UBL variants in the sample cell and wild type Sgt2-N was titrated. The 
bottom row used Sgt2-N variants in the sample cell and wild type Get5-UBL was titrated. 
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affinity decreases rapidly as salt concentration increases. Moreover, mutations of any of 
the lysines on this face of Get5-UBL to alanine (79, 118, 122, and 124) reduce binding 
affinity 5–10-fold. Interestingly, ubiquitin, which contains most of the residues tested, 
binds Sgt2-N with negligible affinity (data not shown). 
We made reciprocal mutations to the conserved face of Sgt2-N and tested their binding to 
Get5-UBL (Figure 4.5). Similar to Get5, mutation of the two exposed hydrophobics to 
alanine had the strongest effect with over 100-fold lower affinity (V35A and C39A). The 
presence of the completely conserved Cys was curious. We decided to do a series of 
typically minimal changes at this position to test for effect on complex formation. A 
slightly bulkier hydrophobic side chain, C39V, resulted in a 100-fold lower affinity while 
removing the sulfhydryl to a smaller amino acid, C39A, resulted in a nearly 300-fold 
lower affinity. The strongest effect was conversion of the sulfhydryl to the more polar 
hydroxyl, C39S, resulting in a ~700-fold lower affinity. Mutations of the acidic residues 
that comprise the charged face have a similar effect on affinity as the basic residues of 
Get5-UBL. One exception is that the peripheral Glu47, located at the beginning of α3, 
had no effect on affinity.  
Characterization of the binding kinetics of Sgt2-N and Get5-UBL 
The complex between the minimal Get5-UBL and Sgt2-N domains appears homogenous 
and stable over multiple rounds of size exclusion chromatography. Multiple lines of 
evidence demonstrate complex formation between Get5 and Sgt2 (Chang et al., 2010; 
Chartron et al., 2011; Liou et al., 2007; Wang et al., 2010). Based on ITC, the complex 
has high affinity; however, investigations using co-immunoprecipitation find variable 
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amounts of Sgt2 or SGTA associated with the Get5/Ubl4A partners. Although there are 
many possible reasons why the in vivo stoichiometry is variable, we hypothesized that 
fast binding kinetics could explain how co-purification could be dependent on 
experimental conditions. To measure the association and disassociation rate constants we 
turned to surface plasmon resonance (SPR). In this experiment, polyhistidine-tagged 
Get5-UBL or Get5-UBL-C was immobilized for SPR analysis and Sgt2-N was used as 
the analyte (Figure 4.7A). Get5-UBL-C includes the C-terminal dimerization domain of 
Get5 that is separated from the UBL domain by a flexible linker (Chartron et al., 2010). 
We previously demonstrated that the less restrictive Get5-UBL-C dimer can bind two 
Sgt2-N domains (Chartron et al., 2011); therefore, we expect that each will act 
independently. The proteins were well behaved on the chip giving stable concentration 
dependent saturation (Figure 4.7B). The rapid saturation of response units after injection 
(<1 s) and then rapid reduction after the analyte injection is stopped are indicative of fast 
on and off rates consistent with our hypothesis.  
The equilibrium-binding constant can be calculated by plotting response units as a 
function of Sgt2-N concentration after response units reach equilibrium (Figure 4.7B–D).  
For Get5-UBL-C, the plot fit to a Kd of 7.49 × 10-7 M. Compared to ITC, this is nearly 
two orders of magnitude lower affinity. Although the different techniques are not 
expected to give identical results due to experimental conditions, the relative results are 
consistent. For example, mutation of charged residues, Sgt2-N D28A and D42A, resulted 
in a significant loss in affinity. We suspect that steric constraints based on interactions 





Figure 4.7. Binding is characterized by rapid on and off rates mediated by 
electrostatics as analyzed by SPR. (A) Scheme used for SPR analysis. Either his-tagged 
Get5-UBL (UBL-6His) or Get5-UBL-C (UBL-C-6His) were attached to an anti-6xHis 
antibody sparsely immobilized on a CM-5 chip. Sgt2-N was flowed over the chip at 
varying concentrations. (B) Representative SPR experiment flowing varying 
concentrations of Sgt2-N over immobilized Get5-UBL-C. Inset, the first two seconds of 
the experiment, used to derive ks for (E). (C) Plot of equilibrium response units versus 
concentration of Sgt2-N for calculation of equilibrium Kd. (D) Table of the effects of 
mutants and salt concentration on binding. An asterisk signifies that the experiment was 
performed in triplicate. (E) Plot of the coefficient that fits ks versus Sgt2-N concentration. 
The slope gives the association constant (ka) while the Y-intercept gives the dissociation 
rate (koff). (F) Plot of a 15N plane from an EXSY-HSQC spectrum showing a side chain 
amide proton of Gln82 in free or complex Get5-UBL. The cross peaks indicate exchange 
between the two states within the timescale of the experiment.  
	  	  
141 
Get5-UBL, which is expected to bring the Sgt2 binding face into close proximity to the 
immobilizing antibody. This set up had consistently lower binding affinities, for example 
wild type binding is reduced approximately 5-fold to a Kd of 3.78 x 10-6 M. Mutants in 
Sgt2-N or Get5-UBL show similar changes in binding affinity compared to ITC. Charged 
mutants Get5-UBL K124A, and Sgt2-N D28A and D31A all had similar affinities on the 
order of 3–4-fold weaker than the wild type protein. Also, residues in the hydrophobic 
interface had the strongest effect, reducing the affinity of Get5-UBL L120A or Sgt2-N 
C39A to below what could be accurately determined in this experimental set up. 
The importance of charge complementarity is consistent with two preformed interfaces 
that are electrostatically steered toward complex formation. These types of protein 
interactions are known to form quickly and then rapidly dissociate (Sheinerman et al., 
2000). Here, the association phase of the SPR data were used to determine a kon of 1.06 x 
107 M-1 s-1 and a dissociation rate constant of ~4 s-1 (Figure 4.7E). The dissociation rate 
constant could be independently estimated from the equilibrium Kd and kon values, which 
gives an approximate koff of 7.9 s-1. Consistent with both the electrostatic mechanism and 
the ITC data, increasing salt concentration from 100 to 300 mM salt resulted in nearly an 
order of magnitude change in Kd (Figure 4.7D). All of this data points to a highly specific 
interface that has rapid dynamics. 
For an independent verification of the kinetics, we measured exchange rates by NMR 
using EXSY spectra (Perrin and Dwyer, 1990). A 2:1 ratio of 15N-labeled Get5-UBL to 
unlabeled Sgt2-N homodimer was prepared, allowing detection of approximately 
equimolar free and complex forms of Get5-UBL. The complex dissociates and reforms 
	  	  
142 
within the timescale of the experiment (mixing times of 60 or 120 ms) and exchange 
cross peaks are observed between the two states of specific Get5-UBL protons (Figure 
4.7F). The side chain amide protons of Gln82 and the main chain amide proton of 
Asn129 gave well-resolved exchange peaks, the magnitudes of which were used to 
calculate a koff,NMR of 8.3 ± 1.4 s-1 and an apparent on rate of 6.5 ± 0.4 s-1. Under these 
conditions the forward and reverse rates are expected to be equal, with apparent on rate as 
the product of the rate constant kon,NMR and Kd. Using the ITC-derived Kd of 34 nM, 
kon,NMR is 1.9 × 108 M-1 s-1, roughly 20-fold faster than measured by SPR. Because the 
solution and immobilized Get5 off rates are similar, the lower binding affinity seen by 
Get5 immobilization in the SPR experiment is from a slower kon. A possible explanation 
could be that restricting the rotational freedom of Get5 reduces the rate acceleration 
caused by an electrostatic steering mechanism. 
Structure of the Sgt2-N and Get5-UBL complex 
Compared to the proteins alone, the NMR spectra of the Sgt2-N/Get5-UBL complex have 
a dramatic reduction in resolution. This is a result of peak broadening due to both slower 
tumbling and the fast kinetics of complex formation and dissociation. Therefore, rather 
than generating a uniformly 13C/15N labeled sample of 235 residues, we opted to 
investigate two asymmetrically labeled complexes to reduce the amount of chemical shift 
overlap. Chemical shift perturbations (CSP) on the 2D 1H-15N-HSQC spectra were 
examined for both proteins (Figure 4.8A). On Sgt2, the most drastic CSPs occur at the 
Get5 binding surface, with very little change occurring in the rest of the protein (Figure 




Figure 4.8. Solution structure of the Sgt2-N/Get5-UBL complex. (A) Plots of the 
change in chemical shifts of the 1H-15N HSQC as a combined chemical shift perturbation 
(CSP) upon complex formation for each residue at 25°C. Changes for residues in gray 
could not be accurately determined due to cross peak overlap. For Sgt2-N, several 
residues were split into two peaks, breaking the symmetry. These are indicated in red. (B) 
Cartoon representation of Sgt2-N illustrating regions of chemical shift change between 
the free protein and the complex (cyan). Coloring is based on values from (A). Residues 
are color ramped from smallest (yellow) to largest (red) CSP. Residues that could not be 
measured are shown in gray. Residues with split chemical shifts upon complex formation 
are shown as green sticks. (C) Cartoon representation of Get5-UBL similar to (B). (D) 
Representative intermolecular NOEs from a 13C-edited NOESY-HSQC spectrum at 37°C 
constrained to be less than 6Å away during docking. Peaks identified as intermolecular 
are highlighted by blue arrowhead and labeled. The red “?” represents a peak that is 
unresolvable from an expected intramolecular NOE. (E) Overlay of the 10 best-scored 
models obtained after NOE, AIR and RDC driven docking. (F and G) Two views of the 
binding interface. In (F), residues determined to interact by ITC are highlighted as sticks. 
In (G), residues at the interface are drawn as sticks with the following color scheme 
positive (blue), negative (red), polar (orange) and hydrophobic (yellow). 
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indeed several residues on the Get5 binding surface face split into two cross peaks with 
reduced peak height (Figures 4.8A and 4.9A). Residues without perturbation maintain a 
single cross peak, indicating that symmetry remains away from the binding site. The 
Get5-UBL domain is more broadly affected by binding to Sgt2-N, but the most intense 
CSPs occur at Ile81 and the loop consisting of residues 123-129, including Gly123 and 
Val125.  
Inspection of NOESY spectra failed to conclusively identify enough new cross peaks 
resulting from intermolecular contacts to directly determine the structure of the complex. 
This is not surprising, based on the presumed interface. Electrostatic interactions between 
a glutamate or aspartate and a lysine yield weak proton NOE cross peaks. Additionally, 
the few expected hydrophobic interactions occur in crowded regions of the spectra. We 
proceeded to determine the individual solution structures of Sgt2-N and Get5-UBL as 
they are in complex. Data collection for the full assignments of the proteins in complex 
was performed at 37°C, which reduced the severity of line broadening effects. This had 
the additional effect of averaging the two states of Sgt2-N. We therefore treated Sgt2-N 
as symmetric in these calculations.  
Overall, the structures of Sgt2-N and Get5-UBL while in complex are not significantly 
different from the free solution structures (Figure 4.9B,C). A few intermolecular NOEs 
could be identified and were used in the calculation of the complex structure (Figure 
4.8D). In the absence of substantial numbers of NOE derived distance restraints, the 




Figure 4.9. Comparison of the structures of free and bound proteins. (A) A section of 
overlaid 1H-15N HSQC spectra of uniformly 13C/15N labeled Sgt2-N (black) or labeled 
Sgt2-N in a saturated complex with natural abundance Get5-UBL (red). Some cross 
peaks split into two indicating asymmetric binding. (B) Overlay views of the backbone 
nitrogen and carbon atoms of the ensembles of Sgt2-N (blue) and Sgt2-N while in 
complex with Get5-UBL (red). For clarity only residues 5-56 are shown. (C). Overlay 
views of ensembles of Get5-UBL structures. In the top panel, the NMR structures of free 
(blue) Get5-UBL and Get5-UBL in complex with Sgt2-N (red). The bottom panel is an 
overlay of the complex NMR structure (red) and the crystal structure (green). 
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experimental data introduced as ambiguous interaction restraints (AIRs) (Dominguez et 
al., 2003). We defined 14 AIRs using the CSP and mutagenesis data, the details of which 
are provided in the methods section of this chapter. Moreover, we collected residual 
dipolar couplings that restrict rotational freedom between the models during docking. We 
performed docking between the two separate complex structures to generate a full model 
of Sgt2-N and Get5-UBL (Figure 4.8E). Statistics for the structure calculation of each 
component as well as the complex are provided in Tables 4.3 and 4.4.  
The experimentally restrained docking returns a well-converged structure where the 
predicted binding faces interact (Figure 4.8E). All of the residues that were identified to 
be involved experimentally are found at the interface (Figure 4.8F). The interface is 
comprised of the hydrophobic patch on Get5-UBL (Ile81, Leu120, Val125, Gly143 and 
Met147) that docks against the reciprocal patch that contains two each of Cys39 and 
Val35 from the Sgt2-N dimer (Figure 4.8G). Additionally, Thr145 packs against one 
copy of Val35. The conserved lysines 79, 85, 118, 122 and 149 all make electrostatic 
contacts to the charged face of Sgt2-N (two each of Asp 28, 31, 38 and Glu42). The 
interface has a surface area of ~700 Å2. 
The complex is a unique UBD/UBL interaction 
Ubiquitin and UBL domains are abundant in cells and all share common features (Winget 
and Mayor, 2010). Perhaps more abundant are the different UBD motifs found in a wide 
variety of frameworks (Hicke et al., 2005; Husnjak and Dikic, 2012). The combinatorial 
use of UBLs and UBDs results in a wide diversity of interactions that are utilized in many 
different contexts. The complex between Sgt2 and Get5 introduces a novel interaction.  
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Table 4.3. NMR structural constraints and structure statistics for proteins in complex 
15N/13C labeled protein Sgt2-N Get5-UBL 
No. of restraintsa,b      NOE-based distance restraints        Intra-residue (|i − j| = 0) 770 597 
     Sequential (|i − j| = 1) 336 378 
     Medium range (2 ≤ |i − j| < 5) 276 198 
     Long range (|i − j| ≥ 5) 208 258 
     Inter-molecular 70  -  
     Ambiguous 668 419 
    Total 2328 1850 
   φ + ψ dihedral angle restraints 204 126 
   Hydrogen bond restraints 100 52 
   Residual dipolar coupling restraints 52 45 
     Magnitude (Da) 6.4 
     Rhombicity (R)  0.61 
Restraints statistics      r.m.s.d. from experimental distance restraints 0.010 ± 0.003 Å 0.014 ± 0.002 Å 
   r.m.s.d. from experimental dihedral restraints 2.2 ± 0.2° 0.37 ± 0.08° 
 Cross-validated RDC Q-factorsc, (No. used for validation) 0.29 ± 0.10 (12) 0.35 ± 0.07 (10) 
   Model Statistics 
     Residue Ranged 5-56 (×2) 73-149 
Coordinate precision r.m.s.d. 
     Backbone 0.36 ± 0.04 Å 0.49 ± 0.09 Å 
   Heavy atom 0.76 ± 0.05 Å 0.88 ± 0.07 Å 
Structural quality 
    Ramachandran statisticse 
       Most favored regions 98.10% 86.10% 
     Allowed regions 1.90% 13.20% 
     Generously allowed regions 0.00% 0.30% 
     Disallowed regions 0.00% 0.40% 
  WHAT-IF Z-scoref 
       Backbone conformation 0.939 ± 0.578 −0.546 ± 0.500 
     2nd generation packing quality 4.137 ± 1.486 4.471 ± 1.997 
     Ramachandran plot appearance −1.227 ± 0.499 −2.464 ± 0.505 
     χ1/χ2 rotamer normality −2.358 ± 0.811 −3.074 ± 0.386 
aFor Sgt2-N, a single NOE generates two restraints for atom pairs from each monomer.  
bStructures were calculated using the full sequence of the protein. 
 cQ-factors were calculated with PALES using RDCs omitted from structure calculations 
(Zweckstetter and Bax, 2000). 
dValidation was performed over the ordered sequence of the protein. 
 eRamachandran statistics calculated by PROCHECK (Laskowski et al., 1993). 
 fZ-scores were calculated by WHAT-IF (Vriend and Sander, 1993). 
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Table 4.4. Calculation of the Get5-UBL and Sgt2-N complex     
No. of restraints 
        Intermolecular NOE-based distance restraints 14 
   Ambiguous Interaction Restraints  10 
   Residual dipolar coupling restraints 97 
   φ + ψ dihedral angle restraints 326 
   Hydrogen bond restraints 152 
Calculation statistics 
     Statistics for top 5 clustersa 1 2 3 4 5 
No. of structures 48 20 16 6 8 
HADDOCK score of 10 best structuresb -63 ± 7 -43 ± 7 -43 ± 15 -40 ± 15 -39 ± 15 
Statistics for 10 best structures of best cluster 
    Buried surface area (Å2) 1125 ± 42 
Backbone r.m.s.d.  0.58 ± 0.22 Å 
Heavy atom r.m.s.d. 0.92 ± 0.22 Å 
RDC Q-factorsc 
          Working + cross-validated (No.) 0.176 ± 0.014 (120) 
     Cross-validated (No.) 0.311 ± 0.036 (23) 
Structural qualityd 
        Ramachandran statisticse 
          Most favored regions 92.80% 
     Allowed regions 6.80% 
     Generously allowed regions 0.40% 
     Disallowed regions 0.00% 
   WHAT-IF Z-scoref 
          Backbone conformation 0.036 ± 0.242 
     2nd generation packing quality 4.258 ± 1.911 
     Ramachandran plot appearance −1.758 ± 0.275 
     χ1/χ2 rotamer normality −5.498 ± 0.412 
aClusters generated using a 2 Å r.m.s.d. interface similarity cutoff (Daura et al., 1999). 
 bHADDOCK score is a sum of electrostatic, van der Waals, desolvation and AIR energy terms. 
cQ-factors were calculated with PALES  (Zweckstetter and Bax, 2000). Cross-validated RDCs were 
omitted from docking, while working RDCs were included used in calculations. 
dValidation was performed over Get5-UBL residues 73-149 and Sgt2-N residues 5-56. 
 eRamachandran statistics calculated by PROCHECK (Laskowski et al., 1993). 
  fZ-scores were calculated by WHAT-IF (Vriend and Sander, 1993). 
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As is typical for the most commonly observed UBD interactions, Sgt2-N binds at the face 
that contains the I44 patch (Figure 4.10A,B). Different from other UBDs, Sgt2 uses a 
symmetrical dimer interface to interact with its UBL. The only other example of a UBD 
dimer is the swapped CUE motif found in Vps9 that binds similar to other CUE domains 
(Figure 4.10B, PDBID:2P3Q) (Prag et al., 2003). Most other of the characterized UBDs 
bind primarily with a single polypeptide. Comparing UBD binding interfaces, Sgt2 buries 
an atypically large surface area (682.8 Å2) (Figure 4.10A,B). The next closest interface 
for a yeast UBD is that of Ufd2 bound to the UBL of Rad23, which has an interface of 
614.3Å2 (Hanzelmann et al., 2010).  
Most of the I44 patch-binding UBDs use α-helical motifs, as does Sgt2. These proteins 
interact with similar groups of residues on their respective UBLs (Figure 4.10C,D). UBLs 
have a number of conserved residues around the I44 patch. For ubiquitin, these include 
Leu8, Arg42, Ile44, His68 and Val70. These interactions are conserved on Get5 in the 
interface with Sgt2 (Ile81, K118, Leu120, Gly123, Thr145 and Met147). For these 
residues, most are similar in nature to the canonical residues except for Thr145 that is a 
histidine in most UBLs.  
Of the remaining Sgt2/Get5 interactions, the most interesting are the residues that are 
unique in the interface relative to all other UBLs (Figure 4.10C,D). Four residues fit this 
description. The most provocative, the highly conserved Ile44 of ubiquitin is a leucine in 
all Get5 homologs. Surprisingly, mutating this to isoleucine had no affect on binding 
affinity (Figure 4.5). The second is Gln82 in Get5 that forms a conserved H-bond 
network with negative charges on Sgt2. In ubiquitin, this residue is a threonine that likely 
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Figure 4.10. The Sgt2-N/Get5-UBL complex is a unique UBD/UBL interface. (A) A 
view of the complex shown as a cartoon diagram. Sgt2-N in cyan and purple, Get5-UBL 
in green. Residues involved in the interface are drawn as sticks. The interface surface 
area, determined by PISA, is indicated (Krissinel and Henrick, 2007). (B) Representative 
structures of various UBD (cyan)/UBL (green) complexes that interact with the “I44” 
face shown as cartoon aligned to the Get5-UBL in (A). Each structure is labeled with its 
PDBID and the UBD group that is represented (Reviewed in Hicke et al., 2005; Husnjak 
and Dikic, 2012). Proteins are named in (D). Interface surface areas are indicated. (C) 
View of the binding interface of representative helical UBDs. Residues at the interface 
are shown as sticks (D). Get5-UBL residues Q83, L120, K122 and T145 are colored red. 
Equivalent residues in other structures are also highlighted. (D) Sequence alignment of S. 
cerevisiae UBL domains with human Ubl4A, Ubl4B and BAG6 UBLs included. 
Alignment is similar to Figure 4.1G. Numbers at the end of the sequence are percent 
identity to Get5. Residues that interact with various UBDs are highlighted based on the 
legend. Stars filled with red are highlighted in (C). 
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cannot contribute to a similar network and, in fact, is pointed away from the I44 patch. 
Next is Lys122, a positive charge that is conserved in Get5 homologs adjacent to the I44 
patch yet is missing in other UBLs. This lysine forms salt bridges with the conserved 
Asp28 and Asp31 on Sgt2. In ubiquitin, this position is an alanine that points its side 
chain away from the interface. The final residue is Thr145 whose equivalent in ubiquitin 
is a histidine (His68). In Ubl4A, the position is an asparagine, a more polar residue. For 
ubiquitin, His68 is typically described as a component of the hydrophobic pocket lining 
the edge of the I44 patch. For the Get5/Sgt2 complex, the smaller threonine is likely 
required to accommodate the tight interface. 
Discussion 
The biogenesis of TA membrane proteins requires sorting in the cytoplasm, targeting to 
the membrane followed by insertion into the bilayer. For TAs destined for the ER, the 
conserved GET pathway governs this process. Sgt2 and Get5 are members of the so-
called yeast TRC that includes Get4 and HSPs. This complex is responsible for binding 
and then sorting of ER destined TAs to the targeting factor Get3 (Wang et al., 2010). 
Sgt2 contains three domains (Figure 4.11A). The C-terminal domain binds hydrophobic 
peptides with varying affinities. Mitochondrial TA proteins are typically less polar 
compared to ER destined substrates and it is thought that this feature allows Sgt2 to 
selectively bind the latter with higher affinity (Wang et al., 2010). The central domain 
contains three TPR repeats that bind multiple classes of HSP proteins whose structure 
was recently solved (Chartron et al., 2011). At the N-terminus is a homodimerization 





Figure 4.11. A model for the role of the Sgt2/Get5 complex. (A) Composite model of 
the Sgt2/Get4/Get5 complex based on all available structural data. Central is the complex 
reported here. Sgt2 is an extended dimer (cyan and magenta). The TPR domains extend 
away from each other (PDBID:3SZ7). The C-terminal domains, represented as rounded 
rectangles, are flexible. The Get4/Get5 complex is an extended homodimer mediated by 
the Get5-C domain (PDBID:3VEJ). Get4 forms a complex with the Get5-N domain 
(PDBID:3LKU). (B) Model of the TRC complex in the GET pathway. Chaperones 
binding hydrophobic proteins rapidly bind and dissociate from the TPR domain of Sgt2. 
The C-terminal domain of Sgt2 binds to ER destined TA proteins. Sgt2 is rapidly binding 
and dissociating from Get4/Get5, which binds to Get3. The TA protein is then transferred 
from Sgt2 to Get3. (C) Model of the mammalian TRC pathway. Chaperones and SGTA 
act analogously to the yeast system in (B). SGTA rapidly binds to and dissociates from 
Ubl4A. The Bag6 complex then sorts substrates between the TA targeting pathway, 




extended dimeric complex with the C-terminal domain moving freely at the end. Get5 
forms an obligate heterotetramer with Get4 (Figure 4.11A). Get5 contains three domains. 
An N-terminal domain that wraps around Get4 forms the heterodimer interface. A C-
terminal domain forming a small, stable dimerization motif whose structure was also 
recently solved (Chartron et al., 2012b). The central domain is a novel UBL domain 
whose structure we report for the first time here. The Get4/Get5 complex is also extended 
in solution (Chartron et al., 2011; Chartron et al., 2010). 
The initial identification of Get4 and Get5 as bona fide members of the GET pathway did 
not reveal the connection to Sgt2 (Jonikas et al., 2009). In hindsight, this is surprising as 
previous biochemical and genetic links had been reported (Liou et al., 2007). Subsequent 
studies clearly linked the N-terminal dimerization domain of Sgt2 to the UBL domain of 
Get5 solidifying the role of Sgt2 in TA targeting (Battle et al., 2010; Chang et al., 2010; 
Chartron et al., 2011; Wang et al., 2010). We previously demonstrated that the interface 
formed was stable to purification, yet sensitive to mutation (Chartron et al., 2011; 
Chartron et al., 2012b). The structures reveal a strong electrostatic component to the 
interface between Get5 and Sgt2. This results in a complex with fast on and off rates.  
The affinity of Sgt2 to Get5 is remarkably high (Figure 4.5). In the cell, every Get4/Get5 
heterotetramer will, on average, be bound by an Sgt2, as one falls off another quickly 
replaces it. Our previous work demonstrated that only a single Sgt2 dimer could bind to 
the Get4/Get5 heterotetramer at one time (Chartron et al., 2011); therefore, Get5 has two 
potential binding sites for Sgt2 that are rapidly sampling. This makes sense in a model for 
TA targeting (Figure 4.11B), as a Get3/Get4/Get5 complex would be stable in the 
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cytoplasm. This complex would screen, over multiple rounds, Sgt2 proteins to find one 
that stably bound an ER destined TA protein. This interaction would lead to a handoff of 
the TA to Get3 that would be released from Get4 to find its ER receptors. How Sgt2 finds 
TA proteins is a matter of conjecture. The simplest model is that it captures free TAs in 
the cytoplasm; however, it remains seductive to imagine that the highly abundant HSPs 
provide at least one route into the pathway. In that context, Sgt2 would bind HSPs 
transiently allowing for multiple rounds of binding to find appropriate substrates. Once a 
TA protein was bound, it would be a stable complex that could be found by Get4/Get5. 
In metazoans the picture becomes more complicated (Figure 4.11C). In addition to 
homologs for all the yeast GET proteins, TA targeting includes a large multidomain 
protein called Bag6. Bag6 contains an N-terminal UBL that has the typical features to 
ubiquitin (Figure 4.10D) and a C-terminal BAG domain. It is linked to TA targeting by 
forming a stable complex with TRC35 and Ubl4A (Mariappan et al., 2010). TRC35 and 
Ubl4A lack the features necessary for direct complex formation in yeast (Chartron et al., 
2010; Chartron et al., 2012b) and it is likely that they both bind Bag6 directly. The first 
structure solved from this complex is the UBL domain from Ubl4A, which has not been 
described in the literature (PDBID:2DZI). Although it has yet to be experimentally 
demonstrated, it seems very likely that SGTA performs a similar role in TA targeting to 
its yeast counterpart (Figure 4.11C). The structure of the dimerization motif of SGTA 
supports this, as it is a highly conserved domain, like Ubl4a-UBL, with all of the features 
that are important for dimer formation. Bag6 is demonstrated to be a dimer (Yihong Ye, 
personal communication) and forms a complex with SGTA via the UBL domain of 
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Ubl4a. This then would mirror all of the components of the yeast system including two 
each of SGTA, Ubl4A and TRC35 (Figure 4.11C). 
In mammalian cells, the Bag6 complex is linked to the degradation of mislocalized 
membrane proteins and dislocated ER products (Hessa et al., 2011; Wang et al., 2011). 
TA proteins can be redirected to the degradation pathway suggesting that the two 
pathways intersect (Hessa et al., 2011). SGTA has now been shown to be an important 
component for targeted degradation of ERAD substrates transiently binding hydrophobic 
membrane proteins prior to handoff to Bag6 (Figure 4.11C) (Xu et al., 2012). This 
additional role would also benefit from rapid sampling of SGTA to the Bag6 complex. 
This raises the possibility that, in yeast, Sgt2 could have multiple roles as well. 
Where the proteins are linked to degradation pathways, it seems plausible that the 
additional role for UBLs may have co-evolved. This is clear for the Bag6-UBL, which 
has all of the features of UBLs involved in degradation and is critical for targeting to the 
proteasome (Hessa et al., 2011; Wang et al., 2011; Xu et al., 2012). The Get5/Ubl4A-
UBL represents a unique class with features that clearly distinguish them from other 
UBLs (Figure 4.10). In fact, when the conserved histidine of the Bag6-UBL is converted 
to an asparagine, it completely loses its ability to bind to standard UBDs (Xu et al., 
2012). A similar effect is not seen when the conserved Leu120 is replaced by an 
isoleucine, although this could be a change to prevent other UBDs from binding Get5.  
Sgt2 and SGTA are novel UBDs that have very specific binding partners. An interface 
dominated by electrostatics is unique amongst UBL/UBD complexes. This presumably 
allows high-affinity, rapid binding while strongly rejecting unfavorable interactions with 
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other UBLs and UBDs. One interesting side note is that in mammals, both Ubl4A and 
SGTA have tissue specific isoforms, Ubl4B and SGTB (Tobaben et al., 2003; Yang et al., 
2007). While SGTA and SGTB have similar conserved sequence elements, Ubl4B is 
missing a number of the residues that likely form the SGTA/Ubl4A interface (Figure 
4.10D). This suggests it may have lower affinity or perhaps an unknown UBD. 
In this chapter we demonstrate a novel, conserved UBD/UBL interaction critical for TA 
targeting. The complex is in a dynamic equilibrium that allows for rapid sampling of the 
various components. This attribute is likely essential for the various roles that Sgt2 
homologs must play. This work opens the door to understanding the steps of target 
selection and discrimination that are required for a regulated process. The finer details of 
the process of TA targeting continue to be resolved at a rapid pace; however, each new 
insight leads to unexpected elaborations. With the recent link to regulated proteolysis, TA 




Expression and purification of samples for NMR  
We previously described the cloning of S. cerevisiae Sgt2 residues 1-72 and Get5 
residues 74-151 (Chartron et al., 2011; Chartron et al., 2010). A hexahistidine tag and 
TEV protease cut site were fused to the N-terminus of Sgt2-N, and a hexahistidine tag 
was fused to the C-terminus of Get5-UBL. Uniformly 15N or 13C/15N labeled proteins 
were produced using the media and protocol described by Marley et al. (2001). Proteins 
were expressed in NiCo21(DE3) cells (New England Biolabs) at 37°C for 5 hours after 
induction with 0.3 mM IPTG. Cell pellets were resuspended in 20 mM Tris, 300 mM 
NaCl and 20 mM imidazole pH 7.5 and lysed by sonication. Clarified lysates were passed 
over Ni-NTA agarose beads (Qiagen) and washed with 20 column volumes of lysis 
buffer. Proteins were eluted using 20 mM Tris, 100 mM NaCl and 300 mM imidazole, 
pH 7.5. For Sgt2-N, the affinity tag was removed by digestion with hexahistidine tagged 
TEV protease while dialyzing against buffer containing 20 mM imidazole. A second Ni-
NTA agarose column removed any remaining tagged Sgt2-N and protease. Samples were 
further purified by size exclusion chromatography (SEC) using a Superdex 75 16/60 
column (GE healthcare) equilibrated with 20 mM sodium phosphate pH 6.1 for Sgt2-N, 
or 20 mM sodium phosphate, 100 mM NaCl pH 6.1 for Get5-UBL. Proteins were then 






Preparation of labeled complexes between Sgt2-N and Get5-UBL 
Two asymmetrically labeled complex samples were prepared for NMR investigation. 
Uniformly 13C/15N labeled Sgt2-N was incubated with 2 equivalents of natural abundance 
Get5-UBL. Excess Get5-UBL was then removed by using a Superdex 75 16/60 column 
equilibrated with low-conductivity buffer RE (10 mM Bis-Tris, 50 mM L-arginine and 50 
mM L-glutamate titrated to pH 6.1 with MES) (Hautbergue and Golovanov, 2008; Kelly 
et al., 2002). The saturated complex between Sgt2-N and Get5-UBL is stable over 
multiple rounds of SEC (Chartron et al., 2011). For the other complex sample, uniformly 
13C/15N labeled Get5-UBL was incubated with a slight excess of natural abundance Sgt2-
N and separated over a Superdex 75 16/60 column equilibrated with buffer RE. Free 
Sgt2-N cannot be completely resolved from the complex by SEC, and so only enough 
Sgt2-N was added for a peak of free protein to be observed within the shoulder of the 
complex peak.  Complex samples were concentrated to 1 mM and D2O was added to 10% 
for data collection.  
Expression and purification of the complex between SGTA-N and Ubl4A-UBL 
Human SGTA residues 1–54 and Ubl4A residues 1–71 were amplified from cDNA 
clones (ATCC, Mammalian Gene Collection numbers MGC:4672 and MGC:49894) and 
inserted into a pET33b-derived plasmid to yield a polycistronic mRNA upon expression. 
A hexahistidine tag and a TEV protease cleavage site were fused to the N-terminus of 
Ubl4A. The proteins were co-expressed using NiCo21(DE3) cells in LB media at 37°C 
for 3 hours after induction with 0.3 mM IPTG. Cells were lysed by sonication in 20 mM 
Tris, 100 mM NaCl, 20 mM imidazole and 5 mM β-mercaptoethanol, pH 7.5. A Ni-NTA 
agarose column was used to capture all Ubl4A from lysate and was washed with 20 
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column volumes lysis buffer. Proteins were eluted in 20 mM Tris, 100 mM NaCl, 300 
mM imidazole and 5 mM β-mercaptoethanol, pH 7.5. The affinity tag on Ubl4A was 
removed by digestion with TEV protease during dialysis against a buffer containing 20 
mM imidazole. A second Ni-NTA agarose column removed protease and any remaining 
tagged protein. The complex between Ubl4A-UBL and co-purified SGTA was separated 
from free Ubl4A-UBL by a Superdex 75 16/60 column equilibrated with 20 mM Tris, 
100 mM NaCl and 5 mM β-mercaptoethanol, pH 7.5 (Figure 4.2C). The complex was 
concentrated to approximately 5 mg/ml for use in crystallization trials.  
Expression and purification of Get5-UBL for crystallization 
Get5 residues 74–148 were amplified from the expression vector used for NMR studies 
and inserted into a pET33b-derived plasmid, fusing a hexahistidine tag and a TEV 
protease cleavage site to the N-terminus. The protein was expressed using NiCo(DE3) 
cells grown in LB media at 30°C for 5 hours after induction with 0.3 mM IPTG. The 
majority of the protein localized in inclusion bodies. Get5-UBL was purified from the 
soluble fraction using the protocol described for the NMR samples. The hexahistidine tag 
was removed by digestion with TEV protease, and the final Superdex 75 16/60 column 
run was equilibrated with 20 mM Tris, 100 mM NaCl, pH 7.5. The protein was 
concentrated to approximately 10 mg/ml for crystallization trials.  
Expression and purification of proteins for ITC and SPR 
Mutants were introduced into the expression vectors used for NMR study by the 
Quikchange method (Stratagene). We previously described the expression plasmid for 
Get5-UBL-C residues 74–212 (Chartron et al., 2010). Proteins were expressed using 
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NiCo(DE3) cells grown in LB media at 37°C for 3 hours after induction with 0.3 mM 
IPTG and purified using the protocol described for the NMR samples. All proteins were 
eluted from a Superdex 75 16/60 column using the same batch of 20 mM Tris and 100 
mM NaCl pH 7.5. Proteins used in the sample cell of the ITC experiments were not 
concentrated following SEC and had concentrations of 30–100 µM. Proteins used in the 
injection syringe of the ITC experiments were concentrated to 800–1000 µM with conical 
centrifugal filter units (Millipore) that were extensively washed with the SEC buffer prior 
to use. Concentrations were determined using either absorbance at 280 nm with 
extinction coefficients calculated from sequence and the Bradford assay using hen egg 
white lysozyme and bovine ubiquitin as standards.  Denaturation of proteins in 8 M urea 
prior to the UV assay did not affect absorbance for any of the proteins tested. Proteins 
used as the analyte in the SPR experiments were concentrated to 1 mM and diluted into 
the sample buffers, which consisted of 20 mM Tris pH 7.5, 0.05% Tween-20, 3 mM 
EDTA and the NaCl concentrations indicated in Figure 4.7. The following protein 
concentrations were used in trials: 4000, 2000, 1600, 1000, 800, 500, 400, 200, 100, and 
50 nM. 
Isothermal titration calorimetry 
Data were collected using a MicroCal iTC-200 calorimeter. Proteins in the sample cell 
were at 30–100 µM and proteins in the injection syringe were concentrated to 800–1000 
µM. For each trial, an initial injection of 0.4 µl was followed by 19 injections of 2 µl 
each. The cell was allowed to equilibrate for 120 seconds in between each titration. Data 
were processed using Origin v7.0 (OriginLab) software using a single binding site model.  
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Surface plasmon resonance 
Data were collected using a Biacore T-100 system upgraded to T-200 sensitivity (GE 
healthcare). Mouse anti-pentahistidine antibody (Qiagen) was covalently linked to a CM5 
dextran chip using standard amide coupling chemistry. Hexahistidine tagged Get5-UBL 
(wild type or mutants) or Get5-UBL-C were then immobilized. Equilibrium binding 
analysis was performed using BIAevaluation software (GE healthcare). Kinetic analysis 
between wild type Sgt2-N and Get5-UBL was performed using Kaleidagraph (Synergy 
Software). The slope values ks at each concentration were determined by linear regression 
fitting of the association phase to the integrated 1st-order rate equation. Values of ks were 
plotted against concentration and the association rate kon was determined from the linear 
fit to equation (1). 
ks = kon × [Sgt2-N] + koff         (1) 
This fit results in a koff of 3.9 s-1, but since this may not accurately be determined by this 
method (Karlsson et al., 1991), we additionally estimate koff using the equilibrium 
dissociation constant as the ratio of koff to kon.  
NMR data collection 
All data for Sgt2-N, Get5-UBL and two complex samples were collected using a Varian 
INOVA 600 MHz spectrometer with a triple resonance probe with the following 
exceptions: HNCACB spectra of Sgt2-N and the labeled Get5-UBL complex, 15N-edited 
NOESY-HSQC spectra of Sgt2-N and the labeled Get5-UBL complex, and a 13C-edited 
NOESY-HSQC spectrum of the labeled Get5-UBL complex were collected using a 
Bruker AVANCE 800 MHz spectrometer with a TCI cryoprobe. Data for the free 
	  	  
162 
proteins were collected at 25°C, and data for the complexes were collected at either 25°C 
or 37°C. Chemical shift assignments were made using standard triple resonance 
experiments (Sattler et al., 1999), including 1H-15N HSQC, HNCACB, HNCO, 
(H)C(CO)NH-TOCSY, CBCA(CO)NH, (H)CCH-TOCSY, H(C)CH-COSY, H(C)CH-
TOCSY, 15N-edited TOCSY-HSQC, and aliphatic or aromatic 1H-13C HSQC. Distance 
constraints were derived from 15N- or 13C-edited NOESY-HSQC spectra. Data were 
processed using NMRPipe (Delaglio et al., 1995) and analyzed using CCPNMR 
(Vranken et al., 2005). Residual dipolar couplings (RDCs) 1DHN-N were measured by 
comparing 15N-edited IPAP-HSQC spectra of unaligned samples to samples partially 
aligned in either 7% (Sgt2-N alone) or 3.5% (complexes) strained polyacrylamide gel 
(Chou et al., 2001). To make the alignment within the two complex samples as similar as 
possible, the same stock of acrylamide solution was used to cast both gels. The gels were 
compressed using the same NMR tube, and data collection began within an hour of either 
sample preparation. Main chain dihedral angle restraints were predicted from chemical 
shifts by the program TALOS+ (Shen et al., 2009). The proline conformations were 
analyzed from chemical shifts by the program PROMEGA (Shen and Bax, 2010) Pro84 
is the only proline with chemical shifts indicating a cis conformation. 
Exchange rates between free Get5-UBL and protein in complex with Sgt2-N were 
determined using three-dimensional EXSY spectra, collected using the standard 15N-
edited NOESY-HSQC pulse sequence. The sample consisted of 400 µM 15N-labeled 
Get5-UBL and 200 µM unlabeled Sgt2-N homodimer in 10 mM phosphate, 100 mM 
NaCl pH 6.1. Mixing times were either 60 or 120 ms for the exchange experiments and 6 
ms mixing time for the reference experiment. Rates were then determined using 
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EXSYCALC (Mestrelab Research) using a side chain amide proton of Gln82 and the 
main chain amide proton of Asn129. The numbers provided in the main text are the 
average of four values obtained from either proton at both 60 ms and 120 ms mixing 
times. The binding reaction and the measured rates are described by equation 2. 
Sgt2-N + Get5-UBL 
koff,NMR
kon,apparent
Sgt2-N/Get5-UBL                            (2) 
The measured association rate determined by EXSYCALC, kon,apparent, is related to the 
rate constant kon,NMR according to equation 3. The dissociation constant Kd is defined by 
equation 4. 
               kon,apparent = kon,NMR × [Sgt2-N]                                          (3) 
        Kd = 
!"#$!!   ×  [!"#$!!"#][!"#$!!/!"#$!!"#] =    !!"",!"#!!",!"#                                        (4) 
Under the conditions used in the EXSY experiment, [Get5-UBL] is approximately equal 
to [Sgt2-N/Get5-UBL] and can be removed from equation 3. Thus kon,apparent becomes the 
product of Kd and kon,NMR, and is expected to be equal to koff,NMR (equation 5). 
              kon,apparent = kon,NMR × Kd = koff,NMR                                                      (5) 
Structure calculation of Sgt2-N and Get5-UBL 
The assignments of the NOESY spectra were performed automatically during structure 
calculation using the ambiguous restraints with iterative assignment method in ARIA2.3 
(Rieping et al., 2007). The initial rounds of structure calculation for Sgt2-N or Get5-UBL 
used only NOE-derived distance restraints and main-chain dihedral angle restraints. For 
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Sgt2-N, every NOE cross peak was initially treated ambiguously as inter- or 
intramolecular between the two symmetric subunits. Secondary structure was predicted 
from backbone dihedral angles, and constraints on possible NOE assignment imposed by 
helices were used to generate an initial set of unambiguous intermolecular contacts 
(Bardiaux et al., 2009). A 15N-filtered, 13C-edit NOESY-HSQC spectra of Sgt2-N in the 
presence of 2 equivalents of natural abundance protein was collected to observe 
unambiguous intermolecular contacts. While these validated the structures, they were not 
required for calculation convergence. The initial structures were used to assign main-
chain hydrogen bond restraints between amide protons and carbonyl oxygens that were 
within 3.3 Å and satisfied expected helix or sheet geometry. The magnitudes (Da) and 
rhombicities (R) of the gel alignment tensors were determined from initial structural 
models and 1DHN-N values using PALES (Zweckstetter and Bax, 2000). Hydrogen bond 
and RDCs were incorporated in subsequent structure calculations. In the final 
calculations 100 structures were generated, and the lowest 10 energy structures were 
selected for further refinement in an explicit water environment (Linge et al., 2003). 
Statistics for solution structure calculations are provided in Table 4.1.  
Calculation of the complex between Sgt2-N and Get5-UBL 
Chemical shift changes between free Sgt2-N or Get5-UBL and the proteins while in 
complex were quantified using the method described by Ayed et al. (2001). For each 
main chain cross peak that could be clearly resolved on 1H-15N HSQC spectra collected at 
25°C, changes in the 1H and 15N dimensions were recorded. The combined chemical shift 




              CSP =    ∆𝛿!! + 0.15 ∗ ∆𝛿!!                                               (6) 
Symmetry within the Sgt2-N dimer is disrupted while in complex with Get5-UBL, and 
for a subset of residues two chemical shift distances were determined, as indicated in 
Figure 4.8 and Figure 4.9A.  
Although we could resolve this in the two-dimensional HSQC experiments, we were 
unable perform complete chemical assignment at 25°C due to signal degradation from 
line broadening. Instead, we collected data at 37°C, significantly improving data quality. 
This also acted to average two states of Sgt2-N for all residues. We therefore artificially 
treated the protein as symmetric during assignment. The 2D 15N-edited HSQC, 15N- or 
13C-edited NOESY-HSQC and 15N-edited TOCSY-HSQC spectra were sufficient to 
reassign main chain and side chain atoms of the helical regions using the data for the free 
protein as a reference. TALOS+ predicted secondary structure and dihedral angles were 
similar to free protein. The structure of Sgt2-N while in complex with Get5-UBL was 
determined using the same protocol as for the free protein, again imposing symmetry. We 
later rely on the Get5-UBL structure to break the symmetry in complex. Statistics for 
solution structure calculations are provided in Table 4.3. Compared to the free structure 
of Sgt2-N, the second helices are slightly arched away from the 2-fold symmetry axis 
(Figure 4.9B).   
We used 1H-15N and 1H-13C HSQC, HNCACB, HNCO, H(C)CH-TOCSY and (H)CCH-
TOCSY spectra to assign chemical shifts for labeled Get5-UBL in complex in natural 
abundance Sgt2-N. We calculated a structure of Get5-UBL in complex using the same 
protocol as described for the free protein. Statistics for solution structure calculations are 
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provided in Table 4.3. There are very little structural differences between the structure of 
Get5-UBL in complex and the crystal and solution structures of free Get5-UBL (Figure 
4.9C). 
We were unable to obtain usable signal on isotope filtered and edited NOESY-HSQC to 
use to assign unambiguous intermolecular NOEs. We instead identified 14 intermolecular 
NOE cross peaks from the 15N- and 13C-edited NOESY-HSQC spectra of the labeled 
Get5-UBL complex. These were cross peaks that could not be explained by the structure 
of Get5-UBL and had chemical shifts matching residues on helix 2 of Sgt2-N. They were 
all between residues that showed chemical shift perturbation or loss of binding affinity 
upon mutation. Only contacts between the main chain or side chain protons of Get5 and 
the main chain amide proton of Sgt2-N were considered, as the amide proton regions of 
the spectra were less crowded than the methylene or methyl proton regions. These NOE 
cross peaks were converted to distance constraints with upper bounds of 6 Å and were 
ambiguous between the two subunits of Sgt2-N.  
We used these constraints as well as residual dipolar couplings and Ambiguous 
Interaction Restraints (AIRs) as input into HADDOCK to calculate a structure of the 
complex (De Vries et al., 2007; Dominguez et al., 2003). AIRs are defined on the level of 
residues based upon chemical shift perturbation, mutagenesis and solvent accessibility. 
Interacting residues are designated as active or passive. A restraint is satisfied if any atom 
from an active residue of one protein falls is within 2 Å of any atom of an active or 
passive restraint on the second protein. Rigid body docking generates an initial set of 
1000 structures, and the 200 lowest energy structures are selected for semi-flexible 
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refinement followed by refinement in explicit solvent. One-half of AIRs are randomly 
deactivated in each structure generated. Since we artificially treated Sgt2-N as symmetric 
while interpreting data, we relied on Get5-UBL to explain asymmetry. We implemented 
this by designating interacting Sgt2-N residues as passive only (Asp31, Val35, and Cys39 
on either subunit). Conversely, all interacting Get5-UBL residues were designated active 
(Lys79, Ile81, Lys118, Leu120, Lys122, Gly123, Lys124, Val125, Thr145, Met147). 
Dihedral and hydrogen bond restraints were also included in the docking calculations to 
preserve geometry during the semi-flexible refinement. Results of the docking calculation 
are presented in Table 4.4.   
Crystallization, data collection and structure determination of SGTA-N and Get5-
UBL 
 Sitting drop vapor diffusion crystallization trials were set up using commercially 
available screens (Hampton Research, Qiagen) and a Mosquito liquid handling robot 
(TTP Labtech). In each condition, 100 nl of protein solution were mixed with 100 nl of 
reservoir solution. Crystals of SGTA-N appeared in 45% 2-methyl-2,4-pentanediol, 0.2M 
ammonium acetate and 0.1 M Tris pH 8.5 at 4°C after two days. Additional crystals, 
corresponding to either single or double covalent adducts between Cys38 and β-
mercaptoethanol, grew after 3 weeks at 4°C in 10% 2-propanol, 0.1 M sodium citrate and 
26% PEG 400 pH 5.0. Crystals from either condition were plates with dimensions of 
approximately 10 × 20 microns. Clusters of crystals of Get5-UBL were initially observed 
overnight in 2.4 M sodium malonate pH 7.0 at 37°C. To slow down the vapor diffusion, a 
layer of 300 µl 1:1 paraffin oil to silicon oil was layered over the 200 µl of reservoir 
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solution.  After 5 days, single microcrystals appeared that were approximately 1–2 
microns across.  
All crystals were flash frozen in liquid nitrogen directly from crystallization drops. 
Diffraction data were collected on beam line 12-2 at the Stanford Synchrotron Radiation 
Lightsource (SSRL) at 100 K using a Pilatus 6M detector and a microbeam. Crystals 
were located within cryoloops using an automated X-ray raster protocol. Datasets were 
collected from single crystals, integrated with XDS, and merged and scaled using 
AIMLESS (Evans, 2006; Kabsch, 2010). Phase information was recovered for crystals of 
SGTA or Get5-UBL by molecular replacement using the respective solution structures as 
a search models. Molecular replacement was performed using PHASER as implemented 
in PHENIX (Adams et al., 2010; McCoy et al., 2007). The Get5-UBL crystals contained 
three copies of the protein in the asymmetric unit. The complete sequence of the Get5-
UBL protein could be modeled in each copy.  All SGTA-N crystals contained a single 
homodimer in the asymmetric units. The 2.4 Å resolution structure has both Cys38 
sulfhydryl groups reduced and is used for structural comparisons in the text. Residues 4–
49 and residues 4–48 could be modeled for either subunit, with the last 5 or 6 residues of 
the C-terminus disordered. Two molecules of MPD are associated with the hydrophobic 
face of the four-helix bundle. 
The other two crystals show a covalent modification at one or both copies of Cys38 
(Figure 4.2E). We modeled this modification as a covalent adduct with β-
mercaptoethanol present in the buffer. It is notable that these crystals appeared after the 
sample aged for several weeks, while the reduced crystals appeared within days of 
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sample preparation. The modification results in the most C-terminal residues, which are 
disordered in the reduced structure, folding over the conserved binding face and 
interacting with the hydroxyl group of the β-mercaptothanol adduct. The entire sequence 
could be modeled for subunits with the modification. Reciprocal space refinement was 
performed using PHENIX and manual rebuilding using COOT (Emsley et al., 2010). 
Statistics for data collection and model refinement are presented in Table 4.2. 
Structure analysis and figures 
Cartoon representations of protein structures were prepared using PyMol (Schrodinger, 
LLC), while surface representations were prepared using UCSF Chimera (Pettersen et al., 
2004). Surface hydrophobicity was determined in Chimera using the scale of Kyte and 
Doolittle (1982) for individual residues. Electrostatic surface potentials were calculated 
using APBS with default values as implemented in the PDB2PQR webserver (Baker et 
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THE COMPLEX PROCESS OF GETTING TAIL-ANCHORED MEMBRANE 
PROTEINS TO THE ER 
Abstract 
Biosynthesis of membrane proteins requires that hydrophobic transmembrane (TM) 
regions be shielded from the cytoplasm while being directed to the correct membrane. 
Tail-anchored (TA) membrane proteins, characterized by a single C-terminal TM, pose 
an additional level of complexity because they must be post-translationally targeted. In 
eukaryotes, the GET pathway shuttles TA proteins to the endoplasmic reticulum. The key 
proteins required in yeast (Sgt2 and Get1–5) have been under extensive structural and 
biochemical investigation during recent years. The central protein Get3 utilizes 
nucleotide linked conformational changes to facilitate substrate loading and targeting. 
Here we analyze this complex process from a structural perspective, as understood in 
yeast, and further postulate on similar pathways in other domains of life. 
Adapted from 
Chartron, J.W., Clemons, W.M., Jr., and Suloway, C.J. (2012). The complex process of 




Delivery of membrane proteins to the proper membrane is a critical process that is highly 
regulated. The field of protein targeting has recently added a new pathway involved in 
targeting the special class of tail-anchored (TA) membrane proteins to the ER. After the 
initial discovery of proteins involved in this pathway a wealth of genetics, biochemistry 
and structural information has rapidly elucidated a complex process of handoffs of the 
TA substrate. The pathway starts by transfer of the substrate to the Get4/Get5/Sgt2 
sorting complex that then loads the TA onto the targeting chaperone Get3, which is 
subsequently released at the membrane by the Get1/Get2 receptor complex. While recent 
reviews describe these initial characterizations (Hegde and Keenan, 2011; Shao and 
Hegde, 2011), in this review we will summarize the current state of the field from a 
structural perspective and more broadly comment on the possibility of similar pathways 
beyond fungi. Figure A.1 is an overall model of TA protein targeting, including the 
various ambiguities in certain steps, which will be referred to throughout the text. 
Structural changes in the Get3 molecular machine 
The general structure and mechanism of Get3, which we briefly summarize here, has 
been recently reviewed (Hegde and Keenan, 2011; Simpson et al., 2010). Get3 is a 
nucleotide hydrolase that modulates its conformation through nucleotide state. Similar to 
other SIMIBI class NTPases (named for representative members signal recognition 
particle, MinD andBioD), Get3 forms a homodimer through interactions between the 
nucleotide hydrolase domains (NHD) (Leipe et al., 2002). The subunits rotate relative to 
each other from an open state in apo form or bound to ADP to a more compact closed 




Figure A.1. A model for TA targeting by the GET pathway. After protein synthesis is 
complete, a complex consisting of cellular chaperones, two copies each of Get4 and Get5 
and at least one dimer of Sgt2 binds the TM helix of TA proteins. The Get4/Get5 
complex recruits Get3, and Sgt2 transfers ER destined TA proteins to Get3. Each Get4 
may bind a separate dimer of Get3, or the same dimer (boxed). The Get3/TA protein 
complex may contain two or four copies of Get3. The stoichiometry of the Get1/Get2 
complex within the ER membrane is unknown but is shown here as a dimer of 1:1 Get1 
to Get2 dimers. Initially Get2 binds the Get3/TA protein complex and is then displaced 
by Get1. Get1 binding is coupled to the opening of Get3, leading to release and 
integration of the TA protein. In the case of a dimeric Get3/TA complex, Get1 and Get2 
could bind the Get3 subunits symmetrically (left pathway). Alternatively, Get2 and Get1 
could bind a tetramer of Get3 asymmetrically (right pathway). 
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hydrophobic groove from α-helices connected to the NHD (Bozkurt et al., 2009; Hu et 
al., 2009; Suloway et al., 2009; Yamagata et al., 2010). 
There are three models for how Get3 sequesters a TA protein predominantly based on 
structures (Figure A.2A,B). The first two models are based on a dimer of Get3, which is 
the dominant form of purified fungal Get3. In the prevailing model, an α-helical TA is 
captured by the hydrophobic groove formed by the closed Get3 dimer (Mateja et al., 
2009) (Figure A.2D). The alternative dimer model posits that pairs of amphipathic α-
helices extending out from either side of the groove bind the TA through a hydrophobic 
patch (Yamagata et al., 2010). The third model correlates the observation that 
heterologously purified Get3/TA complexes contain four copies of Get3 with the 
structure of a tetrameric archaeal homolog. In this model, the TA would be sequestered in 
a hydrophobic chamber formed by the grooves of opposing dimers (Figure A.2E 
and Figure A.3) (Suloway et al., 2012). In all models, similar residues mediate potential 
TA interactions. The importance of these regions in TA binding has been shown through 
various mutagenesis experiments (Mateja et al., 2009; Suloway et al., 2009; Yamagata et 
al., 2010). Additionally, changes in these regions upon TA binding have been 
demonstrated through hydrogen exchange mass spectrometry of Get3 complexed with 
TA protein (Bozkurt et al., 2009). In general, results from biochemical experiments are 
compatible with both dimer and tetramer models. The simplicity of the dimer model is 
consistent with structures seen in complex with partners (see below) and binding of 
functionalized TA substrates (Leznicki et al., 2011). The tetramer model allows for 




Figure A.2. Conformations of Get3 and models for TA binding. (A) Open form 
structures of Get3 in a cartoon representation aligned by the right subunit, using PDB 
IDs 3A36 (purple), 3H84 (blue) and 2WOO (pink). (B) Closed form structures shown as 
in (A), using PDB IDs 3IQW (purple), 3IO3 (blue) and 2WOJ (pink). (C) The NHD of 
aligned Get3 structures from one subunit. Motifs are indicated with arrowheads and 
labeled A (A-loop), P (P-loop), I (switch I) and II (switch II). Structures are colored 
according to the nucleotide bound with white for no nucleotide (PDB ID: 3A36, PDB 
ID: 2WOO, PDB ID: 3SJA and PDB ID: 3SJC), green for ADP (PDB ID: 3IQX and PDB 
ID: 3SJD), cyan for ADP·AlF4− (PDB ID: 2WOJ, PDB ID: 3ZQ6 and PDB ID: 3ZS9) 
and blue for AMPPNP (PDB ID: 3IQW). (D) A model for TA binding by the Get3 dimer. 
Get3 (PDB ID: 2WOJ) is shown in a surface representation colored hydrophobic (green), 
positively (blue) and negatively charged (red). A cartoon representation of a TA from 
Secβ (PDB ID: 1RHZ), colored pink, is shown in the groove formed in the closed 
structure of Get3. The inset shows a cartoon representation of Get3 with the left subunit 
colored ramped and the right subunit in gray. (E) A TA binding model for a tetramer of 
Get3 (Suloway et al., 2012) represented as in (D). The structure of tetrameric Get3 (PDB 
ID: 3UG6) is cut away to show the central cavity with a TA modeled inside, similar to 




Figure A.3. Structures of Get3 tetramers. (A) Tetrameric MjGet3 (PDB ID: 3UG6) 
shown in a cartoon representation with one subunit color ramped from N to C-terminus 
and additional subunits colored gray, blue and green. (B) A crystallographic tetramer 




disassembly steps, yet agrees with complexes analyzed in solution (Bozkurt et al., 2009; 
Favaloro et al., 2010; Suloway et al., 2012). The oligomeric state of Get3 in the native 
TA complex remains a subject for future study. 
Many nucleotide hydrolases are molecular machines that act as switches, utilizing 
nucleotide state and the energy of hydrolysis to alter their conformation with a broad 
spectrum of functionality from signaling interactions to actively driving processes. The 
Get3 homodimer uses ATP hydrolysis to switch between open and closed conformations 
during its targeting cycle (Figure A.2A,B). Related SIMIBI class NTPases in the 
MinD/Mrp family (Leipe et al., 2002) switch by changes in dimer conformation like Get3 
(NifH and ArsA pseudodimer) or convert between monomeric and dimeric states (MinD 
and Soj) (Lutkenhaus and Sundaramoorthy, 2003). Changes from open and closed dimer 
states were originally seen for NifH (Schindelin et al., 1997) and have been modeled for 
ArsA (Ajees et al., 2011). 
In SIMIBI proteins, nucleotide induced conformational changes control interactions with 
protein factors. For Get3, this involves ferrying the TA substrate from the sorting 
complex (Sgt2/Get4/5) to the membrane receptor (Get1/2) (see below). This is analogous 
to ArsA that receives arsenite from ArsD and then exports through the membrane protein 
ArsB (Lin et al., 2007). NifH switches between a MoFe bound state ferrying electrons 
along the nitrogenase cycle (Burgess and Lowe, 1996). In the best characterized of these 
cases, in addition to rotation across the dimer interface, the switch II loop alters its 
conformation among different nucleotide states (Figure A.2C and Figure A.4). This loop 




Figure A.4. Conformations of the NHDs of NifH and ParA in different nucleotide 
states. (A) A structural alignment of NifH NHDs represented as in Figure A.2C. Apo 
(PDB ID: 2AFH), ADP bound (PDB ID: 2AFI), ADP·AlF4− bound (PDB ID: 1M34) and 
AMPPCP bound (PDB ID: 2AFK) forms are shown. (B) As in (A) for ParA structures. 
Apo (PDB ID:3EZ7, PDB ID: 3EZ9, PDB ID: 3EZF), ADP bound (PDB ID: 3CWQ, 




switch II is linked to α6, which is connected to the putative substrate-binding groove 
(Figure A.2C). Therefore, the nucleotide state can modulate transitions associated with 
TA-binding. Similar switch II conformational changes occur during the NifH and ParA 
nucleotide cycle (Figure A.3). 
The ArsA fold 
Get3 belongs to a subset of the SIMIBI family of proteins characterized by the first 
member ArsA. ArsA contains two NHDs linked together forming a pseudodimer (Figure 
A.5A) (Zhou et al., 2000). In the first structure, substrate antimony atoms bind in a 
groove formed by two loops that extended from the NHD, linking the nucleotide-binding 
pocket to liganding cysteines and histidines (Figure A.5B). ATP hydrolysis is proposed to 
induce conformational changes that coordinate the release of the toxic metals to the ArsB 
exporter. Interestingly, the two halves have only 26% identity, and this asymmetry 
appears to play a functional role (Fu et al., 2010). The substrate-binding groove appears 
to be a unique identifier for this family (Figure A.5A,B).  
Fungal Get3 has approximately 25% identity to each half of ArsA; therefore, based on 
homology alone, distinguishing an ArsA from a Get3 is difficult. In most genomic 
annotations members of this fold family are identified as ArsA homologs. Several key 
differences to distinguish Get3 from ArsA have been identified. The simplest is that Get3 
is a homodimer. Instead of containing the ArsA metal ligand residues (Boskovic et al., 
1996; Stefanovic and Hegde, 2007), Get3 homologs contain a unique “Get3 motif” 
insertion (Mateja et al., 2009) (Figure A.5C). Moreover, Get3 homologs typically contain 








presumably to stabilize the dimer, analogous to the ArsA linker (Metz et al., 2006; 
Stefanovic and Hegde, 2007).9 
Archaea contain both ArsA and Get3 homologs (Borgese and Righi, 2010). Only about 
half of the sequenced genomes contain the Get3 homolog and half of these lack the 
CXXC motif (Suloway et al., 2012). While the role of the ArsA homolog is likely similar 
to that in eubacteria, the presence of a Get3 homolog suggests membrane protein 
targeting occurs. Indeed, in heterologous systems archaeal Get3 can form complexes with 
a variety of TA proteins and in one case facilitates insertion (Sherrill et al., 2011; 
Suloway et al., 2012). This implies a unique pathway, as other GET pathway members 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Figure A.5. Members of the Get3/ArsA fold family. (A) Cartoon representations of 
dimers of members of the ArsA fold viewed down the putative TA binding groove. The 
structures are the transition state S. cerevisiae Get3 (PDB ID:2WOJ), the archaeal M. 
jannaschii (PDB ID: 3UG6, monomers color ramped) and M. thermoautotropicum Get3s 
(PDB ID: 3ZQ6, monomers light blue/pink), E. coli ArsA (PDB ID: 1F48, each 
pseudodimer color ramped with the helix filling the groove in brown), and the 
cyanobacterial homolog Nostoc sp. all4481 (PDB ID: 3IGF, monomers color ramped). 
The human α-crystallin structure (PDB ID: 2WJ7) has been aligned in gray to the 
equivalent cyanobacterial domain. Metals are shown as spheres and nucleotides as sticks. 
(B) Surface representations of the structures in (A) rotated 90° with residues colored as 
in figure A.2D. Some foreground residues have been removed for clarity and the 
truncation is colored gray. MjGet3 is shown for the archaeal homologs and the loop 
filling the groove has been removed in the ArsA surface calculation to show the 
comparable groove. (C) An alignment of notable regions of the ArsA family proteins 
from ClustalW. Numbering and region names are based on the S. cerevisiae protein 
similar to figure A.2C. A black bar identifies residues corresponding to α8. The 
sequences are ScGet3 (S. cerevisiae UniProt ID: Q12154), HsTRC40 (Homo 
sapiens UniProt ID: O43681), MjGet3 (Methanocaldococcus jannaschii UniProt 
ID: Q58542), MtGet3 (Methanobacter thermoautotropicum UniProt ID: O27555) CtAFP 
(Chlorobium tepidum UniProt ID: Q46366), NosAFP (Nostoc sp. PCC 7120 UniProt 
ID: Q8YNT0), SynAFP (Synechocystis sp. PCC 6803 UniProt ID: F7UTP7), AthAFP 
(Arabidopsis thaliana UniProt ID: Q6DYE4), PtriAFP (Populus trichocarpa or 
California poplar UniProt ID: B9HWM7) and EcArsA (E. coli plasmid R773 N-terminal 
and C-terminal domains UniProt ID: P08690). Numbers to the right are percentage 
identity to ScGet3 excluding crystallin domains. 	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have not been identified. Recent structural studies of the homologs from Methanobacter 
thermoautotripicum (MtGet3) and Methanocaldococcus jannaschii (MjGet3) confirm the 
structural homology of archaeal Get3 to fungal Get3 (Figure A.5A,B) (Sherrill et al., 
2011; Suloway et al., 2012). Both archaeal structures are in the closed form; however, 
unlike fungal Get3 homologs the substrate binding loops are ordered and extended. 
In MjGet3 this results in a tetramer, a dimer of dimers, with a closed hydrophobic 
chamber stabilized by α8 (Figure A.2E and Figure A.3) (Suloway et al., 2012). Moreover, 
of the archaeal homologs where oligomeric state was analyzed, all are capable of forming 
stable tetramers in solution including the Thermococcus kodakaerensis homolog, which 
lacks the CXXC motif and is competent for TA binding (Suloway et al., 2012). 
Looking more broadly at sequence homology a third class of this fold family becomes 
apparent. Here, the fold is found in photosynthetic organisms. For clarity, we will refer to 
members of this protein class as the “ArsA family Fold associated with Photosynthesis” 
or AFP. They can be found in green sulfur bacteria, cyanobacteria and are nuclear 
encoded with chloroplast-targeting signals in plants. Each of these organisms is 
characterized by photosynthetic machinery in specialized membranes, either the 
chlorosome or thylakoid (Hohmann-Marriott and Blankenship, 2011). A recent structure 
from this class, all4481 from the cyanobacteria Nostoc sp. PCC 7120 (NosAFP), was 
deposited by the Northeast Structural Genomics Consortium. The structure reveals a 
closed Get3-like fold containing the hydrophobic groove but lacking the nucleotide-
binding pocket (Figure A.5A,B). A small heat shock protein (HSP)/crystallin domain is 
appended to the C-terminus that contacts the Get3 surface used in yeast for partner 
recognition (see below). The remarkable structural similarity of NosAFP is not evident 
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from the low sequence identity (9%) to ScGet3; however, similar homologs such as that 
from the green sulfur bacteria Chlorobium tepidum (CtAFP) have higher identity (28%) 
and appear to include the nucleotide-binding pocket (Figure A.5C). The conservation of 
the AFP class from ancient photosynthetic organisms to modern plants suggests a critical 
role in biosynthesis of the photosynthetic membranes. It will be exciting to see if there is 
a role for this protein in protein targeting to membranes. 
Get1 and Get2 regulate membrane insertion steps 
The integral membrane proteins Get1 and Get2 form the ER membrane bound complex 
required for TA-insertion by Get3 (Schuldiner et al., 2008); however, only a homolog for 
Get1 has been found in higher eukaryotes (Vilardi et al., 2011). Both proteins have single 
cytoplasmic domains that can bind Get3 in the absence of the membrane components. 
The Get1 cytoplasmic domain, which connects the first and second transmembrane 
helices, is a coiled-coil motif that extends between the subunits of a Get3 dimer 
(Mariappan et al., 2011; Stefer et al., 2011) (Figure A.6A). A portion of Get1 binds at a 
groove on the surface of Get3 formed by α10 and α11. At the other Get3 subunit, Get1 
extends into the nucleotide-binding pocket, preventing ATP or ADP from binding (Figure 
A.6A,C,D). Get3 is in an open or semi-open conformation, with Get1 acting as a wedge 
that would block a complete transition to the closed state. Nearly the entire cytoplasmic 
loop is modeled in these structures; therefore, bound Get3 must be in close proximity to 




Figure A.6. Interactions between Get3 and other GET pathway members. (A) 
Crystal structure of Get3 in complex with the Get1 cytoplasmic domain (blue) (PDB 
ID 3ZS8). One Get3 subunit is gray and the other pale blue. (B) Crystal structure of Get3 
in complex with the Get2 cytoplasmic domain (red) (PDB ID: 3SJD). (C) Surface 
rendering of open Get3 (PDB ID: 3A36). Regions where Get1 (blue) and Get2 (red) 
interact with the gray subunit are highlighted, with the overlapping region in magenta. 
(D) Close-up of Get3 α10 and α11, colored as in (C). The expected Get4 binding 
interface is indicated with a dotted line. (E) Model of the structure of Sgt2. Two copies of 
the TPR domain (PDB ID: 3SZ7) are displayed over a cartoon of a SAXS model of the 
N-terminal dimerization and TPR domains (gray, adapted from Chartron et al., 2011). 
The additional 107 residues of the C-terminal domains rotate freely from the TPR and a 
potential range of motion is indicated with dotted lines. (F) Structure of the Get4/Get5 
heterotetramer. Residues shown to be critical for Get3 interaction are shown as spheres 
(Chartron et al., 2010). Subunits are arranged based upon SAXS models (Chartron et al., 
2012b). One copy of Get4 is color ramped from N-termini (blue) to C-termini (red). One 
copy of Get5 is colored magenta and the remaining Get4 and Get5 subunits are gray. 
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 The cytoplasmic domain of Get2 consists of the N-terminus of the protein. Overall 
sequence conservation is poor, with the exception of the first 35 amino acids that are 
sufficient to bind Get3 (Mariappan et al., 2011; Stefer et al., 2011). This region forms two 
helices that wrap along the outer surface of Get3, including the groove where Get1 
interacts (Figure A.6B–D). Unlike Get1, the ordered portions of Get2 do not contact both 
subunits of Get3. With bound Mg2+ADP·AlF4−, Get3 is nearly identical to previous 
transition state structures (Bozkurt et al., 2009; Mariappan et al., 2011; Mateja et al., 
2009). A second structure containing Mg2+ADP also is a closed Get3 dimer (Stefer et al., 
2011). Despite this, helices that line the TA protein-binding site are in conformations 
similar to open structures, although resolution limited the extent of modeling and 
refinement (Figure A.3). Intriguingly, in both structures the surface of Get3 that interacts 
with Get2 is unperturbed relative to Get3 alone. Since Get2 does not contact the TA 
protein binding loops or the nucleotide-binding pocket, it is unclear why a closed 
conformation of Get3 would be selected. It is also noteworthy that in the Mg2+ADP 
bound structure a crystallographic axis relates a second Get3 dimer into an arrangement 
similar to the M. jannaschii tetramer (Suloway et al., 2012) (Figure A.3). 
The structures of Get1 and Get2 and other biochemical data led to a general model for 
events at the membrane (Mariappan et al., 2011; Stefer et al., 2011; Wang et al., 2010) 
(Figure A.1). The flexible cytoplasmic domain of Get2 initially captures the Get3/TA 
protein complex. As Get3 approaches the membrane, Get1 first displaces Get2 and then 
facilitates a transition from closed to open Get3. This corresponds with integration of the 
TA protein into the membrane and release of bound nucleotide. ATP then displaces Get1, 
releasing Get3 from the membrane complex. The exact nature, however, of the 
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Get1/Get2/Get3 complex at the membrane remains to be determined and is crucial for 
understanding the mechanism of insertion. Without a clear structural explanation for state 
selectivity for Get2, it is not obvious how the Get3/TA protein complex is favored from 
free Get3 or how immediate rebinding after an insertion cycle is prevented. Uncertainty 
about the stoichiometry of Get1 and Get2 results in alternative models of Get1 and Get2 
binding at different subunits of dimeric or tetrameric Get3. Finally, the biophysical 
mechanism of TA protein insertion into the membrane and the requirements of Get3 or 
full-length Get1 and Get2, in this process are largely unknown. 
Sgt2, Get4 and Get5 load Get3 with TA protein 
The HSP co-chaperone Sgt2 mediates the committed step in TA protein targeting. It 
recruits a variety of HSP families via an internal tetratricopeptide repeat (TPR) domain 
(Chartron et al., 2011; Wang et al., 2010). The Sgt2 C-terminal domain binds the 
transmembrane helix of ER destined TA proteins, which are then handed to Get3 (Wang 
et al., 2010; Wang et al., 2011). In contrast, mitochondrial TA proteins remain associated 
with bound HSPs. This domain, rich in glutamine, methionine and asparagine, contains 
only a short conserved sequence and is weakly predicted as helical. The mechanism of 
TA protein selection and handoff to Get3 are, therefore, intriguing problems. Sgt2 is a 
homodimer mediated by its small N-terminal domain, and the TPR and C-terminal 
domains of the two subunits extend away from each other (Chartron et al., 2011) (Figure 
A.6E). The N-terminal domain also mediates the association with Get5, where a dimer of 
Sgt2 binds a single copy of Get5 (Chang et al., 2010; Chartron et al., 2011). 
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Get4 and Get5 act as an adaptor complex linking Sgt2 to Get3. Get4 is an alpha helical 
repeat protein that tightly binds to the N-terminal domain of Get5 (Bozkurt et al., 2010; 
Chang et al., 2010; Chartron et al., 2010). The Get5 sequence is followed by a ubiquitin-
like domain (Ubl) and a C-terminal homodimerization domain, resulting in an extended 
heterotetrameric complex (Chartron et al., 2010; Chartron et al., 2012b) (Figure A.6F). 
The N-terminal face of Get4 is a conserved basic surface that mediates interaction with 
Get3 (Chang et al., 2010; Chang et al., 2012; Chartron et al., 2010). Although a high-
resolution structure of this complex remains to be determined, mutagenesis and molecular 
modeling indicate that, like Get1 and Get2, Get4 binds Get3 at α10 and α11 (Figure 
A.6D). The in vivo stoichiometry, however, has not been established. In order for a single 
Get4/Get5 heterotetramer to bind both subunits of a Get3 dimer, as it has been proposed 
(Chang et al., 2012; Chartron et al., 2010), the Ubl and C-terminal domains of Get5 
would either thread through the TA binding groove of Get3 or wrap around the NHDs, 
possibly positioning Sgt2 away from the TA protein binding groove. If the two Get4 
copies bind independent Get3 dimers, the Sgt2/TA protein complex could be more 
accessible to Get3. This model also provides a framework for Get3 to tetramerize upon 
TA protein capture (Figure A.1) (Chartron et al., 2012b). 
A complex analogous to Get4/Get5/Sgt2 appears to exist in vertebrates although with 
some differences in architecture and function. The homologs of Get4 and Get5, named 
TRC35 and Ubl4a, bind to Bag6 (alternatively named Bat-3 or Scythe) forming the Bag6 
complex (Mariappan et al., 2010). Bag6 is an approximately 1000-residue protein with an 
N-terminal Ubl domain and a C-terminal Bag domain, with internal proline rich regions. 
SGTA, the homolog of Sgt2, uses its N-terminal domain to associate with Bag6, and 
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although it has not yet been demonstrated experimentally, Ubl4A is expected to bridge 
these proteins (Hegde and Keenan, 2011; Winnefeld et al., 2006). The Bag6 complex not 
only has the ability to load TA proteins onto the Get3 homolog, TRC40 (Leznicki et al., 
2010; Mariappan et al., 2010), but also mediates protein degradation pathways for 
mislocalized membrane proteins, retrotranslocated ER proteins and other defective 
proteins (Hessa et al., 2011; Minami et al., 2010; Wang et al., 2011). Determining how 
the interplay between these functions makes or breaks membrane proteins will provide 
fundamental insight into how TM segments are manipulated by the cell. 
Concluding remarks 
We are rapidly acquiring structural information for all of the components of the TA 
protein-targeting pathway. Careful analysis of analogous systems and components of the 
large and dynamic complexes generate testable models. These are tied together by low-
resolution and biochemical methodologies. Despite recent leaps in understanding, many 
crucial questions remain to be answered. How are TA proteins initially directed towards 
the Get4/Get5/Sgt2 sorting complex? How does this complex recruit Get3 and what is the 
mechanism for handoff? What is the structure of the physiological Get3/TA protein 
complex? How is the TA protein integrated into the membrane? Further afield are 
questions about the functional roles of structurally homologous proteins in other domains 
of life. Clearly, understanding the detailed biosynthesis of this important class of proteins 
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